id,study_name,effect_key,b,s,n,specialty,outcome_group,outcome_flag,outcome_nr,comparison_nr,RCT,study_year,outcome_name,comparison_name,z,gold_answer_GPT4,llama3-8b-8192,llama3-70b-8192,llama-3_1-70b-versatile,mixtral-8x7b-32768,gemma-7b-it,human_response,MV,llama3-8b-8192_cleaned,llama3-70b-8192_cleaned,llama-3_1-70b-versatile_cleaned,mixtral-8x7b-32768_cleaned,gemma-7b-it_cleaned,MV_cleaned,gold_answer_GPT4_cleaned,gemini-1_5-flash-002,gemini-1_5-flash-002_tokens,gemini-1_5-flash-002_logprobs,gemini-1_5-pro-002,gemini-1_5-flash-002_cleaned,gemini-1_5-pro-002_cleaned,meta-llama_Llama-3_2-1B-Instruct,meta-llama_Llama-3_2-1B-Instruct_cleaned,meta-llama_Llama-3_2-3B-Instruct,meta-llama_Llama-3_2-3B-Instruct_cleaned,meta-llama_Llama-3_2-1B-Instruct_probs,meta-llama_Llama-3_2-3B-Instruct_probs,microsoft_Phi-3_5-mini-instruct,google_gemma-2-2b-it,microsoft_Phi-3_5-mini-instruct_cleaned,google_gemma-2-2b-it_cleaned,microsoft_Phi-3_5-mini-instruct_probs,google_gemma-2-2b-it_probs,ibm-granite_granite-3_0-3b-a800m-instruct,ibm-granite_granite-3_0-2b-instruct,ibm-granite_granite-3_0-3b-a800m-instruct_cleaned,ibm-granite_granite-3_0-2b-instruct_cleaned,Qwen_Qwen2_5-3B-Instruct,Qwen_Qwen2_5-3B-Instruct_cleaned,ibm-granite_granite-3_0-3b-a800m-instruct_probs,ibm-granite_granite-3_0-2b-instruct_probs,Qwen_Qwen2_5-3B-Instruct_probs,label,question,question_id,user,status
CD000004,Blecher 1967,STD-Blecher-1967 0.362 0.353 42 38,-1.55227949859415,0.509869905232146,80,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1967.0,Unchanged or worsening pre-eclampsia,Abdominal decompression for suspected fetal compromise/pre-eclampsia,-3.04446189638785,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9981614395267993,"negative
",neg,neg,negative.,neg,negative,neg,0.6767524686179688,0.9711912386663372, negative,"negative 
",neg,neg,0.9465925965321365,0.8122987173222388,neutral. the,negative,neu,neg,negative,neg,0.5738107932693522,0.9734106869597752,0.997212216435396,,"In a medical study on 'Abdominal decompression for suspected fetal compromise/pre-eclampsia', the outcome is 'Unchanged or worsening pre-eclampsia'.",Q0,empty,available
CD000006,Banninger 1978,STD-Banninger-1978 0.441 0.282 80 73,-1.13370360847938,0.379196674468605,153,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1978.0,Short-term pain: pain at day 3 or less (women experiencing any pain),Synthetic sutures versus catgut,-2.9897509256064,negative,neutral,negative,negative.,"negative, as it refers","negative.

pain is",neg,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9947790259105216,"negative
",neg,neg,positive.,pos,negative,neg,0.4820626788760636,0.6145821267845748, negative,"positive 
",neg,pos,0.9764529852884616,0.3419215751723821,neutral. the,positive,neu,pos,negative,neg,0.4493287712861912,0.8660684234373706,0.925684138461235,,"In a medical study on 'Synthetic sutures versus catgut', the outcome is 'Short-term pain: pain at day 3 or less (women experiencing any pain)'.",Q1,empty,available
CD000006,Gemynthe 1996,STD-Gemynthe-1996 1.016 0.035 155 153,0.182521376956474,0.411034252051126,308,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,1996.0,Short-term pain: at 3 days or less,Fast-absorbing synthetic versus standard absorbable synthetic material,0.444053934789288,neutral,neutral,positive,negative,positive,"negative.

short-",neg,negative,neu,pos,neg,pos,neg,neg,neu,"positive
",positive,0.7095214431040864,"negative
",pos,neg,positive.,pos,negative,neg,0.5732691217577432,0.4004550785313112," neutral

","positive 
",neu,pos,0.6162118780038954,0.6954025159048693,positive.,positive,pos,pos,neutral,neu,0.4421186426950932,0.9126908219822424,0.7606852484459687,,"In a medical study on 'Fast-absorbing synthetic versus standard absorbable synthetic material', the outcome is 'Short-term pain: at 3 days or less'.",Q2,empty,available
CD000006,Saint 1993,STD-Saint-1993 0.989 0.026 418 418,-0.0893709058995314,0.211484847970904,836,Pregnancy & Childbirth,efficacy,DICH,1,3,no,1993.0,Short-term pain: pain at 3 days or less,Glycerol impregnated catgut (softgut) versus chromic catgut,-0.422587749226493,negative,neutral,negative,negative.,"negative, because it refers","negative.

pain is",neg,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9977716267183552,"negative
",neg,neg,positive.,pos,negative,neg,0.5068828500558167,0.5036121210338729," neutral

","positive 
",neu,pos,0.5177601785420182,0.4540953493274138,neutral. the,positive,neu,pos,neutral,neu,0.4649094644722193,0.9032541516544592,0.6371375627396078,,"In a medical study on 'Glycerol impregnated catgut (softgut) versus chromic catgut', the outcome is 'Short-term pain: pain at 3 days or less'.",Q3,empty,available
CD000007,Abu Dhabi 1997,STD-Abu-Dhabi-1997 0.529 0.172 827 821,-0.692206245543344,0.18600035093523,1648,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1997.0,PPH clinically estimated blood loss greater than or equal to 500mls,Active vs expectant management (all women),-3.72153193293913,negative,negative,negative,negative.,negative,"negative.

a clinically",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.983214769476174,"negative
",neg,neg,negative.,neg,negative,neg,0.5262995173044033,0.8942198995096511, negative,"negative 
",neg,neg,0.99858936266873,0.5854551496207451,positive.,negative,pos,neg,negative,neg,0.4745139766936262,0.9381382453618512,0.9972793177712732,,"In a medical study on 'Active vs expectant management (all women)', the outcome is 'PPH clinically estimated blood loss greater than or equal to 500mls'.",Q4,empty,available
CD000009,Aycicegi-Dinn 2011,STD-Aycicegi_x002d_Dinn-2011 0.319 1.117 24 23,-1.23837423104327,1.19449219093425,47,Psychiatry & Mental Health,efficacy,DICH,1,8,no,2011.0,Short-term smoking cessation,Electrostimulation vs sham stimulation,-1.03673698366726,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997544718169792,"positive
",pos,pos,positive.,pos,positive,pos,0.6020187943883959,0.6959193309325054, positive,"positive 
",pos,pos,0.977385557863118,0.8574970458563754,positive.,positive,pos,pos,positive,pos,0.5584962183901858,0.5649193281804056,0.991289503841217,,"In a medical study on 'Electrostimulation vs sham stimulation', the outcome is 'Short-term smoking cessation'.",Q5,empty,available
CD000009,Cai 2000,STD-Cai-2000 0.992 0.239 160 170,-0.0101523714640182,0.28942396888688,330,Psychiatry & Mental Health,efficacy,DICH,1,7,no,2000.0,Short-term smoking cessation,Laser therapy vs sham laser,-0.0350778530992579,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.99833854384896,"positive
",pos,pos,positive.,pos,positive,pos,0.5993745785628714,0.6922910242181474, positive,"positive 
",pos,pos,0.7539351313031475,0.8004050235194361,positive.,positive,pos,pos,positive,pos,0.6334800407135508,0.5115270946987318,0.9552059342294836,,"In a medical study on 'Laser therapy vs sham laser', the outcome is 'Short-term smoking cessation'.",Q6,empty,available
CD000009,Clavel 1985,STD-Clavel-1985 0.855 0.189 224 205,-0.197034109841127,0.238346626665503,429,Psychiatry & Mental Health,efficacy,DICH,1,3,no,1985.0,NRT,Acupuncture vs other intervention,-0.82667043623674,neutral,neutral,negative,negative.,"neutral

","neutral.

the outcome",neu,negative,neu,neg,neg,neu,neu,neg,neu,"negative
",negative,0.5578864120259662,"negative
",neg,neg,negative.,neg,neutral,neu,0.3824948539262396,0.5584875300369354, neutral,"neutral 
",neu,neu,0.7802369988071735,0.64102682836046,the outcome ',positive,neg,pos,neutral,neu,0.5070517966962345,0.6040248017340262,0.9951282818196232,,"In a medical study on 'Acupuncture vs other intervention', the outcome is 'NRT'.",Q7,empty,available
CD000009,Clavel 1992,STD-Clavel-1992 0.858 0.182 272 243,-0.189777857470409,0.224675246072811,515,Psychiatry & Mental Health,efficacy,DICH,1,2,no,1990.0,Short-term smoking cessation,Acupuncture vs sham acupuncture,-0.844676308528033,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9991830397938536,"positive
",pos,pos,positive.,pos,positive,pos,0.5791695323472057,0.630319102390486, positive,"positive 
",pos,pos,0.978013317138369,0.7743228589414328,positive. short,positive,pos,pos,positive,pos,0.6368418335393822,0.5044217159640546,0.7530742060207725,,"In a medical study on 'Acupuncture vs sham acupuncture', the outcome is 'Short-term smoking cessation'.",Q8,empty,available
CD000009,Lamontagne 1980,STD-Lamontagne-1980 1.4 0.513 25 25,0.441832752279039,0.669636243353583,50,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1980.0,Short-term smoking cessation,Acupuncture vs waiting list/no intervention,0.659810093411778,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9952069032259776,"positive
",pos,pos,positive.,pos,positive,pos,0.6227105203758098,0.6388757528109473, positive,"positive 
",pos,pos,0.9882975110948288,0.745853400426725,positive. short,positive,pos,pos,positive,pos,0.6017208588543943,0.6348235084315264,0.9962620317234118,,"In a medical study on 'Acupuncture vs waiting list/no intervention', the outcome is 'Short-term smoking cessation'.",Q9,empty,available
CD000009,Li 2009,STD-Li-2009 2.5 0.383 70 70,1.1314021114911,0.459487793372212,140,Psychiatry & Mental Health,efficacy,DICH,1,5,no,2009.0,Short-term smoking cessation,Acupressure vs sham acupressure,2.46231157347547,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.998967702486048,"positive
",pos,pos,positive.,pos,positive,pos,0.6348432414793105,0.7320408184065393, positive,"positive 
",pos,pos,0.9885869383855056,0.828660818747513,positive.,positive,pos,pos,positive,pos,0.5349793433039337,0.598371852987059,0.9648428387891184,,"In a medical study on 'Acupressure vs sham acupressure', the outcome is 'Short-term smoking cessation'.",Q10,empty,available
CD000009,Tian 1996,STD-Tian-1996 13 0.711 60 60,3.09903184339179,0.764927893646039,120,Psychiatry & Mental Health,efficacy,DICH,1,4,no,1996.0,Short-term smoking cessation,Acupressure vs waiting list/no intervention,4.05140388935252,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9991304277272892,"positive
",pos,pos,positive.,pos,positive,pos,0.6516996869142628,0.6875406693987198, positive,"positive 
",pos,pos,0.9928761445211888,0.7742918907373847,positive. short,positive,pos,pos,positive,pos,0.5571595706139916,0.5348859855717868,0.9978728340498506,,"In a medical study on 'Acupressure vs waiting list/no intervention', the outcome is 'Short-term smoking cessation'.",Q11,empty,available
CD000009,Yeh 2009,STD-Yeh-2009 0.967 0.657 30 29,-0.0392207131532814,0.760566590418971,59,Psychiatry & Mental Health,efficacy,DICH,1,6,no,2009.0,Short-term smoking cessation,Continuous auricular stimulation vs sham stimulation,-0.0515677570476452,positive,positive,positive,positive,positive,"positive.

short-",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9954612189403396,"positive
",pos,pos,positive,pos,positive,pos,0.5248462466287288,0.7005587334931423, positive,"positive 
",pos,pos,0.9924210929102314,0.89154362573506,positive.,positive,pos,pos,positive,pos,0.6200818932882838,0.7426893056110495,0.960499184101084,,"In a medical study on 'Continuous auricular stimulation vs sham stimulation', the outcome is 'Short-term smoking cessation'.",Q12,empty,available
CD000010,Kamolratanakul 1999,STD-Kamolratanakul-1999 1.135 0.044 414 422,0.446479824178497,0.154930393353026,836,Infectious Diseases,efficacy,DICH,1,5,no,1999.0,Cure,Active TB: Direct observation of treatment vs self-supervision,2.88180914354966,positive,positive,positive,positive,positive,"positive.

a cure",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9999254992953154,"positive
",pos,pos,negative.,neg,positive,pos,0.4042691789578895,0.6942233745366926, positive,"positive 
",pos,pos,0.9984953427388004,0.7876150266946763,positive.,positive,pos,pos,positive,pos,0.5219166100916729,0.8016942563364917,0.999686458709013,,"In a medical study on 'Active TB: Direct observation of treatment vs self-supervision', the outcome is 'Cure'.",Q13,empty,available
CD000010,Krishnaswami 1981,STD-Krishnaswami-1981 1.325 0.131 75 75,0.745718067569283,0.343356809389702,150,Infectious Diseases,efficacy,DICH,1,2,no,1981.0,Completion of treatment,Active TB: Intensive vs routine defaulter action,2.17184586755322,positive,positive,positive,positive,positive,"positive.

completion of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9999263332235302,"positive
",pos,pos,positive,pos,positive.,pos,0.5055404131036565,0.7470639049653337, positive,"positive 
",pos,pos,0.9859324411992508,0.7488462540720804,positive.,positive,pos,pos,positive,pos,0.5658604640627313,0.8516389575541075,0.9829136802722656,,"In a medical study on 'Active TB: Intensive vs routine defaulter action', the outcome is 'Completion of treatment'.",Q14,empty,available
CD000010,Liefooghe 1999,STD-Liefooghe-1999 1.131 0.07 504 515,0.221918811418314,0.126275790603506,1019,Infectious Diseases,efficacy,DICH,1,3,no,1999.0,Completed treatment,Active TB:Counselling/health education vs. routine care,1.75741375569857,positive,positive,positive,positive,positive,"positive.

completed treatment",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997997901446686,"positive
",pos,pos,positive.,pos,positive,pos,0.4802255126578775,0.763662418052956, positive,"positive 
",pos,pos,0.9796631852265832,0.777027512953521,positive.,positive,pos,pos,positive,pos,0.4899065532824647,0.771623456889555,0.9969346599541744,,"In a medical study on 'Active TB:Counselling/health education vs. routine care', the outcome is 'Completed treatment'.",Q15,empty,available
CD000010,Malotte 1998,STD-Malotte-1998 2.6 0.145 204 100,2.50567520186153,0.292276320923085,304,Infectious Diseases,efficacy,DICH,1,11,no,1998.0,Keeping first appointment,TB evaluation: Incentive ($5) vs routine care,8.57296682108202,positive,positive,positive,positive,positive,"positive.

keeping the",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9967836823669932,"positive
",pos,pos,positive.,pos,neutral,neu,0.4407730629523808,0.4049923290501797, positive,"positive 
",pos,pos,0.9791359244955956,0.7797016456009429,positive. keep,positive,pos,pos,positive,pos,0.2965210795070274,0.5081358916802466,0.555039018232141,,"In a medical study on 'TB evaluation: Incentive ($5) vs routine care', the outcome is 'Keeping first appointment'.",Q16,empty,available
CD000010,Morisky 1990,STD-Morisky-1990 1.072 0.052 43 45,1.41039191269895,1.13938569751948,88,Infectious Diseases,efficacy,DICH,1,4,no,1990.0,Completion of treatment,Active TB: Incentive plus health education vs routine care,1.23785292001599,positive,positive,positive,positive,positive,"positive.

completion of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9994967058650048,"positive
",pos,pos,positive.,pos,positive.,pos,0.6026487648118084,0.7336065383191918, positive,"positive 
",pos,pos,0.936279668120572,0.7517497773907971,positive.,positive,pos,pos,positive,pos,0.6036638387168481,0.8063244741965275,0.766122719538064,,"In a medical study on 'Active TB: Incentive plus health education vs routine care', the outcome is 'Completion of treatment'.",Q17,empty,available
CD000010,Paramasivan 1993,STD-Paramasivan-1993 1.205 0.071 100 100,0.997807589546144,0.381356312221252,200,Infectious Diseases,efficacy,DICH,1,1,no,1993.0,Completion of treatment,Active TB: Defaulter action vs no defaulter action,2.61647062751972,positive,positive,positive,positive,positive,"positive.

completion of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9999239505219082,"positive
",pos,pos,positive,pos,positive.,pos,0.4198858207657064,0.7046150130394154, positive,"positive 
",pos,pos,0.98830845591463,0.8352310496784268,positive.,positive,pos,pos,positive,pos,0.6457523059326967,0.7175453457719779,0.9628472149325178,,"In a medical study on 'Active TB: Defaulter action vs no defaulter action', the outcome is 'Completion of treatment'.",Q18,empty,available
CD000010,Sanmarti 1993,STD-Sanmarti-1993 1.312 0.078 80 77,1.79175946922805,0.526279105579632,157,Infectious Diseases,efficacy,DICH,1,9,no,1993.0,Completion of treatment,Prophylaxis: Health education vs no health education,3.40458028873226,positive,positive,positive,positive,positive,"positive.

completion of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.998939626094152,"positive
",pos,pos,positive.,pos,positive,pos,0.4463552637466783,0.5449607647705723," positive

","positive 
",pos,pos,0.7420833285017098,0.8285973771088186,positive.,positive,pos,pos,positive,pos,0.5556090314090459,0.6989749465819499,0.5292440715677457,,"In a medical study on 'Prophylaxis: Health education vs no health education', the outcome is 'Completion of treatment'.",Q19,empty,available
CD000010,Tanke 1997,STD-Tanke-1997 1.051 0.025 376 325,0.537339000164863,0.264012265967145,701,Infectious Diseases,efficacy,DICH,1,19,no,1997.0,Keeping first appointment,TB Evaluation: Reminders vs no reminders,2.03528043743139,positive,positive,positive,positive,positive,"positive.

keeping the",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999256126671048,"positive
",pos,pos,positive.,pos,positive,pos,0.5956998388281353,0.4952434592121503, positive,"positive 
",pos,pos,0.9956679478984106,0.8004306788307484,positive.,positive,pos,pos,positive,pos,0.4001989985219122,0.5638531410370798,0.949946498050018,,"In a medical study on 'TB Evaluation: Reminders vs no reminders', the outcome is 'Keeping first appointment'.",Q20,empty,available
CD000010,Tulsky 2000,STD-Tulsky-2000 1.679 0.321 43 38,0.796004565999653,0.479596216966232,81,Infectious Diseases,efficacy,DICH,1,7,no,2000.0,Completion of preventive therapy,Prophylaxis: Incentive ($5) vs routine care,1.65973904263657,positive,positive,positive,positive,positive,"positive.

completion of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9998727028729668,"positive
",pos,pos,positive.,pos,positive,pos,0.5196656651338011,0.6219801634423033, positive,"positive 
",pos,pos,0.9830828955035532,0.8755667469809506,the outcome ',positive,neg,pos,positive,pos,0.3433892719822597,0.7555575647605177,0.9384090085047514,,"In a medical study on 'Prophylaxis: Incentive ($5) vs routine care', the outcome is 'Completion of preventive therapy'.",Q21,empty,available
CD000010,White 1998,STD-White-1998 1.106 0.45 31 30,0.133531392624523,0.595662374668967,61,Infectious Diseases,efficacy,DICH,1,8,no,1998.0,Keeping first appointment,Prophylaxis: Incentive ($5) plus health education vs health education alone,0.224172951495772,positive,positive,positive,positive,positive,"positive.

keeping the",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9984129224416946,"positive
",pos,pos,positive.,pos,positive,pos,0.541198503843926,0.6201066568226051, positive,"positive 
",pos,pos,0.9645408589690324,0.8195391824824099,positive. keep,positive,pos,pos,positive,pos,0.4808676270229657,0.5140647195651579,0.8923836487411195,,"In a medical study on 'Prophylaxis: Incentive ($5) plus health education vs health education alone', the outcome is 'Keeping first appointment'.",Q22,empty,available
CD000010,Wurtele 1980,STD-Wurtele-1980 1.102 0.034 629 653,0.366062083519659,0.127404050228936,1282,Infectious Diseases,efficacy,DICH,1,17,no,1980.0,Keeping first appointment,TB Evaluation: Verbal contract vs no contract,2.87323741169822,positive,positive,positive,positive,positive,"positive.

keeping the",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9974896755475045,"positive
",pos,pos,positive.,pos,neutral,neu,0.5043616178559442,0.478565068369518, positive,"positive 
",pos,pos,0.995389242274678,0.7213573249262677,the outcome ',positive,neg,pos,positive,pos,0.3047816366461884,0.5273070777398144,0.7128182839098769,,"In a medical study on 'TB Evaluation: Verbal contract vs no contract', the outcome is 'Keeping first appointment'.",Q23,empty,available
CD000012,Begley 2009,STD-Begley-2009 1.237 0.149 1059 549,0.240453099890958,0.16737008325693,1608,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,2009.0,No analgesia/anesthesia,Alternative versus conventional birth settings - all trials,1.43665519674647,neutral,neutral,negative,negative.,negative,"neutral.

the absence",pos,negative,neu,neg,neg,neg,neu,neg,neu,"negative
",negative,0.9868977279655562,"neutral
",neg,neu,negative.,neg,negative,neg,0.5011580854834997,0.6144761230660124," neutral

","neutral 
",neu,neu,0.5042667501758678,0.4776413043750637,neutral. the,negative.,neu,neg,negative,neg,0.5781812062744155,0.4450386465718614,0.8798841716904211,,"In a medical study on 'Alternative versus conventional birth settings - all trials', the outcome is 'No analgesia/anesthesia'.",Q24,empty,available
CD000013,Amin 2003,STD-Amin-2003 0.294 0.484 80 80,-1.39812881876689,0.536684151636802,160,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2003.0,"Caesarean section, overall","Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM)*",-2.60512410232876,negative,negative,negative,negative.,negative,"negative.

caes",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9901411839211304,"negative
",neg,neg,negative.,neg,negative,neg,0.5053031749018777,0.7925072097697992, negative,"negative 
",neg,neg,0.9834115841632391,0.6578221066842471,the outcome ',negative,neg,neg,negative,neg,0.4306125357364186,0.9297240331209724,0.9783813006821852,,"In a medical study on 'Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM)*', the outcome is 'Caesarean section, overall'.",Q25,empty,available
CD000013,Vergani 1996,STD-Vergani-1996 0.127 0.717 37 33,-2.55681923137829,0.807856162288417,70,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,1996.0,Suspicious/ominous fetal heart rate pattern,"Transabdominal amnioinfusion for cord compression (potential, or diagnosed by fetal heart rate monitor)",-3.16494365053251,negative,negative,negative,negative.,negative,"negative.

a suspicious",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9888432612219276,"negative
",neg,neg,negative.,neg,negative,neg,0.5232117433193236,0.920720090748928, negative,"negative 
",neg,neg,0.9820115737662832,0.9279777547062504,positive.,negative,pos,neg,negative,neg,0.4041203874687095,0.9560099770461196,0.9750617098886634,,"In a medical study on 'Transabdominal amnioinfusion for cord compression (potential, or diagnosed by fetal heart rate monitor)', the outcome is 'Suspicious/ominous fetal heart rate pattern'.",Q26,empty,available
CD000014,Choudhary 2010,STD-Choudhary-2010 0.043 1.015 146 146,-3.30004360297731,1.0288366701739,292,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2010.0,Meconium aspiration syndrome,Amnioinfusion for meconium-stained liquor in labour,-3.20754858243876,negative,negative,negative,negative.,negative,"negative.

mecon",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9983516126852068,"negative
",neg,neg,negative.,neg,negative,neg,0.5365499871116614,0.9651195763852628, negative,"negative 
",neg,neg,0.983076211885032,0.873283354020754,positive. me,negative,pos,neg,negative,neg,0.3742446300235884,0.9866892474840055,0.9998190730386236,,"In a medical study on 'Amnioinfusion for meconium-stained liquor in labour', the outcome is 'Meconium aspiration syndrome'.",Q27,empty,available
CD000015,Fraser 1993,STD-Fraser-1993 0.335 0.331 462 463,-1.21291884403288,0.387434539910941,925,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1991.0,Cessation of contractions,Amniotomy to shorten spontaneous labour,-3.13064200293473,negative,negative,negative,negative.,negative,"positive.

cess",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9974882517317576,"negative
",neg,neg,positive.,pos,negative,neg,0.4096563329169349,0.4832255027532774, negative,"positive 
",neg,pos,0.9883093873942524,0.9307862759548552,the outcome ',negative,neg,neg,positive,pos,0.327413659023949,0.9613603125246912,0.4763296333728964,,"In a medical study on 'Amniotomy to shorten spontaneous labour', the outcome is 'Cessation of contractions'.",Q28,empty,available
CD000015,Johnson 1997,STD-Johnson-1997 1.217 0.305 529 411,0.199036263063436,0.30953251608831,940,Pregnancy & Childbirth,efficacy,DICH,1,3,no,1997.0,Use of oxytocin,Amniotomy to shorten spontaneous labour in multiparae,0.643022147006522,neutral,positive,negative,negative.,"neutral

","positive.

the use",neg,negative,pos,neg,neg,neu,pos,neg,neu,"neutral
",neutral,0.4913291545124447,"negative
",neu,neg,positive.,pos,negative,neg,0.4630051014672283,0.3364035884850929," neutral

","positive 
",neu,pos,0.8435763911902134,0.7578797622081591,the outcome ',positive,neg,pos,neutral,neu,0.4080604503437625,0.8890770239867442,0.9367450365259508,,"In a medical study on 'Amniotomy to shorten spontaneous labour in multiparae', the outcome is 'Use of oxytocin'.",Q29,empty,available
CD000016,Brazil 1983-84,STD-Brazil-1983_x002d_84 0.935 0.496 36 30,-0.0682082500265335,0.500032319576001,66,Infectious Diseases,efficacy,DICH,1,1,no,1983.0,Parasitological conversion,Amodiaquine vs chloroquine in symptomatic participants,-0.136407682776126,positive,neutral,positive,positive.,"negative, because paras","positive.

parasito",pos,negative,neu,pos,pos,neg,pos,neg,pos,"positive
",positive,0.9980932772098972,"positive
",pos,pos,positive,pos,negative,neg,0.3858461890111303,0.3925313699154665, neutral,"positive 
",neu,pos,0.8935026872565591,0.7697474827697053,positive. par,positive,pos,pos,neutral,neu,0.3774209925641084,0.8436574104564855,0.8867133464700865,,"In a medical study on 'Amodiaquine vs chloroquine in symptomatic participants', the outcome is 'Parasitological conversion'.",Q30,empty,available
CD000016,Cameroon-Centre 1994,STD-Cameroon_x002d_Centre-1994 0.896 0.555 54 52,-0.111552485905748,0.558407105536944,106,Infectious Diseases,efficacy,DICH,1,2,no,1994.0,Parasitological conversion on day 7,Amodiaquine vs chloroquine in asymptomatic participants,-0.199769101789066,positive,negative,negative,negative.,"negative, because parasit","positive.

parasito",pos,negative,neg,neg,neg,neg,pos,neg,pos,"positive
",positive,0.9929852947092918,"positive
",pos,pos,positive.,pos,negative,neg,0.4352305806982826,0.4407332887545765, neutral,"negative 
",neu,neg,0.4786503648256666,0.5312476755720446,positive.,positive,pos,pos,neutral,neu,0.4630089926964786,0.8554665214244213,0.923006097367254,,"In a medical study on 'Amodiaquine vs chloroquine in asymptomatic participants', the outcome is 'Parasitological conversion on day 7'.",Q31,empty,available
CD000016,Cameroon-Hévécam2001,STD-Cameroon_x002d_H_x00e9_v_x00e9_cam2001 0.129 1.164 61 62,-2.01204995155986,1.52276337715625,123,Infectious Diseases,efficacy,DICH,1,3,no,2001.0,Parasitological conversion,Amodiaquine vs sulphadoxine-pyrimethamine in symptomatic participants,-1.32131490797825,positive,neutral,negative,positive,"negative, because parasit","positive.

parasito",pos,negative,neu,neg,pos,neg,pos,neg,pos,"positive
",positive,0.9977707953753824,"positive
",pos,pos,positive,pos,negative,neg,0.408170134324827,0.4242032251375141," positive
","positive 
",pos,pos,0.5937220808548974,0.7988491623690028,positive. par,positive,pos,pos,neutral,neu,0.4053972045972231,0.8744937965882447,0.7555165842582916,,"In a medical study on 'Amodiaquine vs sulphadoxine-pyrimethamine in symptomatic participants', the outcome is 'Parasitological conversion'.",Q32,empty,available
CD000018,Amoroso 1998,STD-Amoroso-1998 0.332 0.663 389 388,-1.11691345305051,0.670577095080808,777,Emergency & Trauma,efficacy,DICH,1,1,no,1998.0,Ankle sprain by intervention type,Any intervention v no intervention/control,-1.66560036309609,negative,negative,negative,negative.,"negative, because an an","negative.

an ankle",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997387536307772,"negative
",neg,neg,negative.,neg,negative,neg,0.5785372768177786,0.9286068420899528, negative,"negative 
",neg,neg,0.9431169023612914,0.70962736599664,positive.,negative.,pos,neg,negative,neg,0.5019243331002697,0.6660984475089317,0.9961510601957448,,"In a medical study on 'Any intervention v no intervention/control', the outcome is 'Ankle sprain by intervention type'.",Q33,empty,available
CD000018,Holme 1999,STD-Holme-1999 0.238 0.728 29 38,-1.70474809223843,0.815464999238573,67,Emergency & Trauma,efficacy,DICH,1,13,no,1999.0,Re-injury (recurrent ankle sprain),Rehabilitation: supervised programme (emphasis on balance training) v control,-2.09052270033687,negative,negative,negative,negative.,negative,"negative.

re-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9923635277517034,"negative
",neg,neg,negative.,neg,negative.,neg,0.6873847763162261,0.934374626977772, negative,"negative 
",neg,neg,0.9940818026262608,0.8213524453660179,negative.,negative,neg,neg,negative,neg,0.4355819479986201,0.966579712617924,0.9996070022775748,,"In a medical study on 'Rehabilitation: supervised programme (emphasis on balance training) v control', the outcome is 'Re-injury (recurrent ankle sprain)'.",Q34,empty,available
CD000018,Simon 1969,STD-Simon-1969 1.027 0.688 73 75,0.0285733724440557,0.727033190896703,148,Emergency & Trauma,efficacy,DICH,1,9,no,1969.0,Ankle injury,Adhesive tape v cloth wrap,0.0393013314960409,negative,negative,negative,negative.,"negative, as ankle","negative.

ankle",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9994115904808186,"negative
",neg,neg,negative.,neg,negative,neg,0.5801377281374825,0.9508111045522216, negative,"negative 
",neg,neg,0.9685825818305032,0.5365653381495239,negative. an,negative,neg,neg,negative,neg,0.4329551014119693,0.941846854773736,0.6578137943751304,,"In a medical study on 'Adhesive tape v cloth wrap', the outcome is 'Ankle injury'.",Q35,empty,available
CD000018,Wester 1996,STD-Wester-1996 0.462 0.4 24 24,-1.26566637333128,0.624543345216639,48,Emergency & Trauma,efficacy,DICH,1,14,no,1996.0,Recurrent ankle sprain,Rehabilitation: wobble board (ankle disk) exercises v control,-2.02654688905899,negative,negative,negative,negative.,negative,"negative.

a recurrent",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99791703169569,"negative
",neg,neg,negative.,neg,negative.,neg,0.5842467687762959,0.9458775784367528, negative,"negative 
",neg,neg,0.9924171010213212,0.5733201732672916,negative.,negative,neg,neg,negative,neg,0.5353566068129033,0.9790477029782834,0.999524581079584,,"In a medical study on 'Rehabilitation: wobble board (ankle disk) exercises v control', the outcome is 'Recurrent ankle sprain'.",Q36,empty,available
CD000019,ACTOBAT 1995,STD-ACTOBAT-1995 1.229 0.179 699 698,0.224813869668154,0.194880886688445,1397,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1995.0,Death prior to hospital discharge,TRH + steroids versus steroids alone (intention-to-treat),1.15359629919769,negative,negative,negative,negative.,negative,"negative.

death prior",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9715637890010614,"negative
",neg,neg,negative.,neg,negative.,neg,0.582878752005497,0.8724127413856602, negative,"negative 
",neg,neg,0.9875478857804324,0.617561053341585,positive.,negative,pos,neg,negative,neg,0.2464324916504529,0.9873347127094716,0.9998464820072032,,"In a medical study on 'TRH + steroids versus steroids alone (intention-to-treat)', the outcome is 'Death prior to hospital discharge'.",Q37,empty,available
CD000019,Ballard 1992b,STD-Ballard-1992b 0.761 0.481 91 89,-0.300104592450338,0.527610666943927,180,Pregnancy & Childbirth,efficacy,DICH,1,3,yes,1992.0,Death prior to hospital discharge,TRH + steroids versus steroids alone (timing of delivery subgroups),-0.568799327330947,negative,negative,negative,negative.,negative,"negative.

death prior",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9954612189403396,"negative
",neg,neg,negative.,neg,negative.,neg,0.690673479324049,0.8964594862083007, negative,"negative 
",neg,neg,0.9796406478147958,0.557556995124438,negative.,negative,neg,neg,negative,neg,0.2797088914915206,0.9717844954068144,0.9998971329639152,,"In a medical study on 'TRH + steroids versus steroids alone (timing of delivery subgroups)', the outcome is 'Death prior to hospital discharge'.",Q38,empty,available
CD000019,Campos 1993,STD-Campos-1993 0.747 0.56 66 69,-0.320211715749433,0.612682313877395,135,Pregnancy & Childbirth,efficacy,DICH,1,4,yes,1993.0,Death prior to hospital discharge,TRH + steroids versus steroids alone (optimally treated variously defined),-0.522639071663347,negative,negative,negative,negative.,negative,"negative.

death prior",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9946976278659112,"negative
",neg,neg,negative.,neg,negative.,neg,0.7360655574030798,0.9079085115163968, negative,"negative 
",neg,neg,0.9830736776152604,0.671557225083931,positive.,negative,pos,neg,negative,neg,0.3060009272875922,0.9775068522367444,0.9995522120977136,,"In a medical study on 'TRH + steroids versus steroids alone (optimally treated variously defined)', the outcome is 'Death prior to hospital discharge'.",Q39,empty,available
CD000020,Huchet 1987,STD-Huchet-1987 0.172 1.079 927 955,-1.76722490526431,1.08111068862228,1882,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Incidence of Rhesus D alloimmunisation during pregnancy,Anti-D administration in pregnancy,-1.63463826957106,negative,negative,negative,negative.,"negative, because rhes","negative.

rhesus",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9908749403739174,"negative
",neg,neg,negative.,neg,negative,neg,0.3858678079482934,0.9162873576447136, negative,"negative 
",neg,neg,0.8386611102591494,0.7258010313626188,positive.,negative,pos,neg,negative,neg,0.2911861101026511,0.8624985206065405,0.9704056974160128,,"In a medical study on 'Anti-D administration in pregnancy', the outcome is 'Incidence of Rhesus D alloimmunisation during pregnancy'.",Q40,empty,available
CD000021,International 1966,STD-International-1966 0.045 0.212 3389 1476,-3.73425004005463,0.4213003511728,4865,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1969.0,Immunisation after 6 months,"Anti-D prophylaxis postpartum (overall, irrespective of ABO status)",-8.86362907047043,positive,positive,negative,negative.,positive,"positive.

immunisation",pos,negative,pos,neg,neg,pos,pos,neg,pos,"negative
",negative,0.9896730964395466,"negative
",neg,neg,positive.,pos,neutral,neu,0.3858907391447215,0.4611664794735222, positive,"positive 
",pos,pos,0.9837096911795804,0.7051251413052414,positive.,positive,pos,pos,neutral,neu,0.5409400826514958,0.5545836866036595,0.9734774464661612,,"In a medical study on 'Anti-D prophylaxis postpartum (overall, irrespective of ABO status)', the outcome is 'Immunisation after 6 months'.",Q41,empty,available
CD000021,MRC 1974,STD-MRC-1974 3.355 0.634 898 902,1.39746766171802,0.791981506486565,1800,Pregnancy & Childbirth,efficacy,DICH,1,7,no,1974.0,Immunisation after 6 months,"Dosage comparison, up to 50 ug versus more than 50 ug anti-D",1.76452057310977,neutral,neutral,positive,positive,positive,"positive.

the outcome",pos,negative,neu,pos,pos,pos,pos,neg,neu,"negative
",negative,0.975009897259916,"negative
",neg,neg,positive.,pos,neutral,neu,0.3989812144550251,0.6146785130007577, positive,"positive 
",pos,pos,0.9943888905793724,0.6273426850354831,positive.,positive,pos,pos,neutral,neu,0.5522406660703677,0.702684961198245,0.9125626427412448,,"In a medical study on 'Dosage comparison, up to 50 ug versus more than 50 ug anti-D', the outcome is 'Immunisation after 6 months'.",Q42,empty,available
CD000022,Abele-Horn 1997,STD-Abele_x002d_Horn-1997 1.17 0.593 58 30,0.157185583522413,0.593452345731122,88,Lungs,efficacy,DICH,1,1,no,1997.0,Overall mortality,Topical plus systemic versus no prophylaxis,0.264866395175779,negative,negative,negative,negative.,"negative, as a","negative.

overall mortality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9950172905871582,"negative
",neg,neg,negative.,neg,negative,neg,0.5862659921517395,0.5685565325728189, negative,"negative 
",neg,neg,0.6859986817753692,0.8243014887755153,the outcome ',negative,neg,neg,negative,neg,0.3901025010108851,0.8926196184096313,0.9996240361059192,,"In a medical study on 'Topical plus systemic versus no prophylaxis', the outcome is 'Overall mortality'.",Q43,empty,available
CD000022,Bergmans 2001,STD-Bergmans-2001 0.714 0.283 87 139,-0.337364695404233,0.283419028162946,226,Lungs,efficacy,DICH,1,2,no,2001.0,Overall mortality,Topical versus control,-1.19033890416938,negative,negative,negative,negative.,negative,"negative.

overall mortality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9989013211899984,"negative
",neg,neg,negative.,neg,negative,neg,0.5855408600924563,0.7040130772759489, negative,"negative 
",neg,neg,0.8353131469518369,0.7010568574136388,the outcome ',negative,neg,neg,negative,neg,0.2686381575593937,0.7959451103542984,0.9994748014271028,,"In a medical study on 'Topical versus control', the outcome is 'Overall mortality'.",Q44,empty,available
CD000023,Brink 1951,STD-Brink-1951 0.659 0.087 277 198,-0.90917743967985,0.192294479578258,475,Lungs,efficacy,DICH,1,1,no,1951.0,Symptom of sore throat on day 3,Antibiotics versus placebo for the treatment of sore throats: symptom of sore throat,-4.72804753248178,negative,neutral,negative,negative.,"negative, because it","negative.

a reduction",neg,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9993007651786864,"negative
",neg,neg,negative.,neg,neutral,neu,0.4193702280114322,0.5705295881205689, neutral,"negative 
",neu,neg,0.8818325927911468,0.2831720458509442,the outcome ',positive,neg,pos,negative,neg,0.3626639430322917,0.8157382927548791,0.8886453806027595,,"In a medical study on 'Antibiotics versus placebo for the treatment of sore throats: symptom of sore throat', the outcome is 'Symptom of sore throat on day 3'.",Q45,empty,available
CD000023,Catanzaro 1954,STD-Catanzaro-1954 0.733 0.34 650 220,-0.325422400434628,0.358057437019716,870,Lungs,efficacy,DICH,1,4,no,1954.0,Incidence of acute rheumatic fever within 2 months. Rheumatic fever defined by clinical diagnosis,Antibiotics versus placebo for the treatment of sore throat: incidence of complications,-0.908855303057728,negative,negative,negative,negative.,"negative

the inc","negative.

acute rheumatic",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9961157425196934,"negative
",neg,neg,negative.,neg,negative,neg,0.6338948386880366,0.735182946926611, negative,"negative 
",neg,neg,0.9282993793154802,0.6171941163952946,positive.,negative.,pos,neg,negative,neg,0.3253968543955474,0.9797312640953182,0.9974785407940604,,"In a medical study on 'Antibiotics versus placebo for the treatment of sore throat: incidence of complications', the outcome is 'Incidence of acute rheumatic fever within 2 months. Rheumatic fever defined by clinical diagnosis'.",Q46,empty,available
CD000023,Nelson 1984,STD-Nelson-1984 1.271 0.263 17 18,0.65232518603969,0.712974987873581,35,Lungs,efficacy,DICH,1,2,no,1984.0,Symptom of fever on day 3,Antibiotics versus control for the treatment of sore throat: symptom of fever,0.914934180209075,negative,neutral,negative,negative.,"negative, because the presence","positive.

a reduction",neg,negative,neu,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9989992311035458,"negative
",neg,neg,negative.,neg,negative,neg,0.516593779168535,0.4718667239882957, negative,"negative 
",neg,neg,0.7272578385308578,0.4362339176531405,positive.,negative,pos,neg,negative,neg,0.3601775342545341,0.866711532943619,0.8663487488189676,,"In a medical study on 'Antibiotics versus control for the treatment of sore throat: symptom of fever', the outcome is 'Symptom of fever on day 3'.",Q47,empty,available
CD000024,ARGIS-1 2004,STD-ARGIS_x002d_1-2004 1.277 0.366 83 46,0.246674048724404,0.368612074642891,129,Neurology,efficacy,DICH,1,1,no,2004.0,Dead or dependent at end of follow up (if > 1 month),Anticoagulant versus control in acute presumed ischaemic stroke,0.669196875776195,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99253902588788,"negative
",neg,neg,negative.,neg,negative.,neg,0.614420051783316,0.9353002653698466, negative,"negative 
",neg,neg,0.9783584774965433,0.5843619076727564,the outcome ',negative,neg,neg,negative,neg,0.3325446982528609,0.993775728092192,0.9988061155602024,,"In a medical study on 'Anticoagulant versus control in acute presumed ischaemic stroke', the outcome is 'Dead or dependent at end of follow up (if > 1 month)'.",Q48,empty,available
CD000025,Denmark 2000,STD-Denmark-2000 0.934 0.216 14 17,-0.262364264467491,0.822753351207442,31,Pregnancy & Childbirth,efficacy,DICH,1,9,no,2000.0,Other antihypertensive therapy,Magnesium chloride versus methyl dopa,-0.318885683154562,neutral,neutral,neutral,negative.,neutral,neutral,neu,negative,neu,neu,neg,neu,neu,neg,neu,"negative
",negative,0.8855280758948962,"negative
",neg,neg,positive.,pos,neutral,neu,0.3843843462801042,0.7748305032128026, neutral,"neutral 
",neu,neu,0.5467072990784849,0.8460199002824107,neutral. the,neutral,neu,neu,neutral,neu,0.5617403598638363,0.7432022136477066,0.9942251886594714,,"In a medical study on 'Magnesium chloride versus methyl dopa', the outcome is 'Other antihypertensive therapy'.",Q49,empty,available
CD000025,India 2008,STD-India-2008 0.2 1.524 25 25,-1.69111594344837,1.57536309394497,50,Pregnancy & Childbirth,efficacy,DICH,1,6,no,2008.0,Eclampsia,Magnesium sulphate versus phenytoin,-1.07347693363409,negative,negative,negative,negative.,negative,"negative.

eclamp",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9993737356554282,"negative
",neg,neg,negative.,neg,negative,neg,0.6485907815247575,0.8981613624692123, negative,"negative 
",neg,neg,0.4019825918519925,0.6264357495565396,the outcome ',negative.,neg,neg,negative,neg,0.373687622365118,0.9932158849091496,0.9985941175826256,,"In a medical study on 'Magnesium sulphate versus phenytoin', the outcome is 'Eclampsia'.",Q50,empty,available
CD000025,Magpie Trial 2002,STD-Magpie-Trial-2002 0.576 0.556 1297 1345,-0.554297995148075,0.559136484154963,2642,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2002.0,Maternal death,Magnesium sulphate versus none/placebo (subgroups by severity of pre-eclampsia),-0.99134649742236,negative,negative,negative,negative.,negative,"negative.

maternal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9669140796097389,"negative
",neg,neg,negative.,neg,negative.,neg,0.671631961387277,0.811693733018222, negative,"negative 
",neg,neg,0.9874884815683986,0.4272750818684159,negative.,negative,neg,neg,negative,neg,0.3967859516463279,0.964948607442214,0.9995520929999934,,"In a medical study on 'Magnesium sulphate versus none/placebo (subgroups by severity of pre-eclampsia)', the outcome is 'Maternal death'.",Q51,empty,available
CD000025,Mexico 1992,STD-Mexico-1992 3 1.602 19 19,1.15125602215353,1.66493326352823,38,Pregnancy & Childbirth,efficacy,DICH,1,7,no,1992.0,Eclampsia,Magnesium sulphate versus diazepam,0.69147277393801,negative,negative,negative,negative.,negative,"negative.

eclamp",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.999103050729696,"negative
",neg,neg,negative.,neg,negative,neg,0.6593387999794387,0.9134476373033376, negative,"negative 
",neg,neg,0.460306176860807,0.5449062948556153,the outcome ',negative,neg,neg,negative,neg,0.3951704581938585,0.9948478728181924,0.9988371558939744,,"In a medical study on 'Magnesium sulphate versus diazepam', the outcome is 'Eclampsia'.",Q52,empty,available
CD000025,Nimodipine SG 2003,STD-Nimodipine-SG-2003 0.329 0.434 831 819,-1.13067422112777,0.439252678467964,1650,Pregnancy & Childbirth,efficacy,DICH,1,8,no,2003.0,Eclampsia,Magnesium sulphate versus nimodipine,-2.57408611615384,negative,negative,negative,negative.,negative,"negative.

eclamp",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9985675407505776,"negative
",neg,neg,negative.,neg,negative,neg,0.6694487484793354,0.9232067192539876," neutral

","negative 
",neu,neg,0.5042384676703036,0.6532399727447068,the outcome ',negative,neg,neg,negative,neg,0.3954141287032799,0.994389715731983,0.9985223226761436,,"In a medical study on 'Magnesium sulphate versus nimodipine', the outcome is 'Eclampsia'.",Q53,empty,available
CD000026,Benhamou 1991a,STD-Benhamou-1991a 0.984 0.684 63 62,-0.0170944333593002,0.730883391419396,125,Oncology,efficacy,DICH,1,1,no,1991.0,Death,Antifungals versus placebo or no treatment,-0.0233887287082859,negative,negative,negative,negative.,"negative

while","negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997901359245466,"negative
",neg,neg,negative.,neg,negative.,neg,0.7636828558308308,0.8107988085179245, negative,"negative 
",neg,neg,0.970606792359696,0.6084495301213559,negative.,negative,neg,neg,negative,neg,0.2906243861854858,0.9800482114423548,0.9996332083793188,,"In a medical study on 'Antifungals versus placebo or no treatment', the outcome is 'Death'.",Q54,empty,available
CD000027,Read 1977,STD-Read-1977 0.045 0.72 15 15,-4.51085950651685,1.28388147753274,30,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1977.0,Failure to obtain relief,Antihistamines versus aspirin for itching in late pregnancy,-3.5134547740228,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9971221437902256,"negative
",neg,neg,negative.,neg,negative,neg,0.6959636537500882,0.911152657055614, negative,"negative 
",neg,neg,0.9603516187020577,0.6292725596308008,negative.,negative,neg,neg,negative,neg,0.7544875771271476,0.9588308677930752,0.9873908449982082,,"In a medical study on 'Antihistamines versus aspirin for itching in late pregnancy', the outcome is 'Failure to obtain relief'.",Q55,empty,available
CD000028,Carter 1970,STD-Carter-1970 0.919 0.412 22 26,-0.1261512853269,0.616001988671047,48,Heart & Hypertension,efficacy,DICH,1,1,no,1970.0,Total mortality,Antihypertensive drug therapy vs control in adults 60 years or older,-0.204790386471084,negative,negative,negative,negative.,negative,"negative.

total mortality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9834709932292612,"negative
",neg,neg,negative.,neg,negative.,neg,0.6235763616445881,0.850657374812301, negative,"negative 
",neg,neg,0.8666837790352447,0.5306579606994419,positive.,negative,pos,neg,negative,neg,0.3424997581826091,0.8605059669677273,0.9997043291858108,,"In a medical study on 'Antihypertensive drug therapy vs control in adults 60 years or older', the outcome is 'Total mortality'.",Q56,empty,available
CD000029,CAST 1997,STD-CAST-1997 0.95 0.03 10554 10552,-0.0508720416143071,0.0299284077992531,21106,Neurology,efficacy,DICH,1,1,no,1997.0,Death or dependence at end of follow-up,Antiplatelet drug versus control in acute presumed ischaemic stroke,-1.6997911133641,negative,negative,negative,negative.,negative. death or,"negative.

death or",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9947794990275388,"negative
",neg,neg,negative.,neg,negative.,neg,0.6032952882126953,0.9103579482429508, negative,"negative 
",neg,neg,0.9552431346702552,0.5502491216800769,the outcome ',negative,neg,neg,negative,neg,0.4523478895238161,0.9929695793894742,0.9965722443734866,,"In a medical study on 'Antiplatelet drug versus control in acute presumed ischaemic stroke', the outcome is 'Death or dependence at end of follow-up'.",Q57,empty,available
CD000031,Ahluwalia 2002,STD-Ahluwalia-2002 1.947 0.27 300 300,0.732679570633765,0.294990857831945,600,Psychiatry & Mental Health,efficacy,DICH,1,1,yes,2002.0,Bupropion versus placebo/control. Subgroups by length of follow-up,Bupropion. Abstinence at 6m or greater follow-up,2.48373653345952,neutral,neutral,positive,positive.,neutral. this,neutral,neu,negative,neu,pos,pos,neu,neu,neg,neu,"positive
",Positive,0.7143756746796872,"positive
",pos,pos,positive.,pos,neutral,neu,0.4318564595819113,0.5641279891864448, neutral,"positive 
",neu,pos,0.9941851261689536,0.6553959904015929,neutral. the,positive,neu,pos,neutral,neu,0.4134338773032809,0.5188898383396645,0.984894564229574,,"In a medical study on 'Bupropion. Abstinence at 6m or greater follow-up', the outcome is 'Bupropion versus placebo/control. Subgroups by length of follow-up'.",Q58,empty,available
CD000031,Berlin 1995,STD-Berlin-1995 1.571 0.434 44 44,0.566395474920802,0.53953340127956,88,Psychiatry & Mental Health,efficacy,DICH,1,6,yes,1995.0,MAOIs versus placebo,Monoamine oxidase inhibitors (MAOIs) versus placebo. Abstinence at 6m or greater follow-up,1.04978760087426,neutral,neutral,positive,positive,"neutral

","negative.

maois",neu,negative,neu,pos,pos,neu,neg,neg,neu,"neutral
",neutral,0.51431398205337,"neutral
",neu,neu,positive.,pos,negative,neg,0.4316786797685515,0.377436762620544, neutral,"positive 
",neu,pos,0.9941182047856232,0.920794475641036,the outcome ',positive,neg,pos,neutral,neu,0.4080433764476428,0.9462736476868872,0.9827738833529198,,"In a medical study on 'Monoamine oxidase inhibitors (MAOIs) versus placebo. Abstinence at 6m or greater follow-up', the outcome is 'MAOIs versus placebo'.",Q59,empty,available
CD000031,Cinciripini 2005,STD-Cinciripini-2005 1.223 0.327 71 76,0.253332592437143,0.410169991428498,147,Psychiatry & Mental Health,efficacy,DICH,1,7,yes,1999.0,Venlafaxine versus placebo,Venlafaxine versus placebo. Abstinence at 6m or greater follow-up,0.617628294929287,neutral,neutral,positive,neutral,"to determine whether the outcome ""","positive.

the study",neu,negative,neu,pos,neu,neg,pos,neg,neu,"neutral
",Neutral,0.6411874058314954,"neutral
",neu,neu,negative.,neg,neutral,neu,0.3873239106810522,0.4771644198966586, neutral,"positive 
",neu,pos,0.9966123812453176,0.9381561880281524,the outcome ',positive,neg,pos,neutral,neu,0.4292659220830396,0.9724268351059644,0.8806476194625177,,"In a medical study on 'Venlafaxine versus placebo. Abstinence at 6m or greater follow-up', the outcome is 'Venlafaxine versus placebo'.",Q60,empty,available
CD000031,Covey 2002,STD-Covey-2002 0.706 0.431 68 66,-0.405465108108164,0.500757002704481,134,Psychiatry & Mental Health,efficacy,DICH,1,5,yes,2000.0,SSRI versus placebo/control,Selective Serotonin Reuptake Inhibitors (SSRIs) versus placebo. Abstinence at 6m or greater follow-up.,-0.80970431949695,neutral,neutral,positive,positive,"the outcome ""ssri versus","positive.

the outcome",neu,negative,neu,pos,pos,neg,pos,neg,neu,"neutral
",neutral,0.5991505121857602,"neutral
",neu,neu,positive.,pos,negative,neg,0.4544476441388871,0.3574311908760909, neutral,"positive 
",neu,pos,0.853375962366426,0.927814557810173,the outcome ',positive,neg,pos,neutral,neu,0.3879231863653478,0.9791668982884508,0.9743909859627988,,"In a medical study on 'Selective Serotonin Reuptake Inhibitors (SSRIs) versus placebo. Abstinence at 6m or greater follow-up.', the outcome is 'SSRI versus placebo/control'.",Q61,empty,available
CD000031,Da Costa 2002,STD-Da-Costa-2002 3.912 0.542 68 76,1.54044504094715,0.594841137477881,144,Psychiatry & Mental Health,efficacy,DICH,1,2,yes,2002.0,Nortriptyline versus placebo,Nortriptyline. Abstinence at 6m or greater follow-up,2.58967469445475,neutral,neutral,positive,positive,neutral. the,neutral,neu,negative,neu,pos,pos,neu,neu,neg,neu,"neutral
",Neutral,0.8644647497446152,"neutral
",neu,neu,positive.,pos,negative,neg,0.4537638013060588,0.4005813176054133, neutral,"positive 
",neu,pos,0.9961303590977132,0.6790660236220655,the outcome ',positive,neg,pos,neutral,neu,0.4027611592925788,0.4566637510865173,0.981858356909166,,"In a medical study on 'Nortriptyline. Abstinence at 6m or greater follow-up', the outcome is 'Nortriptyline versus placebo'.",Q62,empty,available
CD000031,Parsons 2009,STD-Parsons-2009 0.507 0.687 71 72,-0.723000143709626,0.727913042543171,143,Psychiatry & Mental Health,efficacy,DICH,1,8,yes,2009.0,St John's wort versus placebo,St John's wort versus placebo. Abstinence at 6m or greater follow-up,-0.993250706408034,neutral,neutral,positive,neutral,"neutral

the","positive.

st john",neu,negative,neu,pos,neu,neu,pos,neg,neu,"neutral
",neutral,0.6102789690775299,"neutral
",neu,neu,negative.,neg,neutral,neu,0.3994163609481385,0.5926793525600543, neutral,"positive 
",neu,pos,0.997397893294162,0.91504407259755,neutral. the,positive,neu,pos,neutral,neu,0.3088756933210582,0.4047677981139965,0.9967900174931345,,"In a medical study on 'St John's wort versus placebo. Abstinence at 6m or greater follow-up', the outcome is 'St John's wort versus placebo'.",Q63,empty,available
CD000031,Sood 2012,STD-Sood-2012 0.7 0.553 80 40,-0.398639143037764,0.620586175777029,120,Psychiatry & Mental Health,efficacy,DICH,1,9,yes,2012.0,SAMe versus placebo,SAMe versus placebo. Abstinence at 6m or greater follow-up,-0.642359044718701,neutral,neutral,positive,positive,"neutral

the","positive.

same",neu,negative,neu,pos,pos,neu,pos,neg,neu,"neutral
",Neutral,0.5922264265165484,"neutral
",neu,neu,positive.,pos,neutral,neu,0.3843582514316366,0.5212615932319822, neutral,"positive 
",neu,pos,0.991512825866465,0.8649280900338437,the outcome ',positive,neg,pos,neutral,neu,0.2957911933488675,0.952269207207372,0.9920517434369226,,"In a medical study on 'SAMe versus placebo. Abstinence at 6m or greater follow-up', the outcome is 'SAMe versus placebo'.",Q64,empty,available
CD000032,Ceesay 1997,STD-Ceesay-1997 0.418 0.429 652 545,-0.889857474806,0.436970427145016,1197,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,1997.0,Stillbirth,Balanced protein/energy supplementation versus control or no intervention in pregnancy,-2.03642493754088,negative,negative,negative,negative.,negative,"negative.

stillbirth",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99883054904136,"negative
",neg,neg,negative.,neg,negative.,neg,0.5914795755141447,0.8528572063435987, negative,"negative 
",neg,neg,0.9840411078331724,0.5959296810783988,the outcome ',negative,neg,neg,negative,neg,0.396556988366074,0.981411049888648,0.999787614158556,,"In a medical study on 'Balanced protein/energy supplementation versus control or no intervention in pregnancy', the outcome is 'Stillbirth'.",Q65,empty,available
CD000032,Kafatos 1989,STD-Kafatos-1989 0.373 0.831 223 208,-1.00124745435012,0.842289139934864,431,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Stillbirth,Nutritional education during pregnancy versus no nutritional education (or normal care),-1.1887217902721,negative,negative,negative,negative.,negative,"negative.

stillbirth",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9989516417119202,"negative
",neg,neg,negative.,neg,negative.,neg,0.5485888359919916,0.8573665443426225, negative,"negative 
",neg,neg,0.9647780317877952,0.6183015152306601,the outcome ',negative,neg,neg,negative,neg,0.394003529543776,0.9750772366544844,0.9996962278277224,,"In a medical study on 'Nutritional education during pregnancy versus no nutritional education (or normal care)', the outcome is 'Stillbirth'.",Q66,empty,available
CD000033,Bohn 1989,STD-Bohn-1989 1 0.365 41 41,0.0,0.498482545817653,82,Emergency & Trauma,efficacy,DICH,1,1,yes,1989.0,Death at the end of follow-up,Barbiturate vs no barbiturate,0.0,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.998012340516628,"negative
",neg,neg,negative.,neg,negative.,neg,0.7636325361840771,0.8491919870083338, negative,"negative 
",neg,neg,0.993698973964972,0.748109028538201,negative.,negative,neg,neg,negative,neg,0.4157876098657634,0.9238943776186446,0.9999487426325072,,"In a medical study on 'Barbiturate vs no barbiturate', the outcome is 'Death at the end of follow-up'.",Q67,empty,available
CD000033,Pérez-Bárcena 2008,STD-P_x00e9_rez_x002d_B_x00e1_rcena-2008 1.778 0.28 21 21,1.45083288225746,0.675976659689108,42,Emergency & Trauma,efficacy,DICH,1,3,no,2008.0,Death at the end of follow-up (6 months),Pentobarbital vs Thiopental,2.14627659322545,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.996516433745142,"negative
",neg,neg,negative.,neg,negative.,neg,0.4996835687525927,0.9342197921948046, negative,"negative 
",neg,neg,0.995660975180434,0.5361658425414858,the outcome ',negative,neg,neg,negative,neg,0.274385563173299,0.9519639175214458,0.9998113272925676,,"In a medical study on 'Pentobarbital vs Thiopental', the outcome is 'Death at the end of follow-up (6 months)'.",Q68,empty,available
CD000033,Schwartz 1984,STD-Schwartz-1984 0.8 0.414 15 14,-0.405465108108164,0.750661084306402,29,Emergency & Trauma,efficacy,DICH,1,2,yes,1984.0,Death at the end of follow-up (1 year),Barbiturate vs Mannitol,-0.540144036483265,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9988486276383728,"negative
",neg,neg,negative.,neg,negative.,neg,0.6860996843182859,0.8932619718246152, negative,"negative 
",neg,neg,0.9940762658300484,0.6143388289155464,the outcome ',negative,neg,neg,negative,neg,0.3348713259526414,0.850980288270935,0.999921566441278,,"In a medical study on 'Barbiturate vs Mannitol', the outcome is 'Death at the end of follow-up (1 year)'.",Q69,empty,available
CD000034,Laurin 1987,STD-Laurin-1987 0.43 0.551 49 58,-0.968115799738741,0.620006378092995,107,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Operative delivery for fetal distress,Bed rest in hospital versus ambulatory management,-1.56146103321784,negative,negative,negative,negative.,negative,"positive.

operative",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9973266713243804,"negative
",neg,neg,negative.,neg,negative,neg,0.5924616756798464,0.9651253505355908, negative,"negative 
",neg,neg,0.9456710329686948,0.773239869717209,the outcome ',negative,neg,neg,negative,neg,0.3619280882406086,0.9900827758825822,0.994023022320446,,"In a medical study on 'Bed rest in hospital versus ambulatory management', the outcome is 'Operative delivery for fetal distress'.",Q70,empty,available
CD000035,Kulier 1997,STD-Kulier-1997 0.427 0.366 13 10,-2.66722820658196,1.19837853414984,23,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1997.0,No improvement in fetal heart rate abnormality,Tocolytics versus no treatment,-2.22569758267087,negative,negative,negative,negative.,negative,"negative.

a lack",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9959925045281528,"negative
",neg,neg,negative.,neg,negative,neg,0.5764784900722503,0.7948661448484252, negative,"negative 
",neg,neg,0.9796650154674672,0.588540225772128,negative.,negative,neg,neg,negative,neg,0.4730174995277698,0.9411637994347252,0.9935196139767736,,"In a medical study on 'Tocolytics versus no treatment', the outcome is 'No improvement in fetal heart rate abnormality'.",Q71,empty,available
CD000035,Magann 1993,STD-Magann-1993 0.286 0.746 23 23,-1.52469668397901,0.867742006863901,46,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1993.0,No improvement in fetal heart rate abnormality,Terbutaline versus Magnesium sulphate,-1.75708525335705,negative,negative,negative,negative.,neutral,"negative.

a lack",neg,negative,neg,neg,neg,neu,neg,neg,neg,"negative
",negative,0.998522136117946,"negative
",neg,neg,negative.,neg,negative,neg,0.5104585834363053,0.7899028525991456, negative,"negative 
",neg,neg,0.9808726170941408,0.5993950139022872,neutral. the,negative,neu,neg,negative,neg,0.3554581872515091,0.8617367200259459,0.6234805126171813,,"In a medical study on 'Terbutaline versus Magnesium sulphate', the outcome is 'No improvement in fetal heart rate abnormality'.",Q72,empty,available
CD000036,Cabero 1988,STD-Cabero-1988 1.171 0.228 44 54,0.283721671235684,0.409636245885491,98,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1988.0,Low birthweight for gestational age,Ritodrine versus control,0.692618570952814,negative,negative,negative,negative.,negative,"negative.

low birth",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998260067985733,"negative
",neg,neg,negative.,neg,negative.,neg,0.5894367389940252,0.9478359649375824, negative,"negative 
",neg,neg,0.989001981971122,0.546168326927415,negative. low,negative,neg,neg,negative,neg,0.4638067221305458,0.9865482584760362,0.9990484241334888,,"In a medical study on 'Ritodrine versus control', the outcome is 'Low birthweight for gestational age'.",Q73,empty,available
CD000037,Campbell 1978,STD-Campbell-1978 1.833 0.298 50 50,0.911517453121497,0.436827144275454,100,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1978.0,Forceps delivery,Prophylactic tocolytics in 2nd stage of labour,2.08667768261835,negative,negative,negative,negative.,negative,"negative.

forceps",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9759438402031886,"negative
",neg,neg,negative.,neg,negative,neg,0.4876451132676414,0.4620066346459588, negative,"negative 
",neg,neg,0.9478163682892748,0.5992914153482669,the outcome ',positive,neg,pos,negative,neg,0.4019668264616803,0.7945836580580116,0.7129793713897139,,"In a medical study on 'Prophylactic tocolytics in 2nd stage of labour', the outcome is 'Forceps delivery'.",Q74,empty,available
CD000038,Alfirevic 1995,STD-Alfirevic-1995 3.041 1.625 72 73,1.12620024518694,1.64141954503702,145,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1995.0,Perinatal deaths including major malformations,Biophysical profile versus conventional fetal monitoring (CTG),0.686113582960617,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.6531340418133769,"negative
",neg,neg,negative.,neg,negative.,neg,0.5833504650140863,0.905761232807196, negative,"negative 
",neg,neg,0.95250362510398,0.8190448276658105,negative.,negative,neg,neg,negative,neg,0.4132588781093149,0.9016921518066948,0.999709928752174,,"In a medical study on 'Biophysical profile versus conventional fetal monitoring (CTG)', the outcome is 'Perinatal deaths including major malformations'.",Q75,empty,available
CD000039,Bath 2000,STD-Bath-2000 2 0.707 16 18,0.693147180559945,0.707106781186547,34,Neurology,efficacy,DICH,1,1,no,2000.0,"Death or dependency, end of trial by intervention",Blood pressure lowering therapy in acute stroke,0.980258143468547,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.989182987226758,"negative
",neg,neg,negative.,neg,negative.,neg,0.5861572210227232,0.923857544479382, negative,"negative 
",neg,neg,0.9840864754669152,0.6967979134804217,the outcome ',negative,neg,neg,negative,neg,0.4482564128644342,0.990577092389257,0.9400844918145786,,"In a medical study on 'Blood pressure lowering therapy in acute stroke', the outcome is 'Death or dependency, end of trial by intervention'.",Q76,empty,available
CD000039,COSSACS 2010,STD-COSSACS-2010 1.105 0.15 379 384,0.099490477838031,0.149938232147918,763,Neurology,efficacy,DICH,1,2,no,2005.0,"Death or dependency, end of trial by C/S",Blood pressure altering by continue or stop prestroke antihypertensives (C/S),0.663543089796344,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.893769595660257,"negative
",neg,neg,negative.,neg,negative,neg,0.63728350360745,0.9162579342953346, negative,"negative 
",neg,neg,0.9953801477034024,0.7837825132239321,the outcome ',negative,neg,neg,negative,neg,0.4259598506804134,0.9898673390748716,0.9504609809756196,,"In a medical study on 'Blood pressure altering by continue or stop prestroke antihypertensives (C/S)', the outcome is 'Death or dependency, end of trial by C/S'.",Q77,empty,available
CD000040,USA 1989,STD-USA-1989 2.981 0.523 36 36,1.15745278869104,0.562923722082412,72,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Preterm labour.,Routine transfusion versus selective transfusion.,2.05614498605477,negative,negative,negative,negative.,negative,"negative.

preterm",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9988486276383728,"negative
",neg,neg,negative.,neg,negative.,neg,0.5209422644015901,0.9006955309412126, negative,"negative 
",neg,neg,0.9576028881761368,0.5059727891598638,the outcome ',negative,neg,neg,negative,neg,0.3968827404184289,0.9817201235892206,0.9979086833450296,,"In a medical study on 'Routine transfusion versus selective transfusion.', the outcome is 'Preterm labour.'.",Q78,empty,available
CD000044,Harrison 1979,STD-Harrison-1979 0.838 0.814 16 14,-0.182321556793955,0.82663978450915,30,Gynaecology & Urology,efficacy,DICH,1,1,no,1979.0,Pregnancy per patient,Bromocriptine vs Placebo,-0.220557442565162,positive,negative,positive,positive,positive,"positive.

pregnancy is",pos,negative,neg,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9994552788144838,"positive
",pos,pos,positive.,pos,negative,neg,0.467321298001676,0.4205753335390135," positive
","positive 
",pos,pos,0.510310340517711,0.7829995059153404,the outcome ',positive,neg,pos,negative,neg,0.3625420899317721,0.3347900591576385,0.5435845782389704,,"In a medical study on 'Bromocriptine vs Placebo', the outcome is 'Pregnancy per patient'.",Q79,empty,available
CD000046,Ingelman 1953,STD-Ingelman-1953 1.79 0.612 25 20,0.606135803570315,0.632797677328939,45,Pregnancy & Childbirth,efficacy,DICH,1,6,no,1953.0,Single injection given before symptoms subsided,Oxytocin versus placebo,0.957866669373433,neutral,positive,positive,neutral.,positive,"positive.

the outcome",neu,negative,pos,pos,neu,pos,pos,neg,neu,"negative
",negative,0.5909192876633463,"negative
",neg,neg,positive.,pos,positive,pos,0.4096597757876509,0.4947078645527589, neutral,"positive 
",neu,pos,0.4540989491452172,0.8556515068422449,positive. the,positive,pos,pos,neutral,neu,0.3672827568674136,0.8688403020183697,0.9677527943153084,,"In a medical study on 'Oxytocin versus placebo', the outcome is 'Single injection given before symptoms subsided'.",Q80,empty,available
CD000046,Kee 1989,STD-Kee-1989 3.603 0.534 35 35,1.38629436111989,0.593616839704664,70,Pregnancy & Childbirth,efficacy,DICH,1,5,no,1989.0,Total Improvement Rating (all outcomes measured by the researcher),Use of Serrapeptase (Danzen) versus placebo,2.33533530115082,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9957264317928918,"positive
",pos,pos,positive,pos,positive.,pos,0.3293406743756668,0.5476782868970479, positive,"positive 
",pos,pos,0.8804165464045153,0.9171299556425137,positive.,positive,pos,pos,neutral,neu,0.4899307612658868,0.8135226583696407,0.9644913999120336,,"In a medical study on 'Use of Serrapeptase (Danzen) versus placebo', the outcome is 'Total Improvement Rating (all outcomes measured by the researcher)'.",Q81,empty,available
CD000046,Murata 1965,STD-Murata-1965 8.02 0.543 35 24,2.26868354131836,0.62341753687826,59,Pregnancy & Childbirth,efficacy,DICH,1,8,no,1965.0,Improvement in symptoms (pain and swelling) measured by researcher,Use of Kimotab (Bromelain and trypsin protease complex) versus placebo,3.63910767200858,positive,positive,positive,positive,positive,"positive.

the outcome",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9996672974377764,"positive
",pos,pos,positive.,pos,positive,pos,0.4116545800639316,0.6761522091032811, positive,"positive 
",pos,pos,0.9940885170919364,0.9686986806651984,positive.,positive,pos,pos,positive,pos,0.6089447137209688,0.6803520330169076,0.8236290206125219,,"In a medical study on 'Use of Kimotab (Bromelain and trypsin protease complex) versus placebo', the outcome is 'Improvement in symptoms (pain and swelling) measured by researcher'.",Q82,empty,available
CD000047,Rabinovici 1987,STD-Rabinovici-1987 3.667 0.592 27 27,1.70474809223843,0.72691752689634,54,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Maternal febrile morbidity,Effect of caesarean delivery of the second twin,2.34517401102853,negative,negative,negative,negative.,negative,"negative.

maternal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9907326292449424,"negative
",neg,neg,negative.,neg,negative.,neg,0.5642265516401543,0.929585559173252, negative,"negative 
",neg,neg,0.9850244395244314,0.5752460506265783,negative.,negative,neg,neg,negative,neg,0.4350224737520585,0.9673397743901468,0.998442456960449,,"In a medical study on 'Effect of caesarean delivery of the second twin', the outcome is 'Maternal febrile morbidity'.",Q83,empty,available
CD000048,LeBard 1989,STD-LeBard-1989 0.341 1.045 11 15,-1.29098418131557,1.20037872811421,26,Neonatal,efficacy,DICH,1,1,no,1989.0,Postoperative apnoea/bradycardia,Caffeine vs placebo with induction of general anesthesia,-1.07548072210818,negative,negative,negative,negative.,negative,"negative.

apno",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9957350617912742,"negative
",neg,neg,negative.,neg,negative,neg,0.4979590511209597,0.9404372392162184, negative,"negative 
",neg,neg,0.975571543437826,0.6462753828597472,negative. post,negative,neg,neg,negative,neg,0.3223309715946915,0.9718517099810596,0.9993306113585312,,"In a medical study on 'Caffeine vs placebo with induction of general anesthesia', the outcome is 'Postoperative apnoea/bradycardia'.",Q84,empty,available
CD000049,Janssens 1985,STD-Janssens-1985 0.496 0.53 50 50,-0.72676379135893,0.553122098585887,100,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1985.0,Preterm birth (< 38 weeks),Flunarizine versus no treatment,-1.31393013082821,negative,negative,negative,negative.,negative,"negative.

preterm",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997545908777462,"negative
",neg,neg,negative.,neg,negative,neg,0.4571433615171861,0.8349708337455383, negative,"negative 
",neg,neg,0.949649470630728,0.6144997836791815,positive. pre,negative,pos,neg,negative,neg,0.2727483617181212,0.9626327502485348,0.999789044076256,,"In a medical study on 'Flunarizine versus no treatment', the outcome is 'Preterm birth (< 38 weeks)'.",Q85,empty,available
CD000050,Ford-London,STD-Ford_x002d_London 0.127 0.847 35 38,-2.65324196460721,1.48754307456957,73,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1995.0,Number lost to follow up,CASE MANAGEMENT vs STANDARD CARE,-1.78364042693348,negative,neutral,negative,negative.,"negative, as it implies","negative.

loss to",neu,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9887492108792102,"negative
",neg,neg,negative.,neg,negative.,neg,0.4933223324592468,0.8147991325956331, negative,"negative 
",neg,neg,0.9950821261950972,0.599065025541149,the outcome ',negative,neg,neg,negative,neg,0.3077056862567304,0.9763763828703784,0.9103666369170488,,"In a medical study on 'CASE MANAGEMENT vs STANDARD CARE', the outcome is 'Number lost to follow up'.",Q86,empty,available
CD000051,Bung 1987,STD-Bung-1987 0.664 0.342 30 31,-0.653141845946246,0.537570701927193,61,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Non-cephalic births,Cephalic version by postural management,-1.21498780272945,negative,negative,negative,negative.,negative,"negative.

cephal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9986955774995872,"negative
",neg,neg,negative.,neg,negative,neg,0.4131924259156538,0.5390446158001405, negative,"positive 
",neg,pos,0.9875585822475484,0.8561673696647937,neutral. the,negative,neu,neg,negative,neg,0.5329987704276948,0.9344057529594232,0.986220251868212,,"In a medical study on 'Cephalic version by postural management', the outcome is 'Non-cephalic births'.",Q87,empty,available
CD000052,Chou 1995,STD-Chou-1995 0.913 0.651 71 81,-0.0971028304188448,0.691435657072421,152,Lungs,efficacy,DICH,1,1,no,1995.0,Hospital admission,Spacer (chamber) versus nebuliser (multiple-treatment studies),-0.140436538708437,negative,negative,negative,negative.,negative,"negative.

hospital admission",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9992083938356088,"negative
",neg,neg,negative.,neg,negative.,neg,0.4995870498764899,0.8878332387651983, negative,"negative 
",neg,neg,0.975530246089271,0.6735502853826111,positive.,negative,pos,neg,negative,neg,0.3962381401828319,0.9512611502232948,0.9996963469717116,,"In a medical study on 'Spacer (chamber) versus nebuliser (multiple-treatment studies)', the outcome is 'Hospital admission'.",Q88,empty,available
CD000052,Ferrés 1989,STD-Ferr_x00e9_s-1989 0.585 0.84 41 48,-0.57251919277133,0.893514576472202,89,Lungs,efficacy,DICH,1,2,no,1989.0,Hospital admission,Spacer (chamber) versus nebuliser (single-treatment studies),-0.640749695468613,negative,negative,negative,negative.,negative,"negative.

hospital admission",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9980733292175747,"negative
",neg,neg,negative.,neg,negative.,neg,0.4920760202465574,0.8797626383717873, negative,"negative 
",neg,neg,0.976973036269592,0.6233009514973961,positive.,negative,pos,neg,negative,neg,0.3892467240257348,0.9674356030351136,0.9994325283456534,,"In a medical study on 'Spacer (chamber) versus nebuliser (single-treatment studies)', the outcome is 'Hospital admission'.",Q89,empty,available
CD000053,Abden Abdi 1989 SOM,STD-Abden-Abdi-1989-SOM 0.915 0.141 100 101,-0.179133610317767,0.282427619799725,201,Infectious Diseases,efficacy,DICH,1,9,yes,1989.0,Parasitological failure,Metrifonate 3 doses 2 weeks apart: 7.5 mg/kg versus 5 mg/kg,-0.634263782149901,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9972845694692384,"negative
",neg,neg,negative.,neg,negative,neg,0.4799817295021917,0.6248034998032033, negative,"negative 
",neg,neg,0.99287109157665,0.6887467200343004,the outcome ',negative,neg,neg,negative,neg,0.3571444613595446,0.9796719952310364,0.9903871637471072,,"In a medical study on 'Metrifonate 3 doses 2 weeks apart: 7.5 mg/kg versus 5 mg/kg', the outcome is 'Parasitological failure'.",Q90,empty,available
CD000053,Basra 2012 GAB,STD-Basra-2012-GAB 0.574 0.186 30 14,-2.43141796483701,1.10038704479453,44,Infectious Diseases,efficacy,DICH,1,14,yes,2009.0,Parasitological failure at six weeks,Mefloquine versus placebo,-2.20960249971955,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9970645429043083,"negative
",neg,neg,negative.,neg,negative,neg,0.5677364102798358,0.778068524822916, negative,"negative 
",neg,neg,0.9908672712417318,0.5990653469047577,positive. par,negative,pos,neg,negative,neg,0.2932668972298553,0.8350992578638599,0.998738451885338,,"In a medical study on 'Mefloquine versus placebo', the outcome is 'Parasitological failure at six weeks'.",Q91,empty,available
CD000053,Borrmann 2001 GAB,STD-Borrmann-2001-GAB 0.337 0.197 89 30,-2.38262780066758,0.515154943084714,119,Infectious Diseases,efficacy,DICH,1,1,yes,2001.0,Parasitological failure,Praziquantel 40 mg/kg single dose versus placebo,-4.62507024857524,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9962927931219668,"negative
",neg,neg,negative.,neg,negative,neg,0.5560292447276,0.6495339736479877, negative,"positive 
",neg,pos,0.9603145699095038,0.8118006493476728,positive. par,negative,pos,neg,negative,neg,0.3143006531014883,0.9517621591406448,0.9995848472696076,,"In a medical study on 'Praziquantel 40 mg/kg single dose versus placebo', the outcome is 'Parasitological failure'.",Q92,empty,available
CD000053,Davis 1981 ZMB,STD-Davis-1981-ZMB 0.168 1.498 45 53,-1.8416491387309,1.52561275816975,98,Infectious Diseases,efficacy,DICH,1,2,yes,1981.0,Parasitological failure at four to six weeks,Praziquantel 40 mg/kg single dose versus lower doses,-1.20715373470021,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9230460260619032,"negative
",neg,neg,negative.,neg,negative,neg,0.6241585919925373,0.828395021111076, negative,"negative 
",neg,neg,0.992413696051666,0.6367652943576039,the outcome ',negative,neg,neg,negative,neg,0.3162847643957207,0.980059432744738,0.998295713370184,,"In a medical study on 'Praziquantel 40 mg/kg single dose versus lower doses', the outcome is 'Parasitological failure at four to six weeks'.",Q93,empty,available
CD000053,Jewsbury 1976 ZWE,STD-Jewsbury-1976-ZWE 0.407 0.164 55 38,-4.74183555147433,1.44923056022399,93,Infectious Diseases,efficacy,DICH,1,7,yes,1976.0,Parasitological failure,Metrifonate multiple doses versus placebo,-3.27196767831163,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9840944438630546,"negative
",neg,neg,negative.,neg,negative,neg,0.6000622243334619,0.7087757814079713, negative,"positive 
",neg,pos,0.96030258552494,0.7648792359017806,the outcome ',negative,neg,neg,negative,neg,0.3777637853898977,0.969814794379654,0.9964558770952198,,"In a medical study on 'Metrifonate multiple doses versus placebo', the outcome is 'Parasitological failure'.",Q94,empty,available
CD000053,Kardaman 1985 SDN,STD-Kardaman-1985-SDN 0.714 0.211 110 101,-0.483646405649522,0.301781047827557,211,Infectious Diseases,efficacy,DICH,1,3,yes,1985.0,Parasitological failure,Praziquantel 40 mg/kg single dose versus 2 x 20 mg/kg split dose,-1.60264008999626,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9976029010412892,"negative
",neg,neg,negative.,neg,negative,neg,0.5842390379391569,0.7494647894535139, negative,"negative 
",neg,neg,0.9783517458154228,0.580581683564991,the outcome ',negative,neg,neg,negative,neg,0.4018655641456583,0.9654838073730848,0.99930049270077,,"In a medical study on 'Praziquantel 40 mg/kg single dose versus 2 x 20 mg/kg split dose', the outcome is 'Parasitological failure'.",Q95,empty,available
CD000053,Keiser 2010 CIV,STD-Keiser-2010-CIV 0.154 0.558 26 20,-3.13549421592915,0.802170967356439,46,Infectious Diseases,efficacy,DICH,1,12,yes,2008.0,Parasitological failure,Praziquantel versus artesunate,-3.90876053051658,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9974486199168832,"negative
",neg,neg,negative.,neg,negative,neg,0.6221703209067271,0.8405511497760332, negative,"negative 
",neg,neg,0.9525415896840956,0.5695101096191333,positive. par,negative,pos,neg,negative,neg,0.3652944321676327,0.9370649242774018,0.9985371800750228,,"In a medical study on 'Praziquantel versus artesunate', the outcome is 'Parasitological failure'.",Q96,empty,available
CD000053,Rey 1984 NER,STD-Rey-1984-NER 0.752 0.21 50 62,-0.53467683958817,0.384862471874114,112,Infectious Diseases,efficacy,DICH,1,8,yes,1984.0,Parasitological failure at one month,Metrifonate multiple doses versus single dose,-1.38926728029502,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9973679481385436,"negative
",neg,neg,negative.,neg,negative,neg,0.6488587438935828,0.8423124307192345, negative,"negative 
",neg,neg,0.9908672712417318,0.5807697595749456,positive.,negative,pos,neg,negative,neg,0.373963069061079,0.9755371673208106,0.996024265504053,,"In a medical study on 'Metrifonate multiple doses versus single dose', the outcome is 'Parasitological failure at one month'.",Q97,empty,available
CD000053,Sacko 2009 MLI,STD-Sacko-2009-MLI 1.16 0.098 150 150,0.357600441459675,0.235231531400485,300,Infectious Diseases,efficacy,DICH,1,4,yes,2009.0,Praziquantel 40 mg/single dose versus praziquantel 2 x 40 mg/kg: parasitological failure,Praziquantel 40 mg/kg single dose versus praziquantel 2 x 40 mg/kg or 3 x 40 mg/kg,1.52020623821411,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9933584710945266,"negative
",neg,neg,negative.,neg,negative,neg,0.592558018652334,0.8293598254584145, negative,"negative 
",neg,neg,0.9914038472605068,0.653884313483514,the outcome ',negative,neg,neg,negative,neg,0.3020724227291574,0.9786084335097592,0.998441862772418,,"In a medical study on 'Praziquantel 40 mg/kg single dose versus praziquantel 2 x 40 mg/kg or 3 x 40 mg/kg', the outcome is 'Praziquantel 40 mg/single dose versus praziquantel 2 x 40 mg/kg: parasitological failure'.",Q98,empty,available
CD000053,van den Biggelaar 02 GAB,STD-van-den-Biggelaar-02-GAB 2.707 0.313 41 21,2.91777073208428,0.700937045185045,62,Infectious Diseases,efficacy,DICH,1,5,yes,nan,Parasitological failure,Praziquantel 40 mg/kg single dose versus multiple doses,4.16267160100519,negative,negative,negative,negative.,negative,"negative.

parasito",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9837228599420847,"negative
",neg,neg,negative.,neg,negative,neg,0.5873820168764962,0.7501019875983186, negative,"negative 
",neg,neg,0.9687988087715924,0.5756639592636312,the outcome ',negative,neg,neg,negative,neg,0.3655258679508241,0.971066334499896,0.9996712097084248,,"In a medical study on 'Praziquantel 40 mg/kg single dose versus multiple doses', the outcome is 'Parasitological failure'.",Q99,empty,available
CD000053,Wilkins 1987 GMB,STD-Wilkins-1987-GMB 0.448 0.264 33 39,-1.75785791755237,0.520429048943587,72,Infectious Diseases,efficacy,DICH,1,10,yes,1987.0,Praziquantel 40 mg/kg single dose versus metrifonate 10 mg/kg single dose: parasitological failure,Praziquantel versus metrifonate,-3.37770906739474,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9886695090403284,"negative
",neg,neg,negative.,neg,negative,neg,0.4724236268614088,0.7496525899763024, negative,"negative 
",neg,neg,0.7871666252080688,0.5112477662156155,the outcome ',positive,neg,pos,negative,neg,0.3714729400067793,0.8660583185484028,0.9404686582477024,,"In a medical study on 'Praziquantel versus metrifonate', the outcome is 'Praziquantel 40 mg/kg single dose versus metrifonate 10 mg/kg single dose: parasitological failure'.",Q100,empty,available
CD000054,Martin 1997,STD-Martin-1997 7.426 2 202 203,1.10848891216402,1.63601450199471,405,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1997.0,Neonatal death,Antibiotic therapy versus placebo or no therapy,0.677554453712052,negative,negative,negative,negative.,negative,"negative.

neonatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9987356485666372,"negative
",neg,neg,negative.,neg,negative.,neg,0.7536742212861612,0.8276584461534359, negative,"negative 
",neg,neg,0.9495506814018606,0.5988209104294173,negative.,negative,neg,neg,negative,neg,0.5031037592048043,0.9194119532029632,0.9999349159632668,,"In a medical study on 'Antibiotic therapy versus placebo or no therapy', the outcome is 'Neonatal death'.",Q101,empty,available
CD000055,Canadian Trial,STD-Canadian-Trial 0.363 0.089 1391 1396,-1.05758548217283,0.0953946120934783,2787,Pregnancy & Childbirth,efficacy,DICH,1,1,no,nan,Not complied with allocated procedure,Chorion villus sampling vs amniocentesis,-11.0864278281932,neutral,neutral,negative,negative.,"negative, because it","negative.

the outcome",neu,negative,neu,neg,neg,neg,neg,neg,neu,"negative
",negative,0.5038927153193015,"negative
",neg,neg,negative.,neg,negative,neg,0.658801929938268,0.8340264454316747, negative,"negative 
",neg,neg,0.914800791274229,0.514440817792089,neutral. the,negative,neu,neg,negative,neg,0.4207071128670661,0.9547417160375314,0.8937824829482801,,"In a medical study on 'Chorion villus sampling vs amniocentesis', the outcome is 'Not complied with allocated procedure'.",Q102,empty,available
CD000055,Danish Trial,STD-Danish-Trial 1.931 0.197 1443 1074,0.714200589757778,0.218001980391916,2517,Pregnancy & Childbirth,efficacy,DICH,1,2,no,nan,Number of abnormal karyotypes,Transabdominal CVS vs amniocentesis,3.27611973282909,negative,negative,negative,negative.,"negative

in the","negative.

an abnormal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9965120574531808,"negative
",neg,neg,negative.,neg,negative,neg,0.3267309433797526,0.7861237724113409, negative,"negative 
",neg,neg,0.7119237873229571,0.7609195809148825,positive.,negative,pos,neg,negative,neg,0.3514927893082971,0.5229025646305032,0.6937185075821563,,"In a medical study on 'Transabdominal CVS vs amniocentesis', the outcome is 'Number of abnormal karyotypes'.",Q103,empty,available
CD000056,Connaughton 1974,STD-Connaughton-1974 1.292 0.506 31 31,0.260883879297057,0.511512755603708,62,Gynaecology & Urology,efficacy,DICH,1,1,no,1974.0,Ovulation following all dose ranges,Clomiphene citrate in oligo-amenorrheic women vs placebo,0.510024190871156,positive,positive,positive,positive,positive,"positive.

ovulation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9981324634206146,"positive
",pos,pos,positive.,pos,positive,pos,0.5261927450112935,0.8312693206364412, positive,"positive 
",pos,pos,0.9966231561692924,0.8329611055035357,positive.,positive,pos,pos,positive,pos,0.5937331929773131,0.5021924612051691,0.9983305238490786,,"In a medical study on 'Clomiphene citrate in oligo-amenorrheic women vs placebo', the outcome is 'Ovulation following all dose ranges'.",Q104,empty,available
CD000057,Battacharya 2008,STD-Battacharya-2008 0.789 0.285 192 193,-0.238222788150325,0.28626354111431,385,Gynaecology & Urology,efficacy,DICH,1,1,yes,2008.0,Live birth per woman randomised,Clomiphene versus placebo or no treatment in unexplained subfertility,-0.832179980807261,positive,positive,positive,positive,positive,"positive.

live birth",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997305369916796,"positive
",pos,pos,positive.,pos,positive,pos,0.5780201175349657,0.5898841539360133, positive,"positive 
",pos,pos,0.9283985238477086,0.8477043901740333,positive.,positive,pos,pos,positive,pos,0.5437911685428185,0.983115039765592,0.999652983018083,,"In a medical study on 'Clomiphene versus placebo or no treatment in unexplained subfertility', the outcome is 'Live birth per woman randomised'.",Q105,empty,available
CD000058,Glassman 1988,STD-Glassman-1988 5.182 0.745 33 38,1.90954250488444,0.824957911384305,71,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1988.0,Smoking Cessation,Clonidine vs placebo,2.31471506428754,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9991764929681884,"positive
",pos,pos,positive.,pos,positive,pos,0.6079600216924397,0.5461511711497389, positive,"positive 
",pos,pos,0.9603523878839078,0.8371455799380835,positive. s,positive,pos,pos,positive,pos,0.4458451680544384,0.7653378527453386,0.9899756297038118,,"In a medical study on 'Clonidine vs placebo', the outcome is 'Smoking Cessation'.",Q106,empty,available
CD000059,Essock 1996 (H/CPZ/Flu),STD-Essock-1996-_x0028_H_x002f_CPZ_x002f_Flu_x0029_ 0.645 0.805 138 89,-0.450927482184922,0.828071241531076,227,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1996.0,Death,CLOZAPINE versus TYPICAL ANTIPSYCHOTICS - OVERALL,-0.544551554949755,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997387536307772,"negative
",neg,neg,negative.,neg,negative.,neg,0.8796695528445299,0.7466883793975253, negative,"negative 
",neg,neg,0.997146427870322,0.7100662281814195,the outcome ',negative,neg,neg,negative,neg,0.3848448828833862,0.9927984719208872,0.9997971469430568,,"In a medical study on 'CLOZAPINE versus TYPICAL ANTIPSYCHOTICS - OVERALL', the outcome is 'Death'.",Q107,empty,available
CD000060,Benito Fernandez 2000,STD-Benito-Fernandez-2000 0.667 0.231 51 51,-0.723918839226699,0.405662778132638,102,Lungs,efficacy,DICH,1,1,no,2000.0,Primary outcome: hospital admissions,Anticholinergic and beta2-agonists versus beta2-agonists alone (all protocols),-1.78453355409897,negative,negative,negative,negative.,negative,"negative.

hospital admissions",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9982178535123036,"negative
",neg,neg,negative.,neg,negative.,neg,0.4067218839281881,0.6307074322173838, neutral,"negative 
",neu,neg,0.8459364607896422,0.8300866955685383,the primary outcome,negative,neg,neg,negative,neg,0.4235287673342648,0.8066474225420832,0.999758182843334,,"In a medical study on 'Anticholinergic and beta2-agonists versus beta2-agonists alone (all protocols)', the outcome is 'Primary outcome: hospital admissions'.",Q108,empty,available
CD000061,Daya 1995a,STD-Daya-1995a 1.723 0.362 115 117,0.554114618819437,0.37060024678788,232,Gynaecology & Urology,efficacy,DICH,1,1,no,1995.0,pregnancy per cycle start,FSH vs hMG in IVF: clinical pregnancy,1.49518146202583,positive,positive,positive,positive,positive,"positive.

pregnancy per",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9914884203612162,"positive
",pos,pos,negative.,neg,positive,pos,0.4108079357897709,0.7331549622292531, positive,"positive 
",pos,pos,0.9859345264816638,0.8308411051093519,positive.,positive,pos,pos,positive,pos,0.3859328790583742,0.9268589192055696,0.9998446944204132,,"In a medical study on 'FSH vs hMG in IVF: clinical pregnancy', the outcome is 'pregnancy per cycle start'.",Q109,empty,available
CD000062,Flint 1989,STD-Flint-1989 0.139 0.162 503 498,-2.60217206795214,0.257972984299229,1001,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Antenatal clinic waiting time > 15 min,Continuity of caregivers during pregnancy and childbirth,-10.0869944774288,negative,negative,negative,negative.,negative,"negative.

a longer",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9923041458995252,"negative
",neg,neg,negative.,neg,negative.,neg,0.4052658727823952,0.9077667398080036, negative,"negative 
",neg,neg,0.9850028107997972,0.6103627566077097,negative.,negative,neg,neg,negative,neg,0.4174914442870641,0.9842679889189732,0.8947159504025689,,"In a medical study on 'Continuity of caregivers during pregnancy and childbirth', the outcome is 'Antenatal clinic waiting time > 15 min'.",Q110,empty,available
CD000063,Athens 1993,STD-Athens-1993 1.1 0.168 746 682,0.104976261050519,0.184716749383225,1428,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1993.0,Cesarean delivery,Continuous electronic fetal heart rate monitoring versus intermittent auscultation,0.568309378554126,negative,negative,negative,negative.,negative,"negative.

cesarean",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99861152312721,"neutral
",neg,neu,negative.,neg,negative,neg,0.4397905576395054,0.8584907041085917, negative,"negative 
",neg,neg,0.8857507628800763,0.8093484737010451,the outcome ',negative,neg,neg,negative,neg,0.3668243670350065,0.8072699852763284,0.9805989223707684,,"In a medical study on 'Continuous electronic fetal heart rate monitoring versus intermittent auscultation', the outcome is 'Cesarean delivery'.",Q111,empty,available
CD000064,Bauer 1973,STD-Bauer-1973 0.425 0.616 28 26,-0.890067536775052,0.64297192893037,54,Neurology,efficacy,DICH,1,1,yes,1973.0,All deaths,Corticosteroids versus placebo,-1.38430232600627,negative,negative,negative,negative.,negative,"negative.

all deaths",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9992904089788696,"negative
",neg,neg,negative.,neg,negative,neg,0.7392459347021498,0.7513068710057068, negative,"negative 
",neg,neg,0.9908600142349614,0.8783525859615742,neutral. the,negative,neu,neg,negative,neg,0.2782564144103728,0.9754884998755352,0.9990132065753192,,"In a medical study on 'Corticosteroids versus placebo', the outcome is 'All deaths'.",Q112,empty,available
CD000065,AMSTERDAM 1980,STD-AMSTERDAM-1980 0.507 0.429 64 58,-0.69203791810566,0.439307169019123,122,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1979.0,RDS,Corticosteroids versus placebo or no treatment,-1.57529393306016,negative,negative,negative,negative.,"negative

i am","negative.

rds (",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9984511856528266,"negative
",neg,neg,negative. r,neg,neutral,neu,0.5530715664563878,0.4621440684125106, negative,"negative 
",neg,neg,0.8423440609250329,0.6358193447964916,the outcome ',negative.,neg,neg,negative,neg,0.3600993982865593,0.9729026586139758,0.9997008741919668,,"In a medical study on 'Corticosteroids versus placebo or no treatment', the outcome is 'RDS'.",Q113,empty,available
CD000066,Buchanan 2010,STD-Buchanan-2010 0.801 0.13 122 123,-0.442698178555468,0.257122736074076,245,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,2010.0,Presence of stretch marks,Topical preparations with active ingredients compared with other topical preparations with active ingredient,-1.72173875136397,negative,negative,negative,negative.,negative,"negative.

stretch marks",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9996993356086,"negative
",neg,neg,positive.,pos,negative,neg,0.4612057335285266,0.5682216423283999, negative,"negative 
",neg,neg,0.9170867369829834,0.5534363525495215,the outcome ',negative,neg,neg,negative,neg,0.3429402611403648,0.989287271415312,0.9052560837479732,,"In a medical study on 'Topical preparations with active ingredients compared with other topical preparations with active ingredient', the outcome is 'Presence of stretch marks'.",Q114,empty,available
CD000066,de Buman 1987,STD-de-Buman-1987 0.75 0.342 60 30,-0.405465108108164,0.488762609953839,90,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1987.0,Presence of stretch marks,Topical preparations with active ingredients compared with placebo or no treatment,-0.829574725747655,negative,negative,negative,negative.,negative,"negative.

stretch marks",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9996104782433056,"negative
",neg,neg,positive.,pos,neutral,neu,0.4823061390569171,0.4778304086806753, negative,"negative 
",neg,neg,0.9348675849259104,0.5850528341220083,the outcome ',negative,neg,neg,negative,neg,0.3694812447893413,0.97589999472531,0.9371993451776488,,"In a medical study on 'Topical preparations with active ingredients compared with placebo or no treatment', the outcome is 'Presence of stretch marks'.",Q115,empty,available
CD000067,Candy 1995,STD-Candy-1995 5.542 0.691 24 19,2.47653840011748,0.854547892654552,43,Gastroenterology,efficacy,DICH,1,1,no,1995.0,Maintenance of remission,Azathioprine versus placebo,2.89806858270332,positive,positive,positive,positive,positive,"positive.

maintenance of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999885928056699,"positive
",pos,pos,positive.,pos,positive,pos,0.4782949871669716,0.5402125357677071, positive,"positive 
",pos,pos,0.985036005862605,0.9017102775037492,positive. maint,positive,pos,pos,positive,pos,0.5276344594065243,0.9266162730745198,0.979336882206631,,"In a medical study on 'Azathioprine versus placebo', the outcome is 'Maintenance of remission'.",Q116,empty,available
CD000067,Mantzaris 2004,STD-Mantzaris-2004 1.016 0.164 16 20,0.0800427076735361,0.850150816182876,36,Gastroenterology,efficacy,DICH,1,4,no,2004.0,Maintenance of remission,Azathioprine + infliximab versus infliximab,0.0941511860600486,positive,positive,positive,positive,positive,"positive.

maintenance of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999455754955092,"positive
",pos,pos,positive.,pos,positive,pos,0.4900020781038388,0.6258126563788625, positive,"positive 
",pos,pos,0.9968260260935996,0.9205798439314892,positive. maint,positive,pos,pos,positive,pos,0.5825351132144034,0.8850780753690071,0.985070939633784,,"In a medical study on 'Azathioprine + infliximab versus infliximab', the outcome is 'Maintenance of remission'.",Q117,empty,available
CD000067,Mantzaris 2009,STD-Mantzaris-2009 1.654 0.195 38 39,1.32422193247751,0.498766952500267,77,Gastroenterology,efficacy,DICH,1,3,no,2009.0,Maintenance of remission,Azathioprine versus budesonide,2.65499132578717,positive,positive,positive,positive,positive,"positive.

maintenance of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9996849247766268,"positive
",pos,pos,positive.,pos,positive,pos,0.4647598227266283,0.6003550445233764, positive,"positive 
",pos,pos,0.9924201538582816,0.8960332778556463,positive. maint,positive,pos,pos,positive,pos,0.5812794352238501,0.9346345826797556,0.986977152228968,,"In a medical study on 'Azathioprine versus budesonide', the outcome is 'Maintenance of remission'.",Q118,empty,available
CD000067,Maté-Jiménez 2000,STD-Mat_x00e9__x002d_Jim_x00e9_nez-2000 2.125 1.247 15 1,1.22377543162212,1.70811213297709,16,Gastroenterology,efficacy,DICH,1,2,no,2000.0,Maintenance of remission,Azathioprine or 6-mercaptopurine versus mesalazine or sulfasalazine,0.71644911829599,positive,positive,positive,positive,positive,"positive.

maintenance of",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9998511444200914,"positive
",pos,pos,positive.,pos,positive,pos,0.4754976110101214,0.6382640056891778, positive,"positive 
",pos,pos,0.9981889206172894,0.912165422551334,positive. maint,positive,pos,pos,positive,pos,0.6042991684755288,0.8443457530875429,0.9786408561949288,,"In a medical study on 'Azathioprine or 6-mercaptopurine versus mesalazine or sulfasalazine', the outcome is 'Maintenance of remission'.",Q119,empty,available
CD000069,Iffland 1989,STD-Iffland-1989 0.161 2.009 14 17,-0.969400557188104,1.67219563583754,31,Gynaecology & Urology,efficacy,DICH,1,1,no,1989.0,Live birth/ongoing pregnancies per woman randomised following treatment,Danazol versus placebo in unexplained subfertility,-0.579717191225995,positive,positive,positive,positive,positive,"positive.

live birth",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9981614395267993,"positive
",pos,pos,positive.,pos,positive,pos,0.5744747602179153,0.7003328460805467, positive,"positive 
",pos,pos,0.9283992432272222,0.845703557013388,positive.,positive,pos,pos,positive,pos,0.5425045562554242,0.9689387997621154,0.9991952701671272,,"In a medical study on 'Danazol versus placebo in unexplained subfertility', the outcome is 'Live birth/ongoing pregnancies per woman randomised following treatment'.",Q120,empty,available
CD000070,Li 1987,STD-Li-1987 0.764 0.369 85 73,-0.270656122861854,0.36966338556474,158,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Induction or elective Caesarean,Dietary regulation for 'gestational diabetes',-0.73216913936004,negative,negative,negative,negative.,negative,"negative.

induction or",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.967899138402028,"negative
",neg,neg,negative.,neg,negative,neg,0.3996928805158756,0.8194073392019421, neutral,"negative 
",neu,neg,0.4941790347150516,0.6310451461633638,neutral. the,negative,neu,neg,negative,neg,0.4230834652676027,0.9353518896648167,0.9466096888187024,,"In a medical study on 'Dietary regulation for 'gestational diabetes'', the outcome is 'Induction or elective Caesarean'.",Q121,empty,available
CD000071,AbuRahma 1996,STD-AbuRahma-1996 2.954 1.161 134 130,1.08322736982863,1.16134355773995,264,Neurology,efficacy,DICH,1,1,no,1996.0,Ipsilateral stroke,Perioperative events: synthetic versus vein (< 30 days),0.932736366090202,negative,negative,negative,negative.,negative,"negative.

an ips",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99736806702481,"negative
",neg,neg,negative.,neg,negative.,neg,0.6451336281806789,0.9379906560138608, negative,"negative 
",neg,neg,0.9914170867882676,0.7136773628922862,the outcome ',negative,neg,neg,negative,neg,0.3685091401755713,0.8881972239852051,0.999629634757054,,"In a medical study on 'Perioperative events: synthetic versus vein (< 30 days)', the outcome is 'Ipsilateral stroke'.",Q122,empty,available
CD000071,AbuRahma 2002,STD-AbuRahma-2002 16.123 1.468 100 100,2.7802464923067,1.46764395180007,200,Neurology,efficacy,DICH,1,2,no,2002.0,Ipsilateral Stroke,Perioperative events: Dacron versus other synthetic patch (< 30 days),1.89436033780313,negative,negative,negative,negative.,negative,"negative.

an ips",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9996017817099592,"negative
",neg,neg,negative.,neg,negative.,neg,0.640170258040468,0.9574383975850832, negative,"negative 
",neg,neg,0.9937002691390906,0.6846330924046142,the outcome ',negative,neg,neg,negative,neg,0.4672716917346661,0.923275306587962,0.9995186262882916,,"In a medical study on 'Perioperative events: Dacron versus other synthetic patch (< 30 days)', the outcome is 'Ipsilateral Stroke'.",Q123,empty,available
CD000071,Hayes 2001,STD-Hayes-2001 1.559 0.541 137 139,0.443783972410301,0.541395488317236,276,Neurology,efficacy,DICH,1,3,no,2001.0,Ipsilateral stroke,Events during long-term (> 1 year) follow-up: synthetic versus vein,0.81970386157016,negative,negative,negative,negative.,negative,"negative.

stroke is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997730897080354,"negative
",neg,neg,negative.,neg,negative,neg,0.531676241816262,0.91231313549882, negative,"negative 
",neg,neg,0.9956664113833196,0.7883069199934942,the outcome ',negative,neg,neg,negative,neg,0.3884946746524498,0.8538299784515065,0.9998056074483616,,"In a medical study on 'Events during long-term (> 1 year) follow-up: synthetic versus vein', the outcome is 'Ipsilateral stroke'.",Q124,empty,available
CD000073,Chester 1992,STD-Chester-1992 0.297 0.897 338 336,-1.40124232255576,1.12070487071451,674,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1992.0,Perinatal deaths,Doppler ultrasound in high risk pregnancies,-1.25032232764582,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9924224529710356,"negative
",neg,neg,negative.,neg,negative.,neg,0.6211897897284009,0.8306228532337051, negative,"negative 
",neg,neg,0.9601449672252044,0.6964896659685197,positive.,negative,pos,neg,negative,neg,0.3363635686378181,0.714965568540308,0.9998288447627128,,"In a medical study on 'Doppler ultrasound in high risk pregnancies', the outcome is 'Perinatal deaths'.",Q125,empty,available
CD000074,Peliowski 1990,STD-Peliowski-1990 0.455 0.429 11 10,-1.94591014905531,1.00888906370182,21,Neonatal,efficacy,DICH,1,1,no,1990.0,Failed treatment in first 48 hours,Doxapram vs placebo,-1.92876523204183,negative,negative,negative,negative.,negative,"negative.

failed treatment",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9995268389360196,"negative
",neg,neg,negative.,neg,negative,neg,0.684034282682014,0.9238824691547162, negative,"negative 
",neg,neg,0.9859316294920976,0.6718617064949028,negative.,negative,neg,neg,negative,neg,0.581122505708237,0.9860009300198774,0.9978366310469018,,"In a medical study on 'Doxapram vs placebo', the outcome is 'Failed treatment in first 48 hours'.",Q126,empty,available
CD000075,Eyal 1985,STD-Eyal-1985 1.556 1.116 9 7,0.538996500732687,1.3451854182691,16,Neonatal,efficacy,DICH,1,1,no,1985.0,Failed treatment in the first 48 hrs,Doxapram vs aminophylline,0.400685655235718,negative,negative,negative,negative.,negative,"negative.

failed treatment",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9953175659360954,"negative
",neg,neg,negative.,neg,negative,neg,0.669957436031897,0.9520112375380848, negative,"negative 
",neg,neg,0.9867656187011647,0.7768012072034575,negative. the,negative,neg,neg,negative,neg,0.484965301833109,0.9901107053526876,0.9990688895232404,,"In a medical study on 'Doxapram vs aminophylline', the outcome is 'Failed treatment in the first 48 hrs'.",Q127,empty,available
CD000076,Abraham 1987,STD-Abraham-1987 0.333 0.549 14 14,-1.88706964903238,0.857527571191466,28,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1987.0,Global impression: 1a. Not improved,ECT versus PLACEBO or SHAM ECT,-2.2005935580712,negative,negative,negative,negative.,negative,"negative.

a global",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998727028729668,"negative
",neg,neg,negative.,neg,negative,neg,0.4730923042302943,0.8289549511050543, negative,"negative 
",neg,neg,0.999029982182954,0.5074662277254123,negative.,negative,neg,neg,negative,neg,0.4690646134690628,0.9771431707926892,0.9960745303195168,,"In a medical study on 'ECT versus PLACEBO or SHAM ECT', the outcome is 'Global impression: 1a. Not improved'.",Q128,empty,available
CD000076,Bagadia 1981,STD-Bagadia-1981 1.125 0.211 20 18,0.405465108108165,0.718795288428261,38,Psychiatry & Mental Health,efficacy,DICH,1,2,no,1981.0,Global impression: 1. Not improved - at end of course of ECT,ECT with or without ANTIPSYCHOTIC DRUGS versus ANTIPSYCHOTIC DRUGS with or without SHAM ECT,0.564089824510073,negative,negative,negative,negative.,negative,"negative.

a global",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9996140520970604,"negative
",neg,neg,negative.,neg,negative,neg,0.552138273549722,0.8116050681028155, negative,"negative 
",neg,neg,0.9980726506258076,0.7487880303500086,negative.,negative,neg,neg,negative,neg,0.4780243745666064,0.991157736332036,0.9968950894438297,,"In a medical study on 'ECT with or without ANTIPSYCHOTIC DRUGS versus ANTIPSYCHOTIC DRUGS with or without SHAM ECT', the outcome is 'Global impression: 1. Not improved - at end of course of ECT'.",Q129,empty,available
CD000076,Baker 1960,STD-Baker-1960 2.533 0.41 24 19,1.7227665977411,0.6774426702154,43,Psychiatry & Mental Health,efficacy,DICH,1,9,no,1960.0,Global impression: Not improved,ECT - NUMBER OF TREATMENTS: 12 versus 20 TREATMENTS,2.5430441179522,negative,negative,negative,negative.,negative,"negative.

a global",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.999392901059182,"negative
",neg,neg,negative.,neg,negative,neg,0.5383269019084893,0.6369620032395684, negative,"negative 
",neg,neg,0.999143857209148,0.8436267868990347,negative,negative,neg,neg,negative,neg,0.4034525131657427,0.9782555665587682,0.9782232823620766,,"In a medical study on 'ECT - NUMBER OF TREATMENTS: 12 versus 20 TREATMENTS', the outcome is 'Global impression: Not improved'.",Q130,empty,available
CD000076,Chanpattana 2000,STD-Chanpattana-2000 1 0.282 23 23,0.0,0.590326052690247,46,Psychiatry & Mental Health,efficacy,DICH,1,7,no,2000.0,Global impression: not improved,ECT - DOSE: THRESHOLD versus SUPRATHRESHOLD ECT,0.0,negative,negative,negative,negative.,negative,"negative.

a global",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.999808966769172,"negative
",neg,neg,negative.,neg,negative,neg,0.5645434064734061,0.7687567803486821, negative,"negative 
",neg,neg,0.999480279338763,0.6956836813396244,neutral. the,negative,neu,neg,negative,neg,0.4352138745228035,0.9668415146991348,0.9961608784950676,,"In a medical study on 'ECT - DOSE: THRESHOLD versus SUPRATHRESHOLD ECT', the outcome is 'Global impression: not improved'.",Q131,empty,available
CD000076,Doongaji 1973,STD-Doongaji-1973 0.905 0.431 35 19,-0.143100843640673,0.619346222713713,54,Psychiatry & Mental Health,efficacy,DICH,1,6,no,1973.0,Global impression: 1. Not improved,ECT - ELECTRODE PLACEMENT: UNILATERAL versus BILATERAL ECT,-0.231051451341168,negative,negative,negative,negative.,negative,"negative.

a global",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998464986125436,"negative
",neg,neg,negative.,neg,negative,neg,0.5724068542743981,0.864554857126885, negative,"negative 
",neg,neg,0.9992901361300172,0.7055447969533628,negative.,negative,neg,neg,negative,neg,0.4384289355948644,0.9855579469824146,0.993431252049218,,"In a medical study on 'ECT - ELECTRODE PLACEMENT: UNILATERAL versus BILATERAL ECT', the outcome is 'Global impression: 1. Not improved'.",Q132,empty,available
CD000077,Copenhagen Trial,STD-Copenhagen-Trial 1.37 0.262 581 579,0.331146557916953,0.274947842853416,1160,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1997.0,Not complied with allocated procedure,Early amniocentesis vs chorion villus sampling,1.20439773042154,neutral,neutral,negative,negative.,negative,"negative.

the outcome",neu,negative,neu,neg,neg,neg,neg,neg,neu,"neutral
",Neutral,0.6315789343442781,"negative
",neu,neg,negative.,neg,negative,neg,0.6790952880312551,0.9059965007247116, negative,"negative 
",neg,neg,0.946527125386136,0.5661194187495189,neutral. the,negative,neu,neg,negative,neg,0.4604190091074011,0.9736847911277032,0.921236072259249,,"In a medical study on 'Early amniocentesis vs chorion villus sampling', the outcome is 'Not complied with allocated procedure'.",Q133,empty,available
CD000078,Zlatnik 1993,STD-Zlatnik-1993 0.556 1.181 18 20,-0.635988766719997,1.27058218347627,38,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1993.0,Birth injury to infant,Planned immediate caesarean section versus planned vaginal delivery in singletons (infant outcomes),-0.5005490986659,negative,negative,negative,negative.,negative,"negative.

birth injury",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9722565004330018,"negative
",neg,neg,negative.,neg,negative.,neg,0.6737210108927643,0.9253112438800808, negative,"negative 
",neg,neg,0.9578944099051554,0.6895576350361127,the outcome ',negative,neg,neg,negative,neg,0.3907300863478671,0.8316388413834763,0.9993272780068878,,"In a medical study on 'Planned immediate caesarean section versus planned vaginal delivery in singletons (infant outcomes)', the outcome is 'Birth injury to infant'.",Q134,empty,available
CD000080,Campbell 1975,STD-Campbell-1975 0.629 0.556 51 51,-0.474457979595116,0.569042637953892,102,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1975.0,Pre-eclampsia,Energy/protein restriction in pregnant women with high weight-for-height or weight gain,-0.833782827418919,negative,negative,negative,negative.,negative,"negative.

pre-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99974685094763,"negative
",neg,neg,negative.,neg,negative.,neg,0.5979596277396542,0.8681052647778804, negative,"negative 
",neg,neg,0.9953819192402024,0.7404504157477974,the outcome ',negative,neg,neg,negative,neg,0.3311411160809547,0.9427187056953716,0.9996868161084356,,"In a medical study on 'Energy/protein restriction in pregnant women with high weight-for-height or weight gain', the outcome is 'Pre-eclampsia'.",Q135,empty,available
CD000081,Belizan 1993,STD-Belizan-1993 0.796 0.343 1298 1308,-0.231723139740679,0.347639848163177,2606,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1993.0,Severe perineal/vaginal trauma,Restrictive versus routine episiotomy (where non-instrumental was intended),-0.666560927825257,negative,negative,negative,negative.,negative,"negative.

severe perine",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.999343618712508,"negative
",neg,neg,negative.,neg,negative.,neg,0.6952740559141863,0.893919826148755, negative,"negative 
",neg,neg,0.978373654017404,0.653751774499692,negative. se,negative,neg,neg,negative,neg,0.460611562787574,0.9522945010702648,0.9996719244964946,,"In a medical study on 'Restrictive versus routine episiotomy (where non-instrumental was intended)', the outcome is 'Severe perineal/vaginal trauma'.",Q136,empty,available
CD000081,Murphy 2008b,STD-Murphy-2008b 1.299 0.439 90 85,0.292811300505197,0.491481771527902,175,Pregnancy & Childbirth,efficacy,DICH,1,4,yes,2008.0,Severe perineal/vaginal trauma,Restrictive versus routine episiotomy (operative vaginal birth was intended),0.59577245275021,negative,negative,negative,negative.,negative,"negative.

severe perine",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99858965027926,"negative
",neg,neg,negative.,neg,negative.,neg,0.6758481801521974,0.9152083030964264, negative,"negative 
",neg,neg,0.9740293908689548,0.6538601107407183,negative. se,negative,neg,neg,negative,neg,0.4388433821796488,0.9607131376591016,0.9995747229853186,,"In a medical study on 'Restrictive versus routine episiotomy (operative vaginal birth was intended)', the outcome is 'Severe perineal/vaginal trauma'.",Q137,empty,available
CD000083,Brocks 1984,STD-Brocks-1984 0.643 0.178 31 34,-1.56370190311142,0.603932826944376,65,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1984.0,Vaginal cephalic birth not achieved (CS + breech vaginal birth) (not prespecified),External cephalic version at term versus no ECV attempt,-2.5891983898657,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9477693670764687,"negative
",neg,neg,negative.,neg,negative,neg,0.5228820880354378,0.8038128737763812, negative,"negative 
",neg,neg,0.7964817537458739,0.7945473804546449,neutral. the,negative,neu,neg,negative,neg,0.4429682135867157,0.94485416145474,0.9290402242785588,,"In a medical study on 'External cephalic version at term versus no ECV attempt', the outcome is 'Vaginal cephalic birth not achieved (CS + breech vaginal birth) (not prespecified)'.",Q138,empty,available
CD000084,Akhtar 2013,STD-Akhtar-2013 0.676 0.213 63 60,-0.689220987844664,0.369574907824927,123,Pregnancy & Childbirth,efficacy,DICH,1,3,yes,2013.0,Non-cephalic presentation at the birth,External cephalic version (ECV) commenced before term versus ECV at term,-1.86490200836675,negative,negative,negative,negative.,negative,"negative.

non-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9879476603418632,"negative
",neg,neg,positive.,pos,negative.,neg,0.4078031286293025,0.91554032456554, negative,"negative 
",neg,neg,0.9668999082817246,0.5540731440876401,neutral. the,negative,neu,neg,negative,neg,0.3794812038853836,0.9793269351285186,0.9782779263308788,,"In a medical study on 'External cephalic version (ECV) commenced before term versus ECV at term', the outcome is 'Non-cephalic presentation at the birth'.",Q139,empty,available
CD000084,Mensink 1980,STD-Mensink-1980 1.04 0.247 50 52,0.0645385211375714,0.40568871482127,102,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1980.0,Non-cephalic presentation at the birth,External cephalic version (ECV) before term versus no ECV,0.159083846258835,negative,negative,negative,negative.,negative,"negative.

non-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.991355678863192,"negative
",neg,neg,positive.,pos,negative,neg,0.3974446616095456,0.9204712540960196, negative,"negative 
",neg,neg,0.9830809361914982,0.4950353658105853,neutral. the,negative,neu,neg,negative,neg,0.3691553190739312,0.98506561770168,0.9882356881631038,,"In a medical study on 'External cephalic version (ECV) before term versus no ECV', the outcome is 'Non-cephalic presentation at the birth'.",Q140,empty,available
CD000084,Van Veelen 1989,STD-Van-Veelen-1989 0.589 0.135 89 90,-1.31765976276032,0.322559544340141,179,Pregnancy & Childbirth,efficacy,DICH,1,2,yes,1989.0,Non-cephalic presentation at the birth,External cephalic version (ECV) commenced before term versus no ECV,-4.08501247562167,negative,negative,negative,negative.,negative,"negative.

non-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9958007984069236,"negative
",neg,neg,positive.,pos,negative,neg,0.4029024139188719,0.9380487608258666, negative,"negative 
",neg,neg,0.982009387947498,0.5561114427782179,neutral. the,negative,neu,neg,negative,neg,0.369670336860352,0.9821411493819784,0.9824687472573996,,"In a medical study on 'External cephalic version (ECV) commenced before term versus no ECV', the outcome is 'Non-cephalic presentation at the birth'.",Q141,empty,available
CD000087,Gadir 1990,STD-Gadir-1990 0.535 0.523 29 30,-0.641853886172395,0.534756872121062,59,Gynaecology & Urology,efficacy,DICH,1,1,no,1990.0,Pregnancy per patient,Daily FSH vs HMG for PCOD Patients,-1.20027234736889,positive,positive,positive,positive,positive,"positive.

pregnancy is",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999876632920344,"positive
",pos,pos,negative.,neg,positive,pos,0.4309958558659699,0.6501137413380301, positive,"positive 
",pos,pos,0.9840925940529544,0.9650156547763789,positive.,positive,pos,pos,positive,pos,0.4969584537989313,0.5641113788546778,0.9941079552744218,,"In a medical study on 'Daily FSH vs HMG for PCOD Patients', the outcome is 'Pregnancy per patient'.",Q142,empty,available
CD000088,Bloch 1995,STD-Bloch-1995 1.744 0.498 32 31,0.710388986994452,0.62693772453268,63,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1995.0,Service utilisation: 1. Hospital admission,ANY FAMILY-BASED INTERVENTIONS (> 5 sessions) vs STANDARD CARE,1.13310933318613,negative,negative,negative,negative.,"negative, as hospital admission","negative.

reduced hospital",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9825572590554768,"negative
",neg,neg,negative.,neg,negative.,neg,0.5179427838879304,0.8476750975828808, negative,"negative 
",neg,neg,0.9554515963883916,0.7602082133194781,the outcome ',negative,neg,neg,negative,neg,0.5520662711525309,0.95437555389598,0.4978255356786728,,"In a medical study on 'ANY FAMILY-BASED INTERVENTIONS (> 5 sessions) vs STANDARD CARE', the outcome is 'Service utilisation: 1. Hospital admission'.",Q143,empty,available
CD000088,Leff 1989,STD-Leff-1989 4.364 1.037 11 12,1.83827948486295,1.21809943508986,23,Psychiatry & Mental Health,efficacy,DICH,1,3,no,1989.0,Global state: 1. Relapse,GROUP FAMILY-BASED INTERVENTIONS vs INDIVIDUAL FAMILY-BASED INTERVENTIONS (> 5 sessions),1.50913745783598,negative,negative,negative,negative.,negative,"negative.

relapse",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9992445802432816,"negative
",neg,neg,negative.,neg,negative.,neg,0.528496343265846,0.7401440768677857, negative,"negative 
",neg,neg,0.9980693255949636,0.6330241028469452,negative.,negative,neg,neg,negative,neg,0.4161971749439436,0.9790451900352776,0.9960325440821056,,"In a medical study on 'GROUP FAMILY-BASED INTERVENTIONS vs INDIVIDUAL FAMILY-BASED INTERVENTIONS (> 5 sessions)', the outcome is 'Global state: 1. Relapse'.",Q144,empty,available
CD000088,Schooler 1997,STD-Schooler-1997 0.978 0.071 272 256,-0.0564304364058583,0.177687343768397,528,Psychiatry & Mental Health,efficacy,DICH,1,2,no,1997.0,Service utilisation: Hospital Admission by 19-24 months,BEHAVIOURAL FAMILY-BASED vs SUPPORTIVE FAMILY-BASED INTERVENTIONS (> 5 sessions),-0.317582756369028,negative,negative,negative,negative.,"negative, because hospital","negative.

hospital admission",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99101494503897,"negative
",neg,neg,positive.,pos,negative.,neg,0.4195746484937864,0.820920885542208, negative,"negative 
",neg,neg,0.3908776055028245,0.9211127596316758,positive.,positive,pos,pos,negative,neg,0.3442767045451269,0.4772888379921984,0.9344987054470542,,"In a medical study on 'BEHAVIOURAL FAMILY-BASED vs SUPPORTIVE FAMILY-BASED INTERVENTIONS (> 5 sessions)', the outcome is 'Service utilisation: Hospital Admission by 19-24 months'.",Q145,empty,available
CD000089,Gustafsson 1986,STD-Gustafsson-1986 0.122 0.958 9 8,-2.63905732961526,1.28173988892331,17,Lungs,efficacy,DICH,1,1,no,1986.0,General paediatric assessment - no improvement,FAMILY THERAPY & DRUG THERAPY vs DRUG THERAPY ALONE,-2.05896481214463,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991441162775964,"negative
",neg,neg,negative.,neg,negative.,neg,0.5074446315811701,0.806986373123426, negative,"negative 
",neg,neg,0.9947748459281436,0.6453402882585699,negative.,negative,neg,neg,negative,neg,0.5969422259933994,0.9907699012930316,0.998567609301954,,"In a medical study on 'FAMILY THERAPY & DRUG THERAPY vs DRUG THERAPY ALONE', the outcome is 'General paediatric assessment - no improvement'.",Q146,empty,available
CD000091,AISS 1994,STD-AISS-1994 0.749 0.157 64 68,-0.66865616055165,0.356307499518462,132,Neurology,efficacy,DICH,1,1,yes,1994.0,Death or dependency at the end of follow-up,Fibrinogen depleting agents versus control,-1.87662668188381,negative,negative,negative,negative.,negative,"negative.

death or",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991441162775964,"negative
",neg,neg,negative.,neg,negative.,neg,0.7369682475103646,0.9243370201362504, negative,"negative 
",neg,neg,0.985017961957345,0.7855605233345201,the outcome ',negative,neg,neg,negative,neg,0.5707032502713051,0.992770155971063,0.9991550438716076,,"In a medical study on 'Fibrinogen depleting agents versus control', the outcome is 'Death or dependency at the end of follow-up'.",Q147,empty,available
CD000092,Acton 1988,STD-Acton-1988 1.695 0.199 203 217,0.53130075846847,0.201135984797292,420,Gynaecology & Urology,efficacy,DICH,1,1,no,1988.0,Pregnancy rate (overall),OIL SOLUBLE VERSUS WATER SOLUBLE CONTRAST MEDIA FOR TUBAL FLUSHING,2.6415002715895,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9995121818919622,"positive
",pos,pos,positive.,pos,neutral,neu,0.5401133714073998,0.5925986371361642, positive,"positive 
",pos,pos,0.8207289283958128,0.9285018020146456,neutral. the,positive,neu,pos,positive,pos,0.4400821752804929,0.9745770918226148,0.6306650286345932,,"In a medical study on 'OIL SOLUBLE VERSUS WATER SOLUBLE CONTRAST MEDIA FOR TUBAL FLUSHING', the outcome is 'Pregnancy rate (overall)'.",Q148,empty,available
CD000092,Ogata 1993,STD-Ogata-1993 3.023 0.389 105 85,1.2476478678286,0.456264896389867,190,Gynaecology & Urology,efficacy,DICH,1,3,no,1993.0,Pregnancy rate,OIL SOLUBLE CONTRAST MEDIUM VERSUS NO TREATMENT FOR TUBAL FLUSHING,2.73448138943066,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997347048569816,"positive
",pos,pos,positive.,pos,positive,pos,0.5137336621201954,0.3590467338814335, positive,"positive 
",pos,pos,0.989005130227136,0.9354792482808186,the outcome ',positive,neg,pos,positive,pos,0.3926769243249178,0.8576071456018673,0.997797344869232,,"In a medical study on 'OIL SOLUBLE CONTRAST MEDIUM VERSUS NO TREATMENT FOR TUBAL FLUSHING', the outcome is 'Pregnancy rate'.",Q149,empty,available
CD000093,Barton 2010,STD-Barton-2010 1.196 0.15 100 110,0.330241686870577,0.278144082149491,210,Emergency & Trauma,efficacy,DICH,1,8,no,2010.0,Number of patients transfused,Long Gamma nail versus sliding hip screw (SHS),1.18730437950891,negative,negative,negative,negative.,negative. a higher number,"negative.

transfusion",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9953175659360954,"negative
",neg,neg,negative.,neg,negative,neg,0.5421030943440663,0.4838158820005127," negative

","negative 
",neg,neg,0.6519310459470333,0.4889695530061613,neutral. the,negative.,neu,neg,neutral,neu,0.3734884165884831,0.6521651109736957,0.7763008781735659,,"In a medical study on 'Long Gamma nail versus sliding hip screw (SHS)', the outcome is 'Number of patients transfused'.",Q150,empty,available
CD000093,Davis 1988,STD-Davis-1988 0.694 0.353 116 114,-0.417986614906206,0.402593499340213,230,Emergency & Trauma,efficacy,DICH,1,10,no,1988.0,Fracture fixation complications,Kuntscher-Y nail versus sliding hip screw (SHS),-1.03823488355182,negative,negative,negative,negative.,negative,"negative.

fracture",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9783824942414266,"negative
",neg,neg,positive.,pos,negative.,neg,0.504533122339842,0.8090369455162254, negative,"negative 
",neg,neg,0.9740291640850912,0.7044296777994342,the outcome ',negative,neg,neg,negative,neg,0.358334322367564,0.8925695678909227,0.9965226398317462,,"In a medical study on 'Kuntscher-Y nail versus sliding hip screw (SHS)', the outcome is 'Fracture fixation complications'.",Q151,empty,available
CD000093,Varela-Egocheaga 2009,STD-Varela_x002d_Egocheaga-2009 1.429 0.267 40 40,0.619039208406224,0.458137653866291,80,Emergency & Trauma,efficacy,DICH,1,13,no,2009.0,Number of patients transfused,Gamma nail versus percutaneous compression plate (PCCP),1.35120788082372,negative,negative,negative,negative.,"negative

in","negative.

transfusion",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.996622927579744,"negative
",neg,neg,negative.,neg,negative,neg,0.5090945688925731,0.5588243109312542," neutral

","negative 
",neu,neg,0.3996629830761473,0.5548501469953316,neutral. the,neutral,neu,neu,neutral,neu,0.3126834941616905,0.590853427066998,0.6300626269916644,,"In a medical study on 'Gamma nail versus percutaneous compression plate (PCCP)', the outcome is 'Number of patients transfused'.",Q152,empty,available
CD000094,Angeleri 1992,STD-Angeleri-1992 0.343 0.608 55 57,-1.17865499634165,0.696066481744773,112,Neurology,efficacy,DICH,1,1,no,1992.0,Case fatality at the end of scheduled follow-up,Ganglioside versus control. Intention-to-treat analysis,-1.69330807796865,negative,negative,negative,negative.,negative,"negative.

case fatality",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.979820642425998,"negative
",neg,neg,negative.,neg,negative.,neg,0.4634520890453057,0.8473338042557197, negative,"negative 
",neg,neg,0.9687661401402252,0.904627293053016,the outcome ',negative,neg,neg,negative,neg,0.2905642831065466,0.9726008011510882,0.999925142169393,,"In a medical study on 'Ganglioside versus control. Intention-to-treat analysis', the outcome is 'Case fatality at the end of scheduled follow-up'.",Q153,empty,available
CD000096,Albizzati 1979,STD-Albizzati-1979 1.481 0.493 46 47,0.398907707562005,0.500171969050657,93,Neurology,efficacy,DICH,1,1,no,1979.0,Death within the scheduled treatment period,CI and/or PICH stroke: intravenous glycerol versus avoid glycerol,0.797541110348798,negative,negative,negative,negative.,negative,"negative.

death is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9967266155431675,"negative
",neg,neg,negative.,neg,negative.,neg,0.6398039591239854,0.9080980034078794, negative,"negative 
",neg,neg,0.9944353354195968,0.5299333454858351,the outcome ',negative,neg,neg,negative,neg,0.3676189491295901,0.9843541505970596,0.999534942523692,,"In a medical study on 'CI and/or PICH stroke: intravenous glycerol versus avoid glycerol', the outcome is 'Death within the scheduled treatment period'.",Q154,empty,available
CD000097,Bachus 1990,STD-Bachus-1990 1.712 0.646 33 26,0.56531380905006,0.678568010927825,59,Gynaecology & Urology,efficacy,DICH,1,1,no,1990.0,Pregnancy per cycle,GnRH-a + HMG/FSH vs HMG/FSH,0.833098230311639,positive,positive,positive,positive,positive,"positive.

pregnancy per",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9990600813005656,"positive
",pos,pos,positive.,pos,positive,pos,0.4475683876165675,0.6344862495299065, positive,"positive 
",pos,pos,0.9953899509881972,0.935818421492826,positive.,positive,pos,pos,positive,pos,0.4776848364386758,0.6602515368495885,0.9977753885233976,,"In a medical study on 'GnRH-a + HMG/FSH vs HMG/FSH', the outcome is 'Pregnancy per cycle'.",Q155,empty,available
CD000098,Cavenee 1993,STD-Cavenee-1993 2.485 0.53 84 164,0.85015092936961,0.505820818921781,248,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1993.0,Failure to achieve microbiological cure,Any penicillin versus any other antibiotic,1.68073534652411,negative,negative,negative,negative.,negative,"negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9984022280987928,"negative
",neg,neg,negative.,neg,negative.,neg,0.6767706409464654,0.929044958862746, negative,"negative 
",neg,neg,0.9648491648124704,0.5657376066185852,negative.,negative,neg,neg,negative,neg,0.3016717911019547,0.969330113732468,0.9980040175979452,,"In a medical study on 'Any penicillin versus any other antibiotic', the outcome is 'Failure to achieve microbiological cure'.",Q156,empty,available
CD000098,Ramus 2001,STD-Ramus-2001 1.218 1.021 43 52,0.198450938723838,1.02195413003835,95,Pregnancy & Childbirth,efficacy,DICH,1,4,no,2001.0,Failure to achieve microbiological cure,Ceftriaxone versus cefixime,0.194187716347299,negative,negative,negative,negative.,negative,"negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9910147101684558,"negative
",neg,neg,negative.,neg,negative.,neg,0.6758322279989438,0.924680896171656, negative,"negative 
",neg,neg,0.9496586086053492,0.5036495844189728,negative.,negative,neg,neg,negative,neg,0.5680578094269967,0.972713468089207,0.9996316598100417,,"In a medical study on 'Ceftriaxone versus cefixime', the outcome is 'Failure to achieve microbiological cure'.",Q157,empty,available
CD000099,Owen 1991,STD-Owen-1991 11.842 1.552 13 12,2.47166142303798,1.55160735371967,25,Gynaecology & Urology,efficacy,DICH,1,2,no,1991.0,Live birth rate per woman randomised,Growth hormone versus placebo: Poor responder as defined by the study,1.59296836091467,positive,positive,positive,positive,positive,neutral,pos,negative,pos,pos,pos,pos,neu,neg,pos,"positive
",positive,0.9998910553598984,"positive
",pos,pos,negative.,neg,positive,pos,0.4203119488079458,0.5152903333272767, neutral,"neutral 
",neu,neu,0.647568631392238,0.4702796641945493,the outcome ',positive,neg,pos,positive,pos,0.2831118302328628,0.985232681919494,0.9654356954161764,,"In a medical study on 'Growth hormone versus placebo: Poor responder as defined by the study', the outcome is 'Live birth rate per woman randomised'.",Q158,empty,available
CD000099,Tapanainen 1992,STD-Tapanainen-1992 0.472 1.271 19 19,-0.750305594399894,1.27058218347627,38,Gynaecology & Urology,efficacy,DICH,1,1,no,1992.0,Live birth rate per woman randomised,Growth hormone versus placebo: Routine use,-0.590521104543655,positive,positive,positive,positive,positive,"positive.

live birth",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9995955868370572,"positive
",pos,pos,negative.,neg,positive,pos,0.3932361956101563,0.5644144093785621, positive,"positive 
",pos,pos,0.4325435602448885,0.731827004143574,positive.,positive,pos,pos,positive,pos,0.3318758509979992,0.9844824968034716,0.9589951796276628,,"In a medical study on 'Growth hormone versus placebo: Routine use', the outcome is 'Live birth rate per woman randomised'.",Q159,empty,available
CD000100,Averhoff 1998,STD-Averhoff-1998 1.308 0.126 891 874,0.307150565345716,0.14430914627938,1765,Hepato-Biliary,efficacy,DICH,1,6,no,1998.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (7 months),Different brands of RV (10 µg Recombinvax-HB versus 20 µg Engerix-B by intramuscular route),2.12842063905691,negative,negative,negative,negative,"negative, because a lower","negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9799745412218632,"negative
",neg,neg,negative.,neg,negative,neg,0.5938443964324936,0.6566392089027888, negative,"negative 
",neg,neg,0.9987487970412616,0.809163997298091,neutral. the,negative,neu,neg,negative,neg,0.5852637771887411,0.9772433435337686,0.993694854313754,,"In a medical study on 'Different brands of RV (10 µg Recombinvax-HB versus 20 µg Engerix-B by intramuscular route)', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (7 months)'.",Q160,empty,available
CD000100,Chan 1992,STD-Chan-1992 1.474 0.261 100 100,0.505548566665147,0.338497315444139,200,Hepato-Biliary,efficacy,DICH,1,3,no,1992.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (12 months),Different doses of plasma-derived vaccine (PDV) by intramuscular route,1.49350834880868,negative,negative,negative,negative,negative,"negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9640493960197138,"negative
",neg,neg,negative.,neg,negative,neg,0.6809473351518242,0.8452893058928496, negative,"negative 
",neg,neg,0.9983938545476448,0.726097690161559,neutral. the,negative,neu,neg,negative,neg,0.5884025188607327,0.9757523114576172,0.999002855889429,,"In a medical study on 'Different doses of plasma-derived vaccine (PDV) by intramuscular route', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (12 months)'.",Q161,empty,available
CD000100,Coleman 1991,STD-Coleman-1991 2.208 0.239 209 216,0.939366972182687,0.279389727586139,425,Hepato-Biliary,efficacy,DICH,1,7,no,1991.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at maximum follow-up,Intradermal route versus intramuscular route,3.36221012955127,negative,negative,negative,negative.,negative,"negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.927347400314092,"negative
",neg,neg,negative.,neg,negative,neg,0.6061835548354455,0.8269574846813496, negative,"negative 
",neg,neg,0.9992864458896336,0.5707218236177497,neutral. the,negative.,neu,neg,negative,neg,0.581942574788214,0.7323513550997068,0.997971604472977,,"In a medical study on 'Intradermal route versus intramuscular route', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at maximum follow-up'.",Q162,empty,available
CD000100,Crosnier 1981,STD-Crosnier-1981 0.686 0.236 184 170,-0.454571778056469,0.284199733223705,354,Hepato-Biliary,efficacy,DICH,1,1,no,1981.0,Hepatitis B events at maximum follow-up - Risk of infection,Plasma-derived vaccine (PDV) versus placebo by intramuscular route,-1.59947996044971,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9912887338832987,"negative
",neg,neg,negative.,neg,negative,neg,0.4891927077887093,0.8291260370254114, negative,"negative 
",neg,neg,0.9133866669353784,0.7746927731758387,the outcome ',negative,neg,neg,negative,neg,0.4609573457832279,0.4930044567899563,0.98911533194984,,"In a medical study on 'Plasma-derived vaccine (PDV) versus placebo by intramuscular route', the outcome is 'Hepatitis B events at maximum follow-up - Risk of infection'.",Q163,empty,available
CD000100,de Lalla 1988,STD-de-Lalla-1988 21.127 1.011 71 75,3.36797173403383,1.04073116444679,146,Hepato-Biliary,efficacy,DICH,1,2,no,1988.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at one year follow-up,Gluteal intramuscular injection versus deltoid intramuscular injection (20 µg plasma-derived vaccine),3.23615920142462,negative,negative,negative,negative,"negative, because having a","negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9863092722717696,"negative
",neg,neg,negative.,neg,negative,neg,0.6279996230294338,0.6106159261163847, negative,"negative 
",neg,neg,0.9988938897945706,0.7676322739929236,neutral. the,negative.,neu,neg,negative,neg,0.623427539959862,0.685650377993545,0.9970386960159444,,"In a medical study on 'Gluteal intramuscular injection versus deltoid intramuscular injection (20 µg plasma-derived vaccine)', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at one year follow-up'.",Q164,empty,available
CD000100,Halliday 1990,STD-Halliday-1990 1.451 0.256 600 200,0.415036689251665,0.282316603273711,800,Hepato-Biliary,efficacy,DICH,1,5,no,1990.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at maximum follow-up,Recombinant vaccine (RV) versus plasma-derived vaccine (PDV),1.47011080623296,negative,negative,negative,negative.,"negative, because a lower","negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9540413620759244,"negative
",neg,neg,negative.,neg,negative,neg,0.5970593685883553,0.8109659176354571, negative,"negative 
",neg,neg,0.998183813094652,0.7528492000680493,neutral. the,negative,neu,neg,negative,neg,0.5356810037481063,0.9188035048394464,0.9989153004717148,,"In a medical study on 'Recombinant vaccine (RV) versus plasma-derived vaccine (PDV)', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at maximum follow-up'.",Q165,empty,available
CD000100,Pennie 1992,STD-Pennie-1992 1.27 0.184 349 344,0.280900826995294,0.215045365573771,693,Hepato-Biliary,efficacy,DICH,1,4,no,1992.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (7 months),Plasma-derived vaccines (PDV) produced in different countries: 20 µg by intramuscular route,1.30623985430149,negative,negative,negative,negative.,negative,"negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9586923801860312,"negative
",neg,neg,negative.,neg,negative,neg,0.7384898347525543,0.7192734533530055, negative,"negative 
",neg,neg,0.9995925894864656,0.8520973696388298,neutral. the,negative,neu,neg,negative,neg,0.6518781621929198,0.8982850492691009,0.9980327521486276,,"In a medical study on 'Plasma-derived vaccines (PDV) produced in different countries: 20 µg by intramuscular route', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) at follow-up (7 months)'.",Q166,empty,available
CD000100,Ricciardi 1990,STD-Ricciardi-1990 5.2 0.768 50 65,1.79175946922805,0.815280650869711,115,Hepato-Biliary,efficacy,DICH,1,8,no,1990.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) by recombinant vaccine,"Rapid schedule (0, 1, and 2 months) versus standard schedule (0, 1, and 6 months)",2.19772107594688,negative,negative,negative,negative,"negative, because having a","negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9871275528708264,"negative
",neg,neg,negative.,neg,negative,neg,0.5548997236072953,0.6138214043884112, negative,"negative 
",neg,neg,0.999736259406968,0.8951007901796247,neutral. the,negative,neu,neg,negative,neg,0.7550424079306423,0.9677550259119808,0.9943778103556812,,"In a medical study on 'Rapid schedule (0, 1, and 2 months) versus standard schedule (0, 1, and 6 months)', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) by recombinant vaccine'.",Q167,empty,available
CD000100,Williams 2001,STD-Williams-2001 1.154 0.28 13 15,0.405465108108165,0.799305253885453,28,Hepato-Biliary,efficacy,DICH,1,9,no,2001.0,Number of health-care workers without protective anti-HBs level (< 10 IU/litre) after booster vaccination,Booster vaccination with recombinant vaccine in non-responders,0.507271916626574,negative,negative,negative,negative.,"negative, because it","negative.

a protective",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.8971418690080147,"negative
",neg,neg,negative.,neg,negative,neg,0.6038245879964147,0.7530888841214318, negative,"negative 
",neg,neg,0.9932698650062812,0.5684649729212891,neutral. the,negative,neu,neg,negative,neg,0.4895794977892183,0.991917897682368,0.9955897193892304,,"In a medical study on 'Booster vaccination with recombinant vaccine in non-responders', the outcome is 'Number of health-care workers without protective anti-HBs level (< 10 IU/litre) after booster vaccination'.",Q168,empty,available
CD000101,Harrison 1985,STD-Harrison-1985 0.054 0.914 10 10,-3.80666248977032,1.58564993434418,20,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1985.0,Miscarriage,HCG vs placebo for recurrent spontaneous miscarriage (RSM),-2.40069539141042,negative,negative,negative,negative.,negative,"negative.

miscarriage",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9999251418860085,"negative
",neg,neg,negative.,neg,negative,neg,0.741235826446403,0.8779549042185048, negative,"negative 
",neg,neg,0.985033808724941,0.6997887068088339,the outcome ',negative,neg,neg,negative,neg,0.4362350357219844,0.95908125301393,0.999224311275048,,"In a medical study on 'HCG vs placebo for recurrent spontaneous miscarriage (RSM)', the outcome is 'Miscarriage'.",Q169,empty,available
CD000102,"Connor AN, IP, PNb",STD-Connor-AN_x002c_-IP_x002c_-PNb 0.305 0.357 121 127,-1.39091330697619,0.403378747236983,248,Infectious Diseases,efficacy,DICH,1,1,no,1994.0,HIV infection status in the child,Any zidovudine vs placebo/no treatment,-3.44815713892589,negative,negative,negative,negative.,"negative, because hiv infection","positive.

hiv infection",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.9976752015395272,"negative
",neg,neg,negative.,neg,negative,neg,0.5272251147981499,0.6757612333990792, negative,"positive 
",neg,pos,0.551542068912983,0.8077515398405641,positive.,positive,pos,pos,negative,neg,0.4436809799418234,0.8807854839234128,0.8696310465170216,,"In a medical study on 'Any zidovudine vs placebo/no treatment', the outcome is 'HIV infection status in the child'.",Q170,empty,available
CD000102,"Guay IP, PNb",STD-Guay-IP_x002c_-PNb 0.578 0.185 246 250,-0.685447784137899,0.229350685223008,496,Infectious Diseases,efficacy,DICH,1,7,no,1999.0,HIV infection status in the child,Nevirapine versus zidovudine,-2.98864502397893,neutral,neutral,negative,negative.,"negative, because hiv","positive.

hiv infection",neg,negative,neu,neg,neg,neg,pos,neg,neu,"negative
",negative,0.9725165953576688,"negative
",neg,neg,negative.,neg,negative.,neg,0.5117518508712569,0.6774340731992463, neutral,"positive 
",neu,pos,0.5024404574846616,0.5430647071337998,positive.,positive,pos,pos,negative,neg,0.4012761050144485,0.9436355853191823,0.9185293513026134,,"In a medical study on 'Nevirapine versus zidovudine', the outcome is 'HIV infection status in the child'.",Q171,empty,available
CD000102,MOD,STD-MOD 0.168 0.608 170 200,-1.87651815563131,0.626519749954658,370,Infectious Diseases,efficacy,DICH,1,5,no,1999.0,HIV infection status in the child,Caesarean section versus vaginal delivery,-2.99514605208713,negative,negative,negative,negative.,"negative, as hiv infection","negative.

hiv infection",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9989995880460348,"negative
",neg,neg,negative.,neg,negative.,neg,0.7193777685867382,0.7638184008157594, neutral,"neutral 
",neu,neu,0.3977853447909106,0.7083315737791944,positive.,positive,pos,pos,neutral,neu,0.3549344504799191,0.5554128154398418,0.5360221148394817,,"In a medical study on 'Caesarean section versus vaginal delivery', the outcome is 'HIV infection status in the child'.",Q172,empty,available
CD000102,"Stiehm AN, IP, PNb",STD-Stiehm-AN_x002c_-IP_x002c_-PNb 0.674 0.423 230 224,-0.414029348167004,0.444182858071884,454,Infectious Diseases,efficacy,DICH,1,6,no,1999.0,HIV infection status in the child,HIVIG plus zidovudine versus IVIG plus zidovudine,-0.932114647477009,negative,negative,negative,negative.,"neutral, as the","positive.

hiv infection",neg,negative,neg,neg,neg,neu,pos,neg,neg,"negative
",negative,0.8391802806262064,"negative
",neg,neg,negative.,neg,negative,neg,0.4893027922180014,0.6228696217565199, neutral,"negative 
",neu,neg,0.5385656484189544,0.5226852482026256,neutral. the,positive,neu,pos,negative,neg,0.2853855411223808,0.8934880350692573,0.7914738401018816,,"In a medical study on 'HIVIG plus zidovudine versus IVIG plus zidovudine', the outcome is 'HIV infection status in the child'.",Q173,empty,available
CD000103,ALIAS-Part 1 2011,STD-ALIAS_x002d_Part-1-2011 1.514 0.423 207 217,0.437404700763307,0.444967998306775,424,Neurology,efficacy,DICH,1,1,no,2011.0,Mortality at early follow-up (not later than 28 days),"Haemodilution, all types, versus control",0.983002603395642,negative,negative,negative,negative.,negative,"negative.

mortality at",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9940885279176253,"negative
",neg,neg,negative.,neg,negative.,neg,0.5598371072717868,0.8062642684226262, negative,"negative 
",neg,neg,0.9932904472229171,0.8665241435191523,positive.,negative,pos,neg,negative,neg,0.3239117524737668,0.952413217372764,0.999557571742546,,"In a medical study on 'Haemodilution, all types, versus control', the outcome is 'Mortality at early follow-up (not later than 28 days)'.",Q174,empty,available
CD000104,Clark 1992,STD-Clark-1992 1.059 0.529 37 28,0.0707690708882072,0.647818444519791,65,Neonatal,efficacy,DICH,1,1,yes,1992.0,Death by 28 to 30 days,HFOV versus CV (all trials),0.109242136414727,negative,negative,negative,negative.,negative,"negative.

death within",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9951321585304722,"negative
",neg,neg,negative.,neg,negative.,neg,0.702224730884021,0.8662367394407379, negative,"negative 
",neg,neg,0.9975221907669928,0.5033569158643609,the outcome ',negative,neg,neg,negative,neg,0.2683414255385286,0.9824866996296576,0.999864954118506,,"In a medical study on 'HFOV versus CV (all trials)', the outcome is 'Death by 28 to 30 days'.",Q175,empty,available
CD000104,Dani 2006,STD-Dani-2006 1.846 1.157 13 12,0.693147180559945,1.29684932888065,25,Neonatal,efficacy,DICH,1,6,yes,2006.0,Death by 36 to 37 weeks or discharge,HFOV versus CV subgrouped by age at randomisation,0.534485514333592,negative,neutral,negative,negative,"negative, because death","negative.

death during",neg,negative,neu,neg,neg,neg,neg,neg,neg,"negative
",negative,0.94787980949302,"negative
",neg,neg,negative.,neg,negative,neg,0.6106703216816599,0.7219184505975632, negative,"negative 
",neg,neg,0.7251498977769181,0.5845031283267936,positive.,negative,pos,neg,negative,neg,0.3448643788702624,0.7838210440813053,0.9990424750574808,,"In a medical study on 'HFOV versus CV subgrouped by age at randomisation', the outcome is 'Death by 36 to 37 weeks or discharge'.",Q176,empty,available
CD000105,Rush 1980,STD-Rush-1980 1.694 0.249 249 256,0.534773035057438,0.253817554364473,505,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1980.0,SGA,High protein supplementation in pregnancy,2.10691902849841,negative,negative,negative,negative.,"negative

sga","negative.

sga",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.995094260639003,"negative
",neg,neg,positive.,pos,negative,neg,0.3510170300793753,0.7782286097720849, negative,"negative 
",neg,neg,0.9737223140263116,0.6328095242898655,the outcome ',negative.,neg,neg,negative,neg,0.3428892854932087,0.986967513606674,0.9989566970900982,,"In a medical study on 'High protein supplementation in pregnancy', the outcome is 'SGA'.",Q177,empty,available
CD000106,Cameron 1993,STD-Cameron-1993 0.984 0.26 127 125,-0.0196084713883762,0.320847411235342,252,Emergency & Trauma,efficacy,DICH,1,1,no,1993.0,Dead by the end of scheduled follow-up,Organised inpatient rehabilitation vs Conventional care,-0.0611146317586877,negative,negative,negative,negative.,negative,"negative.

the outcome",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9968270208719808,"negative
",neg,neg,negative.,neg,negative.,neg,0.7181714366707123,0.901232097455226, negative,"negative 
",neg,neg,0.9919204778466396,0.813964786594002,negative.,negative,neg,neg,negative,neg,0.4337339076205363,0.9700801469266668,0.9999187058723578,,"In a medical study on 'Organised inpatient rehabilitation vs Conventional care', the outcome is 'Dead by the end of scheduled follow-up'.",Q178,empty,available
CD000107,Brooks-Gunn 1994,STD-Brooks_x002d_Gunn-1994 1.047 0.321 345 551,0.0455014602422144,0.319747729101975,896,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1994.0,Child injury,Additional home based support vs usual support for socially disadvantaged mothers,0.142304248321035,negative,negative,negative,negative.,negative,"negative.

child injury",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991306657901246,"negative
",neg,neg,negative.,neg,negative.,neg,0.6838635320650074,0.9233319150965728, negative,"negative 
",neg,neg,0.9755308130142402,0.6033598384321793,negative.,negative,neg,neg,negative,neg,0.386486023591979,0.9676580156926864,0.9988331121506548,,"In a medical study on 'Additional home based support vs usual support for socially disadvantaged mothers', the outcome is 'Child injury'.",Q179,empty,available
CD000108,Duenhoelter 1976,STD-Duenhoelter-1976 0.557 0.622 315 307,-0.595626225458455,0.631985688345929,622,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1976.0,Fetal death,Oestriol levels reported versus not reported,-0.94246790147632,negative,negative,negative,negative.,negative,"negative.

fetal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9971987223211012,"negative
",neg,neg,negative.,neg,negative.,neg,0.674091037847208,0.8144583204520647, negative,"negative 
",neg,neg,0.9932779800813308,0.6128353649708695,positive.,negative,pos,neg,negative,neg,0.3342613491663543,0.9802983435246696,0.9996035479401092,,"In a medical study on 'Oestriol levels reported versus not reported', the outcome is 'Fetal death'.",Q180,empty,available
CD000110,Crowther 1989,STD-Crowther-1989 0.986 0.993 140 138,-0.0145987994211527,1.00727320920794,278,Pregnancy & Childbirth,efficacy,DICH,1,1,yes,1989.0,Perinatal death,Hospitalisation for bed rest for women with a multiple pregnancy,-0.0144933859926964,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9750102404634604,"negative
",neg,neg,negative.,neg,negative.,neg,0.6507613984896357,0.8754498801023657, negative,"negative 
",neg,neg,0.9858999954709488,0.6108915207671815,negative.,negative,neg,neg,negative,neg,0.5053944419443572,0.6587343734018346,0.9998364716001732,,"In a medical study on 'Hospitalisation for bed rest for women with a multiple pregnancy', the outcome is 'Perinatal death'.",Q181,empty,available
CD000111,Cammu 1994,STD-Cammu-1994 0.935 0.071 54 56,-0.573187865480966,0.605266035369603,110,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1994.0,Mode of birth (spontaneous vaginal birth),Immersion in water versus no immersion during first stage of labour,-0.947001536491225,positive,positive,positive,positive,positive,"positive.

spontaneous",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9995364907536158,"positive
",pos,pos,positive.,pos,positive,pos,0.4308994288161781,0.666901458877098, positive,"positive 
",pos,pos,0.880777989736479,0.9529727050317242,positive.,positive,pos,pos,positive,pos,0.4388222215927757,0.8858107200716719,0.998562973436008,,"In a medical study on 'Immersion in water versus no immersion during first stage of labour', the outcome is 'Mode of birth (spontaneous vaginal birth)'.",Q182,empty,available
CD000111,Chaichian 2009,STD-Chaichian-2009 1.259 0.072 53 53,3.36567179390073,1.45917014850527,106,Pregnancy & Childbirth,efficacy,DICH,1,3,yes,2009.0,Mode of birth (spontaneous vaginal birth),Immersion in water versus no immersion during any stage of labour,2.30656568553601,positive,positive,positive,positive,positive,neutral,pos,negative,pos,pos,pos,pos,neu,neg,pos,"positive
",positive,0.9993629030724864,"positive
",pos,pos,positive.,pos,positive,pos,0.3840038211341527,0.6868012851477844, positive,"positive 
",pos,pos,0.730745279686145,0.9453943602917728,positive.,positive,pos,pos,positive,pos,0.4414985860702789,0.9056247220111088,0.9979281525447108,,"In a medical study on 'Immersion in water versus no immersion during any stage of labour', the outcome is 'Mode of birth (spontaneous vaginal birth)'.",Q183,empty,available
CD000111,Eriksson 1997,STD-Eriksson-1997 2.211 0.238 100 100,1.12723678324295,0.325619657084124,200,Pregnancy & Childbirth,efficacy,DICH,1,4,no,1997.0,Use of pharmacological analgesia (epidural/spinal analgesia/paracervical block),Early versus late immersion in water,3.46182043595643,neutral,negative,negative,negative.,"neutral

","positive.

pharmacological",neg,negative,neg,neg,neg,neu,pos,neg,neu,"negative
",negative,0.9683805556124307,"negative
",neg,neg,positive.,pos,negative,neg,0.4124158663354641,0.5770347847031747, neutral,"negative 
",neu,neg,0.9072546454928214,0.5891088621012681,the outcome ',positive,neg,pos,neutral,neu,0.4181095079828617,0.655954657476551,0.8577521906220037,,"In a medical study on 'Early versus late immersion in water', the outcome is 'Use of pharmacological analgesia (epidural/spinal analgesia/paracervical block)'.",Q184,empty,available
CD000111,Nikodem 1999,STD-Nikodem-1999 1.017 0.029 60 60,0.710241613919242,1.23862445149961,120,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1999.0,Mode of birth (spontaneous vaginal birth),Immersion in water versus no immersion during second stage of labour,0.573411588201207,positive,positive,positive,positive,positive,"neutral.

the mode",pos,negative,pos,pos,pos,pos,neu,neg,pos,"positive
",positive,0.999182444580694,"positive
",pos,pos,positive.,pos,positive,pos,0.4150734610390214,0.6575200099643945, positive,"positive 
",pos,pos,0.8595737736586275,0.9470079732078608,positive.,positive,pos,pos,positive,pos,0.3990717595031077,0.9139248289312067,0.9984448337161088,,"In a medical study on 'Immersion in water versus no immersion during second stage of labour', the outcome is 'Mode of birth (spontaneous vaginal birth)'.",Q185,empty,available
CD000112,Cauchi 1991,STD-Cauchi-1991 0.703 0.66 20 22,-0.361790044605503,0.670034988972133,42,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1991.0,Live birth rate,Paternal white cell immunization versus placebo,-0.539956943383668,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.99950444378856,"positive
",pos,pos,positive.,pos,positive,pos,0.581016974522773,0.5790580051080633, positive,"positive 
",pos,pos,0.8437029832844343,0.8516449220674049,positive.,positive,pos,pos,positive,pos,0.3518947677511376,0.8382743415833545,0.9424791226614178,,"In a medical study on 'Paternal white cell immunization versus placebo', the outcome is 'Live birth rate'.",Q186,empty,available
CD000112,Christiansen 1995,STD-Christiansen-1995 3.447 0.87 14 8,1.38629436111989,0.978945010372561,22,Pregnancy & Childbirth,efficacy,DICH,1,4,no,1995.0,Live birth rate,Intravenous immunoglobulin versus placebo,1.4161105541488,positive,positive,positive,positive,positive,"positive.

a live",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9997305369916796,"positive
",pos,pos,positive.,pos,positive,pos,0.4345828303951781,0.6266101818791588, positive,"positive 
",pos,pos,0.8990961007217836,0.8638827357041617,positive.,positive,pos,pos,positive,pos,0.4360959491557285,0.7372945635606263,0.880050320605456,,"In a medical study on 'Intravenous immunoglobulin versus placebo', the outcome is 'Live birth rate'.",Q187,empty,available
CD000112,Johnson 1991,STD-Johnson-1991 0.396 0.663 17 20,-0.965080896043587,0.688626422094265,37,Pregnancy & Childbirth,efficacy,DICH,1,3,no,1991.0,Live birth rate,Trophoblast membrane immunization versus placebo,-1.40145783704982,positive,positive,positive,positive,positive,"positive.

a live",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.999931812914845,"positive
",pos,pos,positive.,pos,positive,pos,0.6146610737056079,0.5330257113921668, positive,"positive 
",pos,pos,0.9688497194645022,0.8821360157701454,positive,positive,pos,pos,positive,pos,0.3341970422014599,0.7535205346780953,0.9984012218245056,,"In a medical study on 'Trophoblast membrane immunization versus placebo', the outcome is 'Live birth rate'.",Q188,empty,available
CD000114,Barkai 1989,STD-Barkai-1989 2.231 0.296 84 84,1.05769316433378,0.379041106963134,168,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1989.0,Failure to obtain sample greater than 5 mg,Portex cannula compared with silver cannula (transcervical),2.79044447924919,negative,negative,negative,negative.,"negative, as it indicates","negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9889749760050592,"negative
",neg,neg,negative.,neg,negative,neg,0.547407439926323,0.9113596451083292, negative,"negative 
",neg,neg,0.9808746816262268,0.580817359316392,negative. the,negative,neg,neg,negative,neg,0.4291076236072819,0.9915356788853642,0.9977245962736536,,"In a medical study on 'Portex cannula compared with silver cannula (transcervical)', the outcome is 'Failure to obtain sample greater than 5 mg'.",Q189,empty,available
CD000114,Battagliarin 2009,STD-Battagliarin-2009 1.02 0.324 99 101,0.0238106486937188,0.385762749178089,200,Pregnancy & Childbirth,efficacy,DICH,1,7,no,2009.0,Failure to obtain sample > 5 mg on first attempt,Standard syringe with hand-grip device compared with vacutainer needle techniques (transabdominal),0.0617235561091632,negative,negative,negative,negative.,negative,"negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9690452660427884,"negative
",neg,neg,negative.,neg,negative.,neg,0.5221610569057945,0.9294155218238848, negative,"negative 
",neg,neg,0.9840920166533054,0.5531009066490882,negative. this,negative,neg,neg,negative,neg,0.3431015363364048,0.9904662140041564,0.9974616986325036,,"In a medical study on 'Standard syringe with hand-grip device compared with vacutainer needle techniques (transabdominal)', the outcome is 'Failure to obtain sample > 5 mg on first attempt'.",Q190,empty,available
CD000114,Buyukkurt 2010,STD-Buyukkurt-2010 2.735 0.474 43 42,1.27324149983891,0.577008108328027,85,Pregnancy & Childbirth,efficacy,DICH,1,8,no,2010.0,Failure to obtain sample > 5 mg on first attempt,Standard syringe compared with fixed piston syringe needle techniques (transabdominal),2.20662670326822,negative,negative,negative,negative.,negative,"negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.981942198851546,"negative
",neg,neg,negative.,neg,negative,neg,0.5214408024838891,0.9204234821924075, negative,"negative 
",neg,neg,0.9755751722803506,0.5643896159752182,negative. this,negative,neg,neg,negative,neg,0.379264871106967,0.9908037216373624,0.997270188516318,,"In a medical study on 'Standard syringe compared with fixed piston syringe needle techniques (transabdominal)', the outcome is 'Failure to obtain sample > 5 mg on first attempt'.",Q191,empty,available
CD000114,Chalkiadakis 1993,STD-Chalkiadakis-1993 0.111 1.438 12 12,-2.5828870581482,1.55559290337985,24,Pregnancy & Childbirth,efficacy,DICH,1,6,no,1993.0,First insertion failed,Flexible catheter compared with catheter with a stiff guided probe (transcervical),-1.6603875297556,negative,negative,negative,negative.,negative,"negative.

first insertion",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9964889875692354,"negative
",neg,neg,negative.,neg,negative,neg,0.5479876777619929,0.9263161639009464, negative,"negative 
",neg,neg,0.9883081070702148,0.5464266727866499,negative. the,negative,neg,neg,negative,neg,0.3692168896418728,0.9957177032448052,0.984306565023823,,"In a medical study on 'Flexible catheter compared with catheter with a stiff guided probe (transcervical)', the outcome is 'First insertion failed'.",Q192,empty,available
CD000114,MacKenzie 1986,STD-MacKenzie-1986 1.87 0.321 35 31,1.06566813294876,0.521245849396448,66,Pregnancy & Childbirth,efficacy,DICH,1,3,no,1986.0,Difficult insertion,Portex cannula compared with malleable cannula (transcervical),2.04446353708657,negative,negative,negative,negative.,negative,"negative.

difficult insertion",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9964616624221702,"negative
",neg,neg,negative.,neg,negative,neg,0.6661904844040656,0.8920547345690368, negative,"negative 
",neg,neg,0.9914207191716552,0.5269699107754607,negative. the,negative,neg,neg,negative,neg,0.4510510716288464,0.955875657043646,0.9914196647265048,,"In a medical study on 'Portex cannula compared with malleable cannula (transcervical)', the outcome is 'Difficult insertion'.",Q193,empty,available
CD000114,Pons 1989,STD-Pons-1989 5.333 0.406 60 60,2.33075596996074,0.502144870430308,120,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Failure to obtain sample > 5 mg,Aspiration cannula compared with biopsy forceps (transcervical),4.64160067584365,negative,negative,negative,negative.,negative,"negative.

a failure",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9970401315734108,"negative
",neg,neg,negative.,neg,negative,neg,0.5534612915685702,0.8896565401882771, negative,"negative 
",neg,neg,0.9755749469537316,0.5111767087209838,negative. the,negative,neg,neg,negative,neg,0.3699794938823532,0.9906302011424428,0.996837516320904,,"In a medical study on 'Aspiration cannula compared with biopsy forceps (transcervical)', the outcome is 'Failure to obtain sample > 5 mg'.",Q194,empty,available
CD000115,Boyer 1986,STD-Boyer-1986 0.138 0.342 85 79,-2.28968168815814,0.434313295476939,164,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1983.0,Infant colonisation with Group B strep,Intrapartum antibiotics for Group B streptococcal colonisation,-5.27195854237835,negative,negative,negative,negative.,"negative, as infant","negative.

infant colon",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9963214058662936,"negative
",neg,neg,negative.,neg,negative,neg,0.4499164595492359,0.8111793067036712, negative,"negative 
",neg,neg,0.9668510990441423,0.6801828502463229,positive.,positive,pos,pos,negative,neg,0.3291825319313419,0.76418648522425,0.9116175446508414,,"In a medical study on 'Intrapartum antibiotics for Group B streptococcal colonisation', the outcome is 'Infant colonisation with Group B strep'.",Q195,empty,available
CD000116,Amer-Wahlin 2001,STD-Amer_x002d_Wahlin-2001 0.919 0.092 2519 2447,-0.0926274659089659,0.100741924666464,4966,Pregnancy & Childbirth,efficacy,DICH,1,1,no,2001.0,Caesarean section,Fetal ECG plus CTG versus CTG alone,-0.919453010408887,negative,negative,negative,neutral.,negative,"negative.

a caes",neg,negative,neg,neg,neu,neg,neg,neg,neg,"negative
",negative,0.997468316529763,"neutral
",neg,neu,negative.,neg,negative,neg,0.437795578259005,0.6842001005713546, negative,"negative 
",neg,neg,0.8641027994545538,0.7935083826791018,positive.,positive,pos,pos,negative,neg,0.4121661652597037,0.7578088210902069,0.9737469552546772,,"In a medical study on 'Fetal ECG plus CTG versus CTG alone', the outcome is 'Caesarean section'.",Q196,empty,available
CD000117,Burma 1976,STD-Burma-1976 0.055 0.616 30 25,-4.34267547823064,1.47942858030606,55,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1976.0,Low pre delivery haemoglobin,Routine iron versus no iron or placebo in pregnancy,-2.93537351923553,negative,negative,negative,negative.,negative,"negative.

low pre",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9987934426763122,"negative
",neg,neg,negative.,neg,negative,neg,0.5219089263106604,0.9529751972051638, negative,"negative 
",neg,neg,0.9971978725938258,0.7535620132742069,negative.,negative,neg,neg,negative,neg,0.5162521385643122,0.993195423098144,0.9998361140890488,,"In a medical study on 'Routine iron versus no iron or placebo in pregnancy', the outcome is 'Low pre delivery haemoglobin'.",Q197,empty,available
CD000117,Finland 1991,STD-Finland-1991 1.357 0.138 1358 1336,0.307574780664184,0.139295564668137,2694,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1991.0,Caesarean section,Selective versus routine iron in pregnancy,2.20807303805374,negative,negative,negative,negative.,negative,"negative.

caes",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9979493526561224,"negative
",neg,neg,negative.,neg,negative,neg,0.5080548191552481,0.9201705710746324, negative,"negative 
",neg,neg,0.8663247631098298,0.7319321802165119,the outcome ',negative,neg,neg,negative,neg,0.4119474540144248,0.9608090937070614,0.9957721921215246,,"In a medical study on 'Selective versus routine iron in pregnancy', the outcome is 'Caesarean section'.",Q198,empty,available
CD000118,Mardones 1988,STD-Mardones-1988 1.61 0.147 391 391,0.479798026838023,0.148510276741171,782,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1988.0,SGA birth,Isocaloric balanced protein supplementation in pregnancy,3.2307395647389,negative,negative,negative,negative.,negative,"negative.

sga",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9956682701235468,"negative
",neg,neg,negative.,neg,negative,neg,0.3912655485156834,0.8967325110562324, negative,"negative 
",neg,neg,0.9923646224384328,0.5540376760153335,negative. s,negative,neg,neg,negative,neg,0.3493514825748756,0.987064834372199,0.999447651013234,,"In a medical study on 'Isocaloric balanced protein supplementation in pregnancy', the outcome is 'SGA birth'.",Q199,empty,available
CD000120,Crawford 1972,STD-Crawford-1972 0.528 0.509 61 86,-0.690403694614195,0.555408723299523,147,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1972.0,low Apgar score (as defined by authors),Lateral tilt vs supine position for Caesarean,-1.24305518738112,negative,negative,negative,negative.,negative,"negative.

a low",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9969242595112252,"negative
",neg,neg,negative.,neg,negative.,neg,0.6621636805808279,0.9354733030061144, negative,"negative 
",neg,neg,0.9971957388782434,0.607262438587839,negative.,negative,neg,neg,negative,neg,0.4313520574371551,0.9782781541039846,0.9995139816437812,,"In a medical study on 'Lateral tilt vs supine position for Caesarean', the outcome is 'low Apgar score (as defined by authors)'.",Q200,empty,available
CD000121,Dahle 1995,STD-Dahle-1995 0.18 0.611 34 35,-2.06576143777575,0.815285460487115,69,Pregnancy & Childbirth,efficacy,DICH,1,5,no,1995.0,women with persisting leg cramps,Magnesium versus placebo,-2.53378913017964,negative,negative,negative,negative.,"positive, as it","negative.

leg cramps",neg,negative,neg,neg,neg,pos,neg,neg,neg,"negative
",negative,0.9949391544498948,"negative
",neg,neg,positive.,pos,negative,neg,0.4214567528460013,0.8156300313660287, neutral,"positive 
",neu,pos,0.8314011398573198,0.6514094096483221,positive.,positive,pos,pos,neutral,neu,0.3406180677185859,0.73566817599902,0.8857703103925286,,"In a medical study on 'Magnesium versus placebo', the outcome is 'women with persisting leg cramps'.",Q201,empty,available
CD000121,Hammar 1981,STD-Hammar-1981 0.051 0.611 21 21,-4.04305126783455,0.970319776071918,42,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1981.0,Women with persisting leg cramps,Calcium versus placebo or no treatment,-4.16672046425949,negative,negative,negative,negative.,"negative, as leg cr","negative.

leg cramps",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9986954586548203,"negative
",neg,neg,negative.,neg,negative,neg,0.4885574145086293,0.8925915070433494, negative,"negative 
",neg,neg,0.6698087236638469,0.6511802928405989,the outcome ',negative.,neg,neg,negative,neg,0.2674942629464301,0.7457438014058118,0.7960785047858743,,"In a medical study on 'Calcium versus placebo or no treatment', the outcome is 'Women with persisting leg cramps'.",Q202,empty,available
CD000121,Thauvin 1992,STD-Thauvin-1992 0.226 0.764 11 18,-1.72722094809048,0.914391114956347,29,Pregnancy & Childbirth,efficacy,DICH,1,4,no,1992.0,women with persisting leg cramps,Multivitamin and mineral supplements versus placebo,-1.8889301523593,negative,negative,negative,negative.,neutral,"negative.

leg cramps",neg,negative,neg,neg,neg,neu,neg,neg,neg,"negative
",negative,0.9775406346619252,"negative
",neg,neg,positive.,pos,negative,neg,0.4315244813695791,0.9015655911193432, negative,"negative 
",neg,neg,0.6112529072052209,0.5172255117546415,the outcome ',negative,neg,neg,neutral,neu,0.3095997758873116,0.6279066870094727,0.6359505415172663,,"In a medical study on 'Multivitamin and mineral supplements versus placebo', the outcome is 'women with persisting leg cramps'.",Q203,empty,available
CD000122,Braz 2006,STD-Braz-2006 1.002 0.157 95 93,0.0031868909285189,0.292559275734023,188,Neonatal,efficacy,DICH,1,1,yes,1997.0,"Acute ROP, all infants < 2001 g birth weight",Reduced light versus controls,0.0108931460830394,negative,negative,negative,negative.,"negative, since acute","negative.

acute r",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.997110053458395,"negative
",neg,neg,negative.,neg,negative,neg,0.5930417713149825,0.9501526570593384, negative,"negative 
",neg,neg,0.9956582573219414,0.6036858236112311,negative.,negative,neg,neg,negative,neg,0.2724206211860114,0.9639849902907176,0.9990826922849118,,"In a medical study on 'Reduced light versus controls', the outcome is 'Acute ROP, all infants < 2001 g birth weight'.",Q204,empty,available
CD000123,Castano 1999,STD-Castano-1999 0.187 1.57 31 31,-1.67503519491991,1.57023703205305,62,Heart & Hypertension,efficacy,DICH,1,1,no,1999.0,All-cause mortality,Any lipid-lowering regimen vs control: all trials,-1.06674034602906,negative,negative,negative,negative.,negative. a lower all,"negative.

all-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9481547724261624,"negative
",neg,neg,negative.,neg,negative.,neg,0.5099669888207438,0.6938438265755528, negative,"negative 
",neg,neg,0.7769481340429605,0.6676637309478661,positive,negative,pos,neg,negative,neg,0.2451151453464852,0.8273269502514793,0.9994927834293588,,"In a medical study on 'Any lipid-lowering regimen vs control: all trials', the outcome is 'All-cause mortality'.",Q205,empty,available
CD000126,Forssell 1989,STD-Forssell-1989 1.973 0.836 56 55,0.71219537553064,0.887749229095171,111,Neurology,efficacy,DICH,1,1,yes,1989.0,Any stroke within 30 days of operation,Local versus general anaesthetic: randomised trials,0.802248373965401,negative,negative,negative,negative.,negative,"negative.

a stroke",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9987356485666372,"negative
",neg,neg,negative.,neg,negative.,neg,0.5922041905277746,0.9357740502511672, negative,"negative 
",neg,neg,0.9902845111396802,0.5890011082436285,positive.,negative,pos,neg,negative,neg,0.3987316857391955,0.7727762874071673,0.9987738878845434,,"In a medical study on 'Local versus general anaesthetic: randomised trials', the outcome is 'Any stroke within 30 days of operation'.",Q206,empty,available
CD000127,Bangladesh 1998,STD-Bangladesh-1998 0.429 0.675 100 100,-0.889409345737331,0.70516128843906,200,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1998.0,Maternal death,Magnesium sulphate versus diazepam,-1.26128498588759,negative,negative,negative,negative.,negative,"negative.

maternal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9972846882458376,"negative
",neg,neg,negative.,neg,negative,neg,0.7605127025546636,0.8051368450149878, negative,"negative 
",neg,neg,0.9769139852143964,0.5859563637098578,negative.,negative,neg,neg,negative,neg,0.4973373030262357,0.9050609406249488,0.9996691844880348,,"In a medical study on 'Magnesium sulphate versus diazepam', the outcome is 'Maternal death'.",Q207,empty,available
CD000128,Brazil 2003,STD-Brazil-2003 0.254 1.616 41 31,-1.4065790322914,1.65031813219595,72,Pregnancy & Childbirth,efficacy,DICH,1,4,no,2003.0,Pulmonary oedema,Magnesium sulphate vs phenytoin (subgroup by IV or IM magnesium maintenance),-0.852307809537164,negative,negative,negative,negative.,negative,"negative.

pulmonary",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.998812114395334,"negative
",neg,neg,negative.,neg,negative.,neg,0.6576102540021428,0.891145555480007, negative,"negative 
",neg,neg,0.9902815884566716,0.5213185780151596,the outcome ',negative,neg,neg,negative,neg,0.393421639469263,0.9384789280289316,0.9997976235963072,,"In a medical study on 'Magnesium sulphate vs phenytoin (subgroup by IV or IM magnesium maintenance)', the outcome is 'Pulmonary oedema'.",Q208,empty,available
CD000128,Collab Trial 1995,STD-Collab-Trial-1995 0.499 0.381 388 387,-0.722679528124963,0.394170392452084,775,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1995.0,Maternal death,Magnesium sulphate versus phenytoin,-1.8334191049441,negative,negative,negative,negative.,negative,"negative.

maternal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.994614591188899,"negative
",neg,neg,negative.,neg,negative,neg,0.7693395065921843,0.8077009883916798, negative,"negative 
",neg,neg,0.980785801058958,0.6683939462381219,negative.,negative,neg,neg,negative,neg,0.450235213320123,0.9032824507715944,0.9996283244068774,,"In a medical study on 'Magnesium sulphate versus phenytoin', the outcome is 'Maternal death'.",Q209,empty,available
CD000129,CS Burkina Faso 1988,STD-CS-Burkina-Faso-1988 1.77 0.478 35 35,0.583251509736728,0.486576517461481,70,Infectious Diseases,efficacy,DICH,1,2,no,1988.0,New malaria infection,CS-NANP vaccine versus placebo,1.19868404825537,negative,negative,negative,negative.,negative,"negative.

new malaria",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9985673029916744,"negative
",neg,neg,negative.,neg,negative,neg,0.6361387707022835,0.7482340269162002, negative,"negative 
",neg,neg,0.9283728409808478,0.6920817454313525,positive.,negative.,pos,neg,negative,neg,0.3376935842393531,0.7581153768234323,0.9991987216687592,,"In a medical study on 'CS-NANP vaccine versus placebo', the outcome is 'New malaria infection'.",Q210,empty,available
CD000129,MSP/RESA PNG 1998,STD-MSP_x002f_RESA-PNG-1998 2.506 0.512 30 30,0.952008814476234,0.531441020947149,60,Infectious Diseases,efficacy,DICH,1,4,no,1998.0,Clinical malaria episodes,MSP/RESA vaccine versus placebo,1.7913724702311,negative,negative,negative,negative.,"negative, because clinical","negative.

clinical malaria",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9985895313472398,"negative
",neg,neg,negative.,neg,negative,neg,0.559503717874055,0.7840397212543889, negative,"negative 
",neg,neg,0.5932776250045511,0.7434522974908474,positive.,negative.,pos,neg,negative,neg,0.4971998053145713,0.7631083940542108,0.9999326512895288,,"In a medical study on 'MSP/RESA vaccine versus placebo', the outcome is 'Clinical malaria episodes'.",Q211,empty,available
CD000129,"RTS,S Gambia 1998",STD-RTS_x002c_S-Gambia-1998 0.791 0.264 131 119,-0.236038839299943,0.265493323180398,250,Infectious Diseases,efficacy,DICH,1,3,no,1998.0,New malaria infection (P. falciparum),"RTS,S vaccine versus placebo",-0.889057534375577,negative,negative,negative,negative.,"negative, as new mal","negative.

new malaria",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.99867500827769,"negative
",neg,neg,negative.,neg,negative,neg,0.6375094407820355,0.7727700231289274, negative,"negative 
",neg,neg,0.8438976101035475,0.8648530954942828,positive.,negative.,pos,neg,negative,neg,0.4501531291432261,0.4887063875059544,0.9998175238758824,,"In a medical study on 'RTS,S vaccine versus placebo', the outcome is 'New malaria infection (P. falciparum)'.",Q212,empty,available
CD000129,SPf66 Brazil 1991,STD-SPf66-Brazil-1991 0.862 0.188 269 271,-0.14886143139567,0.188362129568222,540,Infectious Diseases,efficacy,DICH,1,1,no,1991.0,New malaria infection (P. falciparum),SPf66 vaccine versus placebo,-0.79029384376202,negative,negative,negative,negative.,"negative, as new mal","negative.

new malaria",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998391125037815,"negative
",neg,neg,negative.,neg,negative,neg,0.5963427462261824,0.7447471701500847, negative,"negative 
",neg,neg,0.8980308880782591,0.8661986360597326,positive.,negative.,pos,neg,negative,neg,0.4637782209752873,0.7883647745571788,0.9997990535283232,,"In a medical study on 'SPf66 vaccine versus placebo', the outcome is 'New malaria infection (P. falciparum)'.",Q213,empty,available
CD000132,Chandra 1986,STD-Chandra-1986 0.399 0.564 35 36,-0.970778917158225,0.603524998854583,71,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1986.0,Incidence of atopic eczema in first 12-18 months,Maternal antigen avoidance during lactation in women at high risk for atopic offspring,-1.60851484031423,negative,negative,negative,negative.,"negative, because at","negative.

a higher",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9953178024235771,"negative
",neg,neg,negative.,neg,negative,neg,0.4471913582185552,0.6633878658812766, negative,"negative 
",neg,neg,0.6075585731869582,0.7124948591508168,neutral. the,negative,neu,neg,negative,neg,0.3540079824655683,0.5003695651471265,0.9936196425630917,,"In a medical study on 'Maternal antigen avoidance during lactation in women at high risk for atopic offspring', the outcome is 'Incidence of atopic eczema in first 12-18 months'.",Q214,empty,available
CD000133,Falth-Magnusson 1987,STD-Falth_x002d_Magnusson-1987 1.31 0.263 76 95,0.361601062274788,0.353702735507693,171,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1987.0,Atopic eczema in first 12-18 months,Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring,1.02233040905312,negative,negative,negative,negative.,negative,"negative.

atopic",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9991573288069548,"negative
",neg,neg,negative.,neg,negative,neg,0.417951885755368,0.8888192895663666, negative,"negative 
",neg,neg,0.9706435168465742,0.5793258999406422,the outcome ',positive,neg,pos,negative,neg,0.2743978294379877,0.8942896781487192,0.9994325283456534,,"In a medical study on 'Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring', the outcome is 'Atopic eczema in first 12-18 months'.",Q215,empty,available
CD000133,Lovegrove 1994,STD-Lovegrove-1994 0.729 0.413 12 14,-0.624154309072994,0.796570028009973,26,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1994.0,Incidence of atopic eczema in first 18 months,Maternal antigen avoidance during lactation in women at high risk for atopic offspring,-0.783552339563018,negative,negative,negative,negative.,"negative, because at","negative.

a higher",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9858279662718472,"negative
",neg,neg,negative.,neg,negative,neg,0.4617510449796281,0.670573539352654, negative,"negative 
",neg,neg,0.6592309705444999,0.6498207813888217,neutral. the,positive,neu,pos,negative,neg,0.4486228151260885,0.4193958751158607,0.9904542850360746,,"In a medical study on 'Maternal antigen avoidance during lactation in women at high risk for atopic offspring', the outcome is 'Incidence of atopic eczema in first 18 months'.",Q216,empty,available
CD000135,New Guinea 1971,STD-New-Guinea-1971 0.73 0.147 498 534,-0.373548629625477,0.173389555153407,1032,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1991.0,Death during infancy and early childhood,Iodine supplementation versus no supplementation,-2.15438945728294,negative,negative,negative,negative.,negative,"negative.

death during",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9966231649753536,"negative
",neg,neg,negative.,neg,negative.,neg,0.8161760062688197,0.7862936929067035, negative,"negative 
",neg,neg,0.9723743074157322,0.5341192072050032,negative.,negative,neg,neg,negative,neg,0.3612910499107994,0.918204202088549,0.9997407870116448,,"In a medical study on 'Iodine supplementation versus no supplementation', the outcome is 'Death during infancy and early childhood'.",Q217,empty,available
CD000136,Thorp 1995,STD-Thorp-1995 1.073 1.397 41 44,0.0723206615796261,1.43117288052614,85,Pregnancy & Childbirth,efficacy,DICH,1,2,no,1995.0,Assisted vaginal delivery,Prophylactic maternal oxygen,0.0505324427004507,neutral,positive,positive,positive.,"neutral

","positive.

assisted vaginal",neg,negative,pos,pos,pos,neu,pos,neg,neu,"negative
",negative,0.9743793975300358,"negative
",neg,neg,positive.,pos,positive,pos,0.4647999367279875,0.35567329994884," neutral

","positive 
",neu,pos,0.6182862580110446,0.6295993541227604,positive. ass,positive,pos,pos,neutral,neu,0.3597612479441151,0.7134959380455668,0.9724675301228862,,"In a medical study on 'Prophylactic maternal oxygen', the outcome is 'Assisted vaginal delivery'.",Q218,empty,available
CD000137,Battaglia 1992,STD-Battaglia-1992 0.43 0.407 17 19,-1.64865862558738,0.72589467343622,36,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1992.0,Perinatal mortality,Maternal oxygen therapy versus no treatment,-2.27120915184982,negative,negative,negative,negative.,negative,"negative.

perinatal",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9942692756065412,"negative
",neg,neg,negative.,neg,negative.,neg,0.4287172689923976,0.8672185048283859, negative,"negative 
",neg,neg,0.957838412095449,0.5618403135242415,the outcome ',negative,neg,neg,negative,neg,0.3362481071925244,0.9744754262910172,0.9999283603516352,,"In a medical study on 'Maternal oxygen therapy versus no treatment', the outcome is 'Perinatal mortality'.",Q219,empty,available
CD000138,Ohrt 1997,STD-Ohrt-1997 0.04 0.35 68 69,-6.09630219882355,1.44703012737714,137,Infectious Diseases,efficacy,DICH,1,1,no,1997.0,Smear positive malarial illness,Mefloquine versus placebo or no drug,-4.212975309556,negative,negative,negative,negative.,"negative, because being","positive.

smear",neg,negative,neg,neg,neg,neg,pos,neg,neg,"negative
",negative,0.996776932968174,"negative
",neg,neg,negative.,neg,negative,neg,0.5733818580296649,0.4094321202926586, negative,"positive 
",neg,pos,0.932488107386736,0.7348118825038598,positive.,positive,pos,pos,negative,neg,0.5851605283560556,0.7568230637860199,0.9987740068314034,,"In a medical study on 'Mefloquine versus placebo or no drug', the outcome is 'Smear positive malarial illness'.",Q220,empty,available
CD000139,Barrington 1993,STD-Barrington-1993 1.5 0.796 10 10,0.538996500732687,1.04937623195424,20,Neonatal,efficacy,DICH,1,1,yes,1993.0,Failed extubation,Methylxanthine vs control - all preterm infants,0.513635133253324,negative,negative,negative,negative.,negative,"negative.

failed ext",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9995955868370572,"negative
",neg,neg,negative.,neg,negative,neg,0.8185585895925009,0.9511426164996456, negative,"negative 
",neg,neg,0.9465641852998472,0.6683504231284767,negative.,negative,neg,neg,negative,neg,0.5267586590399469,0.9855818000202016,0.9992008640322412,,"In a medical study on 'Methylxanthine vs control - all preterm infants', the outcome is 'Failed extubation'.",Q221,empty,available
CD000140,Erenberg 2000,STD-Erenberg-2000 0.576 0.269 45 37,-0.957448804367663,0.460988248609946,82,Neonatal,efficacy,DICH,1,1,no,2000.0,Failed apnoea reduction after 2 - 7 days,Any methylxanthine vs control,-2.07694839782735,negative,negative,negative,negative.,negative,"negative.

reduced ap",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9984267064259684,"negative
",neg,neg,negative.,neg,negative,neg,0.7493878019354719,0.9221800457611482, negative,"negative 
",neg,neg,0.9978166908567728,0.5309516286106327,negative. the,negative,neg,neg,negative,neg,0.6735785091219489,0.9771095928799848,0.9986534394256176,,"In a medical study on 'Any methylxanthine vs control', the outcome is 'Failed apnoea reduction after 2 - 7 days'.",Q222,empty,available
CD000141,Corbet 1995,STD-Corbet-1995 0.816 0.182 416 410,-0.233693762209362,0.208885167110868,826,Neonatal,efficacy,DICH,1,1,no,1995.0,Pneumothorax,Multiple vs single dose surfactant for severe RDS,-1.1187666670718,negative,negative,negative,negative.,negative,"negative.

pne",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9994207566662312,"negative
",neg,neg,negative.,neg,negative,neg,0.7378750133479675,0.9084687668692754, negative,"negative 
",neg,neg,0.981983063389093,0.68372112641262,the outcome ',negative,neg,neg,negative,neg,0.2915385120324725,0.9366454612463088,0.9997895207110944,,"In a medical study on 'Multiple vs single dose surfactant for severe RDS', the outcome is 'Pneumothorax'.",Q223,empty,available
CD000143,Annibale 1994,STD-Annibale-1994 0.926 0.277 40 42,-0.125163142954006,0.45331026469564,82,Neonatal,efficacy,DICH,1,1,yes,1994.0,Failure,Nasal CPAP vs Headbox,-0.276109218568087,negative,negative,negative,negative.,negative,"negative.

failure of",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9998644850129856,"negative
",neg,neg,negative.,neg,negative,neg,0.7566803937678815,0.924511928174115, negative,"negative 
",neg,neg,0.9808630965515158,0.5923333251295795,the outcome ',negative,neg,neg,negative,neg,0.4241486647332189,0.973558452842867,0.9997803455340089,,"In a medical study on 'Nasal CPAP vs Headbox', the outcome is 'Failure'.",Q224,empty,available
CD000144,Ainsworth 2000,STD-Ainsworth-2000 0.456 0.289 99 100,-1.00347462676294,0.360477593548117,199,Neonatal,efficacy,DICH,1,1,no,2000.0,Mortality,Animal derived surfactant extract versus protein free synthetic surfactant,-2.78373647828127,negative,negative,negative,negative.,negative,"negative.

mortality is",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9982724927613152,"negative
",neg,neg,negative.,neg,negative.,neg,0.63628520337485,0.8208306011372226, negative,"negative 
",neg,neg,0.9867348594287672,0.7990081174537574,the outcome ',negative,neg,neg,negative,neg,0.5587457083418516,0.9903333799725836,0.9997710513900582,,"In a medical study on 'Animal derived surfactant extract versus protein free synthetic surfactant', the outcome is 'Mortality'.",Q225,empty,available
CD000145,Carlsson 2000,STD-Carlsson-2000 0.233 0.759 17 16,-1.45528723260684,0.75907211527659,33,Pregnancy & Childbirth,efficacy,DICH,1,14,no,2000.0,Effect on persistent vomiting,Acupuncture or acupressure for hyperemesis gravidarum,-1.91719232378411,positive,negative,negative,negative,positive,"negative.

persistent vomiting",neg,negative,neg,neg,neg,pos,neg,neg,pos,"negative
",negative,0.9990506780614548,"negative
",neg,neg,positive.,pos,negative,neg,0.5506342651255229,0.3370352326256604, neutral,"positive 
",neu,pos,0.4617928260354136,0.8714834792996671,positive.,positive,pos,pos,negative,neg,0.4300119223907906,0.8431290585861139,0.9519406928113456,,"In a medical study on 'Acupuncture or acupressure for hyperemesis gravidarum', the outcome is 'Effect on persistent vomiting'.",Q226,empty,available
CD000145,Cartwright 1951,STD-Cartwright-1951 0.626 0.46 39 38,-0.468266009347195,0.459928055705586,77,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1951.0,Effect on nausea,All antiemetic medication compared with placebo,-1.0181288215367,neutral,neutral,negative,negative,this would be considered a positive,"negative.

nausea",neg,negative,neu,neg,neg,pos,neg,neg,neu,"negative
",negative,0.997912397878712,"positive
",neg,pos,positive.,pos,negative,neg,0.4209246039112816,0.3987114136343475, positive,"positive 
",pos,pos,0.5604463540797012,0.8612113929734468,positive. the,positive,pos,pos,neutral,neu,0.3676004998595825,0.799866666433772,0.8007643562454247,,"In a medical study on 'All antiemetic medication compared with placebo', the outcome is 'Effect on nausea'.",Q227,empty,available
CD000145,De Aloysio 1992,STD-De-Aloysio-1992 0.178 0.596 26 28,-1.72722094809048,0.596284793999944,54,Pregnancy & Childbirth,efficacy,DICH,1,7,no,1988.0,Effect on morning sickness,"Acupuncture or acupressure, compared with sham or dummy acupuncture or acupressure",-2.89663758906897,neutral,positive,negative,negative,positive,"positive.

morning sickness",neg,negative,pos,neg,neg,pos,pos,neg,neu,"negative
",negative,0.9955689875317716,"positive
",neg,pos,positive.,pos,positive,pos,0.5014446933924943,0.5722259886503673, positive,"positive 
",pos,pos,0.4900788969562375,0.8765774778392116,positive.,positive,pos,pos,neutral,neu,0.4137612109863248,0.4460666413025274,0.9948325352534546,,"In a medical study on 'Acupuncture or acupressure, compared with sham or dummy acupuncture or acupressure', the outcome is 'Effect on morning sickness'.",Q228,empty,available
CD000145,Ditto 1999,STD-Ditto-1999 0.638 0.96 25 25,-0.449916870678998,0.960346885066768,50,Pregnancy & Childbirth,efficacy,DICH,1,11,no,1999.0,Effect on persistence of vomiting,Diazepam versus placebo for hyperemesis gravidarum,-0.468494121941904,negative,neutral,negative,negative.,"neutral

the","negative.

persistence of",neg,negative,neu,neg,neg,neu,neg,neg,neg,"negative
",negative,0.9953887967939244,"negative
",neg,neg,positive.,pos,negative,neg,0.4672384103019343,0.4778826170439225, neutral,"positive 
",neu,pos,0.9683865725897156,0.8919710745443765,the outcome ',positive,neg,pos,negative,neg,0.340852356962683,0.5832912887996509,0.9556831235559076,,"In a medical study on 'Diazepam versus placebo for hyperemesis gravidarum', the outcome is 'Effect on persistence of vomiting'.",Q229,empty,available
CD000145,Nelson-Piercy 2001,STD-Nelson_x002d_Piercy-2001 1.96 0.828 12 12,0.672944473242426,0.828078671210825,24,Pregnancy & Childbirth,efficacy,DICH,1,9,no,2001.0,Effect on persistent vomiting within 4 days of treatment,Adrenocorticotropic hormone or steroids versus placebo for hyperemesis gravidarum,0.812657657585166,neutral,neutral,negative,negative,"positive, since reducing persistent","positive.

the reduction",neg,negative,neu,neg,neg,pos,pos,neg,neu,"negative
",negative,0.9951714783720266,"negative
",neg,neg,positive.,pos,negative,neg,0.492329760956967,0.3942043256889999," positive
","positive 
",pos,pos,0.5350941178401825,0.92818012801918,positive.,positive,pos,pos,negative,neg,0.345284666236306,0.8586716476203953,0.995799852694335,,"In a medical study on 'Adrenocorticotropic hormone or steroids versus placebo for hyperemesis gravidarum', the outcome is 'Effect on persistent vomiting within 4 days of treatment'.",Q230,empty,available
CD000145,Safari 1998,STD-Safari-1998 1.588 0.974 20 20,0.462623521948113,0.973505222533836,40,Pregnancy & Childbirth,efficacy,DICH,1,12,no,1998.0,Effect on persistence of vomiting,Methylprednisolone versus promethazine for hyperemesis gravidarum,0.475214216872918,negative,neutral,negative,negative.,"neutral

the","negative.

persistence of",neg,negative,neu,neg,neg,neu,neg,neg,neg,"negative
",negative,0.9991947049642304,"negative
",neg,neg,positive.,pos,neutral,neu,0.4998226172945668,0.4585045075519876, neutral,"positive 
",neu,pos,0.9944177708650906,0.9052347842883334,the outcome ',negative,neg,neg,negative,neg,0.4303447633573888,0.4009464124154937,0.7651384837907648,,"In a medical study on 'Methylprednisolone versus promethazine for hyperemesis gravidarum', the outcome is 'Effect on persistence of vomiting'.",Q231,empty,available
CD000145,Sahakian 1991,STD-Sahakian-1991 0.301 0.559 31 28,-1.19915351788999,0.558630472190077,59,Pregnancy & Childbirth,efficacy,DICH,1,5,no,1991.0,Effect on vomiting,Vitamin B6 compared with placebo,-2.14659524960888,neutral,negative,negative,negative.,"positive, if reduction in","negative.

vomiting",neg,negative,neg,neg,neg,pos,neg,neg,neu,"negative
",negative,0.9989755547027402,"negative
",neg,neg,negative.,neg,neutral,neu,0.3667325916148073,0.5094189324492975, neutral,"negative 
",neu,neg,0.3670389198737927,0.4706618518953441,the outcome ',positive,neg,pos,neutral,neu,0.3677329958072621,0.7468265836129002,0.8191768811649538,,"In a medical study on 'Vitamin B6 compared with placebo', the outcome is 'Effect on vomiting'.",Q232,empty,available
CD000145,Sullivan 1996,STD-Sullivan-1996 0.286 1.22 15 15,-1.25276296849537,1.21987509118567,30,Pregnancy & Childbirth,efficacy,DICH,1,13,no,1996.0,Effect on persistence of vomiting,Ondansetron versus promethazine for hyperemesis gravidarum,-1.02696003676715,neutral,neutral,negative,negative.,"positive, as it","negative.

persistence of",neg,negative,neu,neg,neg,pos,neg,neg,neu,"negative
",negative,0.9960036233525392,"negative
",neg,neg,positive.,pos,negative,neg,0.4988701899031052,0.4485743648561347, neutral,"positive 
",neu,pos,0.9859382351916658,0.9025881233914416,the outcome ',positive,neg,pos,negative,neg,0.3629684737450496,0.7021366716855482,0.8601751706153552,,"In a medical study on 'Ondansetron versus promethazine for hyperemesis gravidarum', the outcome is 'Effect on persistence of vomiting'.",Q233,empty,available
CD000145,Vutyavanich 2001,STD-Vutyavanich-2001 0.313 0.51 32 35,-1.16141318990714,0.510044044702251,67,Pregnancy & Childbirth,efficacy,DICH,1,6,no,2001.0,Effect on vomiting,Ginger compared with placebo,-2.2770841106186,neutral,negative,negative,negative.,positive,"negative.

vomiting",neg,negative,neg,neg,neg,pos,neg,neg,neu,"negative
",negative,0.9985425794703194,"negative
",neg,neg,positive.,pos,positive,pos,0.3828068869994688,0.343068817184288," positive
","positive 
",pos,pos,0.5757482706250567,0.7532850460129672,positive.,positive,pos,pos,neutral,neu,0.3949184401834646,0.9003262561880565,0.935626679480802,,"In a medical study on 'Ginger compared with placebo', the outcome is 'Effect on vomiting'.",Q234,empty,available
CD000146,Abelin 1989,STD-Abelin-1989 1.53 0.36 100 99,0.493814277939454,0.416106295861498,199,Psychiatry & Mental Health,efficacy,DICH,1,1,no,1989.0,Smoking cessation at 6+ months follow up,Any type of NRT versus placebo/no NRT control,1.18675031560643,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9915538662100156,"positive
",pos,pos,positive.,pos,positive,pos,0.4356690096556701,0.7066855218543613, positive,"positive 
",pos,pos,0.99509156974545,0.8286577070552297,positive.,positive,pos,pos,positive,pos,0.52504455747593,0.5260060083229682,0.9981674222057504,,"In a medical study on 'Any type of NRT versus placebo/no NRT control', the outcome is 'Smoking cessation at 6+ months follow up'.",Q235,empty,available
CD000146,Berlin 2014,STD-Berlin-2014 1.078 0.425 203 199,0.0795618228361859,0.448785505039356,402,Psychiatry & Mental Health,efficacy,DICH,1,5,no,2014.0,Smoking cessation,NRT in pregnancy,0.177282514570538,positive,positive,positive,positive,positive,"positive.

smoking cessation",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.997565392276413,"positive
",pos,pos,positive.,pos,positive,pos,0.570555773505805,0.7659442150813712, positive,"positive 
",pos,pos,0.9830807054690271,0.8554748073034942,positive. s,positive,pos,pos,positive,pos,0.5505765043220484,0.8826295128771554,0.9973362304609183,,"In a medical study on 'NRT in pregnancy', the outcome is 'Smoking cessation'.",Q236,empty,available
CD000146,Bolliger 2000b,STD-Bolliger-2000b 0.497 1.229 200 200,-0.698184974589902,1.22885134604583,400,Psychiatry & Mental Health,efficacy,DICH,1,6,no,2000.0,Palpitations/chest pains,Palpitations in NRT vs placebo users,-0.568160645985787,negative,negative,negative,negative.,negative,"negative.

palpit",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9990150557763005,"negative
",neg,neg,negative.,neg,negative,neg,0.4332936295393623,0.8269838308770798, negative,"negative 
",neg,neg,0.955304379416378,0.5430553848902734,positive.,negative,pos,neg,negative,neg,0.2972874244470682,0.7134712936853014,0.9997628297719524,,"In a medical study on 'Palpitations in NRT vs placebo users', the outcome is 'Palpitations/chest pains'.",Q237,empty,available
CD000148,Herre 1976,STD-Herre-1976 0.536 0.514 16 15,-0.965080896043587,0.775364737520656,31,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1976.0,Low weight for gestational age (< 5th centile),Calf blood extract versus placebo,-1.24467988978913,negative,negative,negative,negative.,negative,"negative.

low weight",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9990890052379156,"negative
",neg,neg,negative.,neg,negative,neg,0.6182132202089748,0.9467606482305352, negative,"negative 
",neg,neg,0.9850306850366152,0.5345793397727112,negative.,negative,neg,neg,negative,neg,0.4180346511935274,0.9857394243015424,0.999297397584294,,"In a medical study on 'Calf blood extract versus placebo', the outcome is 'Low weight for gestational age (< 5th centile)'.",Q238,empty,available
CD000148,Viehweg 1987,STD-Viehweg-1987 1.111 0.279 15 15,0.287682072451781,0.760116950066092,30,Pregnancy & Childbirth,efficacy,DICH,1,3,no,1987.0,Small-for-gestational age (birthweight < 10th centile),Glucose versus bed rest,0.37847080298205,negative,negative,negative,negative.,negative,"negative.

small-",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997131503492304,"negative
",neg,neg,negative.,neg,negative.,neg,0.589768876101086,0.9688089899743324, negative,"negative 
",neg,neg,0.9859089175725098,0.5769717784206799,positive.,negative,pos,neg,negative,neg,0.3332021428537938,0.9802314449003592,0.999112440845014,,"In a medical study on 'Glucose versus bed rest', the outcome is 'Small-for-gestational age (birthweight < 10th centile)'.",Q239,empty,available
CD000149,Kafatos 1989,STD-Kafatos-1989 1.007 0.37 265 250,0.0066711388170221,0.370726381678767,515,Pregnancy & Childbirth,efficacy,DICH,1,1,no,1989.0,Small for gestational age,Nutritional advice during pregnancy,0.0179947776762288,negative,negative,negative,negative.,negative,"negative.

small for",neg,negative,neg,neg,neg,neg,neg,neg,neg,"negative
",negative,0.9997387536307772,"negative
",neg,neg,negative.,neg,negative.,neg,0.4404426310338168,0.9415392312450204, negative,"negative 
",neg,neg,0.9723204333014436,0.6326589704015751,positive.,negative,pos,neg,negative,neg,0.3660487819854268,0.9671906536140262,0.9995385154874428,,"In a medical study on 'Nutritional advice during pregnancy', the outcome is 'Small for gestational age'.",Q240,empty,available
CD000150,Aafjes 1983,STD-Aafjes-1983 2.513 0.857 27 32,0.958850346292951,0.909291809158588,59,Gynaecology & Urology,efficacy,DICH,1,1,no,1983.0,pregnancy rate (per patient),Androgens with stimulatory effect versus no treatment/placebo,1.05450234637022,positive,positive,positive,positive,positive,"positive.

pregnancy rate",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9950172905871582,"positive
",pos,pos,negative.,neg,positive.,pos,0.4456482417871044,0.4566251285606034, positive,"positive 
",pos,pos,0.7960263115227814,0.937509588077088,the outcome ',positive,neg,pos,neutral,neu,0.3149421895217011,0.992668535868676,0.9239776172490562,,"In a medical study on 'Androgens with stimulatory effect versus no treatment/placebo', the outcome is 'pregnancy rate (per patient)'.",Q241,empty,available
CD000151,Ainmelk 1987,STD-Ainmelk-1987 7.898 1.438 16 16,1.73864964391411,1.59046269300711,32,Gynaecology & Urology,efficacy,DICH,1,1,no,1987.0,pregnancy,Anti-oestrogens versus placebo/no treatment,1.09317222689884,positive,negative,positive,positive,positive (note: in,"negative.

pregnancy is",pos,negative,neg,pos,pos,pos,neg,neg,pos,"positive
",positive,0.9904299977407924,"positive
",pos,pos,negative.,neg,negative.,neg,0.5106837528572563,0.7842121126948467, neutral,"positive 
",neu,pos,0.5713302475926673,0.8168281604439122,positive.,positive,pos,pos,neutral,neu,0.4065469391019998,0.9745714317608004,0.8101939513441268,,"In a medical study on 'Anti-oestrogens versus placebo/no treatment', the outcome is 'pregnancy'.",Q242,empty,available
CD000152,Hovatta 1979,STD-Hovatta-1979 0.441 1.189 20 18,-0.864997437486604,1.27087827070391,38,Gynaecology & Urology,efficacy,DICH,1,1,no,1979.0,pregnancy rate (per patient),Bromocriptine versus placebo/no treatment,-0.680629653859374,positive,positive,positive,positive,positive,"positive.

pregnancy rate",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9968013253949528,"positive
",pos,pos,negative.,neg,neutral,neu,0.4614743065652295,0.4647988562640736, positive,"positive 
",pos,pos,0.4617621091600006,0.9337564088007988,positive.,positive,pos,pos,neutral,neu,0.3764713041106674,0.9829519176791456,0.977216931953292,,"In a medical study on 'Bromocriptine versus placebo/no treatment', the outcome is 'pregnancy rate (per patient)'.",Q243,empty,available
CD000153,Izzo 1984,STD-Izzo-1984 7.426 1.441 15 14,1.68089687641625,1.59469106453741,29,Gynaecology & Urology,efficacy,DICH,1,1,no,1984.0,Pregnancy rate (per patient),Kinin enhancing drugs versus placebo/no treatment,1.05405800144986,positive,positive,positive,positive,positive,"positive.

a higher",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9971467988374484,"positive
",pos,pos,negative.,neg,neutral,neu,0.4806014026229776,0.5148822485400886, positive,"positive 
",pos,pos,0.6231219063526738,0.944239537632361,positive.,positive,pos,pos,neutral,neu,0.384318849047723,0.9750627305902054,0.9466547678106976,,"In a medical study on 'Kinin enhancing drugs versus placebo/no treatment', the outcome is 'Pregnancy rate (per patient)'.",Q244,empty,available
CD000154,Agarwal 2016,STD-Agarwal-2016 0.37 0.588 25 25,-0.994933859193268,0.588354647937302,50,Gynaecology & Urology,efficacy,DICH,1,4,yes,2016.0,Response to treatment,COCP versus CVR,-1.6910444451852,positive,positive,positive,positive.,the term 'response to treatment,"positive.

response to",pos,negative,pos,pos,pos,neg,pos,neg,pos,"positive
",positive,0.7177465619720709,"positive
",pos,pos,positive.,pos,positive,pos,0.5050834787106687,0.7413673652455126," positive
","positive 
",pos,pos,0.9027022505565396,0.9261496641263696,the outcome ',positive,neg,pos,neutral,neu,0.4185670634424538,0.5438360292646722,0.844207843403335,,"In a medical study on 'COCP versus CVR', the outcome is 'Response to treatment'.",Q245,empty,available
CD000154,Endrikat 2009,STD-Endrikat-2009 0.146 0.734 19 20,-1.92529086185258,0.73395536389516,39,Gynaecology & Urology,efficacy,DICH,1,3,yes,2009.0,Treatment success (PBAC < 100 at end of treatment or no requirement for alternative treatment ),COCP versus LNG IUS,-2.6231715940257,positive,positive,positive,positive,positive,"positive.

treatment success",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9990887672249702,"positive
",pos,pos,positive.,pos,positive,pos,0.5983223866480243,0.632115773374372, positive,"positive 
",pos,pos,0.9908741767058404,0.9121174225221138,positive.,positive,pos,pos,positive,pos,0.4977966352939411,0.8538766479041732,0.9884965396405592,,"In a medical study on 'COCP versus LNG IUS', the outcome is 'Treatment success (PBAC < 100 at end of treatment or no requirement for alternative treatment )'.",Q246,empty,available
CD000154,Fraser 2011,STD-Fraser-2011 59.211 1.021 136 76,4.08109933547208,1.0213510144592,212,Gynaecology & Urology,efficacy,DICH,1,1,yes,2011.0,Response to treatment,COCP vs placebo,3.99578526647177,positive,positive,positive,positive.,positive,"positive.

response to",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9714440433715116,"positive
",pos,pos,positive.,pos,positive,pos,0.5030051405734183,0.7608114411729832," positive
","positive 
",pos,pos,0.6844200501773969,0.9040219809289028,the outcome ',positive,neg,pos,neutral,neu,0.3580663321182979,0.5109691384749115,0.5877355211787392,,"In a medical study on 'COCP vs placebo', the outcome is 'Response to treatment'.",Q247,empty,available
CD000155,Bayer 1988,STD-Bayer-1988 0.611 0.473 37 36,-0.501878837776184,0.479629911440974,73,Gynaecology & Urology,efficacy,DICH,1,1,no,1988.0,Clinical pregnancy,Ovulation suppression versus placebo,-1.04638769560549,positive,positive,positive,positive,"negative, because the","positive.

clinical pregnancy",pos,negative,pos,pos,pos,neg,pos,neg,pos,"positive
",positive,0.9980848465512092,"positive
",pos,pos,positive.,pos,positive,pos,0.3936503175852691,0.6023928125968212, positive,"positive 
",pos,pos,0.8164661086417991,0.8196009901775149,positive.,positive,pos,pos,positive,pos,0.4842694804090323,0.5037676663471401,0.9955504920057944,,"In a medical study on 'Ovulation suppression versus placebo', the outcome is 'Clinical pregnancy'.",Q248,empty,available
CD000155,Burry 1989,STD-Burry-1989 4.359 0.657 30 14,1.79175946922805,0.84656167328002,44,Gynaecology & Urology,efficacy,DICH,1,3,no,1989.0,Clinical Pregnancy,GnRHa versus danazol,2.11651380611864,positive,positive,positive,positive,positive,"positive.

clinical pregnancy",pos,negative,pos,pos,pos,pos,pos,neg,pos,"positive
",positive,0.9987745339974808,"positive
",pos,pos,positive.,pos,positive,pos,0.3658538227822225,0.6990481091520577, positive,"positive 
",pos,pos,0.9914198992527372,0.9216810326339372,positive. c,positive,pos,pos,positive,pos,0.4573373529883637,0.7889716750473346,0.9968570618715378,,"In a medical study on 'GnRHa versus danazol', the outcome is 'Clinical Pregnancy'.",Q249,empty,available
